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There are a number of levels of biological organization and each level offers unique  
problems and insights, and each level finds its explanation of mechanism in the levels 
below, and its significance in the levels above.  
                                                                                       George A. Bartholomew, 1964 
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Summary  
 
 
 
 
The majority of microbial cells on Earth live in intimate relationship with other microbial 
cells to form multicellular communities, also called biofilms. Most biofilms can be regarded 
as beneficial, however, occasionally they can be harmful such as in cases where they are the 
cause of persistent infections. One challenge is to unravel processes involved in the 
development of biofilms, and learn about interactions taking place between the participating 
biofilm cells, and interactions taking place between the biofilm cells and their environment. 
Consolidated knowledge derived from research work addressing these issues will enhance 
the understanding of the microbial biofilm mode of living, and reveal new paths that might 
help to develop strategies to prevent and treat persistent infections.  
The objective of this experimental thesis work was to address the differentiation of a 
biofilm to gain insight into mechanisms involved in biofilm development, structural 
composition, and to learn about interactions between biofilm cells and between biofilm 
cells and their environment. As model-system was used flow-chamber-grown mushroom-
shaped P. aeruginosa biofilms. In a first study, the role of excreted biosurfactants on 
differentiation of the mushroom-shaped biofilm was investigated. It was found that the 
biosurfactants impact on i) differentiation of the stalk-forming cell subpopulation, 
potentially by facilitating cellular aggregation, and ii) differentiation of the cap-forming cell 
subpopulation, potentially by facilitating cellular migration. Further experiments showed 
that flagella are required for differentiation of the cap-forming subpopulation, as a flagella 
mutant is impaired in colonization on top of the stalk-forming subpopulation. Additionally, 
the chemotaxis cluster IV was found to be involved in modulating the shape of the cap-
forming subpopulation, as the cap formed by various cluster IV-mutants are differentially 
shaped compared to the cap formed by the wild type. 
A previous study had shown that exposure of P. aeruginosa biofilms to the antimicrobial 
peptide colistin preferentially induced cell death in the cells of the stalk-forming 
subpopulation, whereas the cap-forming subpopulation survived the treatment under 
involvement of the pmr-operon. In the context of this thesis work it was addressed in more 
detail, why this particular subpopulation was able to develop colistin-tolerance, in contrast 
to the stalk-forming subpopulation. The results provide evidence that the cap-forming 
subpopulation is composed of metabolic/physiological active cells, which are able to adapt 
to colistin by developing tolerance via a mechanism involving the pmr-operon and mexAB-
oprM-genes. In contrast, the stalk-forming subpopulation, exhibiting low metabolic activity, 
is not able to induce tolerance and is therefore killed by colistin. Other membrane-targeting 
compounds, such as the antimicrobial peptide novispirin G10 or the antiseptic chlorhexidine 
gluconate, were found to induce cell death specifically in the cells of the stalk-forming 
subpopulation as well. Furthermore, evidence was provided that the metabolic active cells 
of the cap-forming subpopulation are susceptible to conventional antimicrobial compounds, 
such as ciprofloxacin, tetracycline and imipinem. Intriguingly, systematic combined 
antimicrobial treatments, simultaneously targeting the two distinct physiological 
subpopulations (cap & stalk), were found to eradicate almost all cells in the biofilm. 
Together, the results obtained from this thesis work reveal different factors that impact on 
biofilm development and differentiation of distinct subpopulations in this P. aeruginosa 
model system. Moreover, the data provide evidence that upon adverse changes in 
environmental conditions a particular subpopulation of cells can obviously sense and adapt 
to these conditions. Finally, knowledge about the physiology of the biofilm cells revealed a 
strategy to almost entirely eradicate the biofilm. These findings might have implications for 
the development of systematic treatment strategies in medical settings. 
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1 Introduction 
 
 
 
 
This chapter aims at introducing the basic aspects and methodology underlying the 
objective of this thesis. At first, the role of microorganisms from the human perspective will 
be presented in a historical context. Thereafter the microbial biofilm mode of living and 
planktonic mode of living in nature will be depicted. At last, tools used to cultivate and 
study biofilms under laboratory conditions will be introduced. 
 
1.1 Microorganisms – in historical context 
Bacteria were the first life-forms on Earth and presumably will also be the last ones. They 
populate terrestrial and aquatic environments as well as the air and have established 
intimate relationships with animals and plants. Every process in the biosphere appears to be 
dependent on microorganisms. They convert key elements of life, such as carbon, nitrogen, 
oxygen and sulfur, into forms accessible to all other living matter (Madsen, 2005; Whitman 
et al., 1998). It is assumed, that bacteria inhabit this planet for approximately 3.0 billion 
years (Cavalier-Smith et al, 2006), and consequently animals and plants have evolved in the 
presence of bacteria. The field of studies of microorganisms is a relatively young area, 
compared to zoology and botany, simply due to the small size of the objects to be studied 
and hence usually invisible for the naked eye. Microorganisms remained unseen, until 
Robert Hooke (1635-1703) looked through his compound microscope at some hairy fungi 
arising from putrefaction of vegetables, cheese, leaves and leather (e.g. Fig. 1a). Antonie 
van Leeuwenhoek (1632-1723) was the first who observed and recorded bacterial cells 
using his relatively simple microscope (Fig. 1b), which allowed a higher magnification 
compared to the microscope used by Hooke. 
 
           
            
 
Fig. 1. The first microscopic observations of microorganisms. a) Robert Hooke was the first who 
published detailed ‘descriptions of minute bodies made by magnifying glasses’ in Micrographia (1664, 
Royal Society). A drawing of the handcrafted microscope he used to make observations for Micrographia 
is depicted to the left. To the right: A drawing made by Hooke from hairy fungi, which he observed on 
the leather-cover of a small book (Source: Micrographia/Project Gutenberg). b) Antonie van 
Leeuwenhoek was the first who published observations of bacteria. The handcrafted microscope, he made 
these observations with, is depicted to the left. To the right: A drawing made by Leeuwenhoek of bacteria 
(rods, motile rods, cocci, and spirilla), which he observed in a sample of tooth plaque. (Source: Dunn and 
Jones, 2004). Images are not shown to scale. 
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The discovery of microorganisms in relation to infectious diseases 
Already ancient people recognized that some diseases were ‘communicable’ and that 
frequently those who recover from a particular disease were not attacked again. However, it 
was not until the 19th century, that Louis Pasteur (1822-1895) and Robert Koch (1843-
1910) set the foundation for the field of microbiology through groundbreaking research 
work on the germ theory of disease. Pasteur disproved the theory of spontaneous generation 
of life through experiments involving unique designed swan-necked flasks. And as he was 
working on fermentation, he discovered that chemical changes can be caused by living 
organisms. Moreover, he developed vaccination against chicken cholera, anthrax, and 
rabies. Koch invented methods to purify and grow pure cultures of bacteria (including agar 
plates and the Petri dish) and generally improved bacterial methodology. He formulated 
four criteria, the Koch’s postulates, designed as a standard proof to verify a causal 
relationship between a causative microorganism and a disease. Applying these criteria, he 
identified the etiologic agents of tuberculosis (Mycobacterium tuberculosis), cholera (Vibrio 
cholera), and anthrax (Bacillus anthracis) (Beck, 2000; Lederberg, 2000). Since then, 
increasing numbers of researchers systematically applied scientific analysis to learn about 
the nature of microorganisms. 
 
The discovery of antimicrobial compounds produced by microorganisms 
A major breakthrough in the field of modern medicine occurred with the discovery that 
microorganisms can produce molecules, which can kill other microorganisms. It was 
fortuity that Alexander Fleming (1881-1955) observed that a compound released by a 
colony of Penicillium notatum situated on an agar plate was able to inhibit growth of 
Staphylococci situated in close proximity (Fig. 2) (Fleming, 1929). Howard W. Florey 
(1898-1968) and Ernst B. Chain (1906-1979) were able to isolate the active compound 
penicillin and detected its excellent pharmacological and chemotherapeutic properties 
(Chain et al., 1940). At the same time, they already report on “An enzyme from bacteria 
able to destroy penicillin” (Abraham and Chain, 1940). Nevertheless, since its discovery, 
penicillin has saved the lives of millions of people suffering from a great range of infectious 
diseases. Interestingly, already in 1946 Fleming noted that, "the administration of too small 
doses leads to the production of resistant strains of bacteria” (Amyes et al., 2001). It was 
also Fleming, some years prior to the discovery of penicillin, who discovered the 
bacteriolytic activities of lysozyme he found in human tissues and secretions (Fleming, 
1922).  
 
Pioneering research work on a variety of natural product antibiotics was performed by 
Selman A. Waksman (1888-1973) and Rene J. Dubos (1901-1982), which led to the 
discovery of antibiotics, such as streptomycin, effective against various human pathogens 
e.g. Mycobacterium tuberculosis (Beck, 2000). Among the first described peptide 
antibiotics were gramicidin, tyrocidin, subtilin, bacitracin, and polymyxin, produced by 
bacterial species such as Bacillus brevis, Bacillus subtilis, and Paenibacillus polymyxa 
(Ainsworth et al., 1947; Benedict and Langlykke, 1947; Hotchkiss and Dubos, 1940; Katz 
and Demain, 1977; Stansly et al., 1947). Altogether, the discovery and subsequent 
increasing application of antimicrobial agents certainly affects human ecology, but also 
causes evolutionary changes in other living organisms on Earth (e.g. Palumbi, 2001). It can 
be assumed that microorganisms in nature produce an astonishing diversity of small 
compounds exhibiting biological activity, and that they also must constantly be exposed to 
and sense and respond to these compounds. However, remarkably little is known about the 
natural role of these small chemical products. Observations suggest that these molecules 
have various functions, such as that they serve inter- and intra-species signaling and 
communication or as chemical weapons (Firn and Jones, 2000; Yim et al., 2006). 
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Fig. 2. The discovery of penicillin. Alexander Fleming noticed that when he left a culture plate with 
colonies of Staphylococcus on a bench for an extended period, a colony of a contaminating mould 
(Penicillium) had developed, and that growth of Staphylococcus colonies situated around the Penicillium 
colony was inhibited (see image) (Source: Fleming, 1929). Moreover, he carried out detailed 
investigations with culture fluids of Penicillium and found that it contained a compound, termed 
‘penicillin’, that can inhibit growth of various bacteria, such as Streptococcus pyogenes, Streptococcus 
pneumoniae, and Corynebacterium diphteriae (Fleming, 1929).  
 
The biology of microorganisms  
Empirical research work, supported by more and more advanced methodology, greatly 
enhanced knowledge about the biology of microorganisms. In the first half of the 20th 
century series of groundbreaking laboratory research work uncovered the basic components 
and processes of life, to a major degree using bacteria as objects of investigations (e.g. 
Avery, et al., 1944; Beadle and Tatum, 1941; Crick, et al., 1961; Franklin and Gosling, 
1953; Jacob and Monod, 1961; Littlefield, et al., 1955; Meselson and Stahl, 1958; Watson 
and Crick, 1953a; Watson and Crick, 1953b; Wilkins, et al., 1953). Intriguing details about 
the bacterial structural organization, biochemistry, physiology, adaptation mechanisms, 
stress response, host-microbe, and microbe-microbe interactions have been revealed so far. 
About three decades ago it was re-discovered that in nature bacteria preferably live in 
multicellular communities, associated with terrestrial surfaces or animals and plants (e.g. 
Costerton et al., 1987; Geesey et al., 1977, Marshall, 1976; see also chapter 1.2). Since 
then, a major focus has been to unravel the genetic determinants and environmental 
conditions that promote and regulate the formation of these multicellular communities using 
so-called model organisms (e.g. Götz 2002; Klausen et al., 2006; Lasa, 2006, see also 
chapter 2 and 3).  
 
1.2 Bacterial lifestyles in nature: A binary view 
In nature, no bacterium exists in isolation. Instead, each bacterial cell is part of a population 
of cells. Observations on bacteria revealed that they exist as populations of cells in which 
either i) the individual cells are spatially associated with each other and hence live in 
multicellular communities of a definable three-dimensional structure, termed the ‘biofilm 
mode of life’, or in which ii) the individual cells are not firmly associated to each other, and 
hence are free living, termed the ‘planktonic mode of life’ (Fig. 3). Although not mutually 
exclusive, biofilms are commonly found to be associated with solid and semi-solid matter, 
whereas planktonic cells are usually associated with liquid matter. Bacteria are capable of 
switching between the two modes of life and both modes of bacterial life are linked to other 
processes of life in nature. The following section will focus on the biofilm mode of life, 
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however, a brief outline about the role of the bacterial planktonic way of living will be 
given thereafter. 
 
                              
Fig. 3. Schematic illustration of the two bacterial modes of life. Populations of bacteria can be found 
in nature either as multicellular aggregates, so called biofilms (depicted to the left) or as free-living, so-
called planktonic cells (depicted to the right). Observations indicate, that bacteria are able to switch 
between the two modes of life. Image is not drawn to scale. 
1.2.1 The biofilm mode of life 
Biofilms come in a great variety of shapes and sizes. Nevertheless, it appears that they share 
some common features. Biofilm cells are hold together by interconnecting compounds, such 
as excreted polysaccharides and proteins, cell lysis products and matter from the immediate 
surrounding environment, which altogether constitute the so-called ‘matrix’. This allows 
cells to form long-term relationships and establish metabolic cooperations (e.g. Costerton et 
al., 1987; Pamp et al., 2007b).  
 
Bacterial multicellular communities can be composed of mono-species populations of cells, 
such as the fruiting bodies formed by Myxococcus spp., or mycelial multicellular structures 
by Streptomyces spp. However, it appears that biofilms in nature predominantly are 
composed of cells derived from various species or even microorganisms of different 
domains (Davey and O’Toole, 2000). Stromatolites, as can be found in Western Australia 
(Fig. 4a) or the Bahamas, are recognized as ancient forms of biofilms (Reid et al., 2000). 
Sedimentary rock formations in Pilbara Craton (Australia) have been found and, although 
controversial, claimed to be 3.4 billion years old fossils of stromatolites (Allwood et al., 
2006). Biofilms are frequently established on hydrous solid and semi-solid surfaces, such as 
soil, rock material, or surfaces of animals (Fig. 4b) and plants (Fig. 4c). However, biofilms 
at air/liquid interfaces can also be found, such as ‘microbial mats’ floating on the surface of 
waters (Fig. 4d) (Guerrero et al., 2002; Steunou et al., 2006). Water is essential for 
development and maintenance of biofilms, as it is generally critical for life, but also 
facilitates the transport and exchange of low molecular weight compounds, and 
dissemination of bacteria. The abundance of biofilms is many times higher in environments 
of high nutrient concentration; however, they can also form in nutrient-depleted 
environments, as well as in extreme habitats such as hypersaline, alkaline, or polar regions. 
Overall, the prevailing environmental conditions in a certain habitat greatly impact on the 
abundance and composition of biofilms (Costerton et al., 1987; Davey and O’Toole, 2000; 
Marsh and Bowden, 2000).  
Bacterial communities play key roles in food webs in nature as they perform degradation of 
detritus material and participate in nutrient cycling. Many of these processes are 
interdependent and require cooperation between various bacterial species with different 
metabolic capacities (Costerton et al., 1987; Davey and O’Toole, 2000). The fact that in 
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biofilms the participating microbial members are situated in close proximity seems to be 
convenient, since metabolites can easily be transferred and metabolized further. Matrix 
components can support the adsorption of organic matter and other compounds and thereby 
provide a mechanism by which the community can concentrate nutrients. In cases of 
adverse conditions such as desiccation, osmotic shock, or exposure to toxic compounds, UV 
radiation, predators or other stresses, the microbial community as whole can provide 
protection. Moreover, multicellular communities provide ideal conditions for horizontal 
gene transfer, which is important for microbial evolution and genetic diversity (Costerton et 
al., 1987; Davey and O’Toole, 2000; Marsh and Bowden, 2000; Molin and Tolker-Nielsen, 
2003). 
 
                                       
Fig. 4. The biofilm mode of life. a) Photograph of modern stromatolites (~3000 years old) from Shark 
Bay, Hamelin Pool Marine Nature Reserve, Western Australia (Source: www.ucl.ac.uk/star). 
Stromatolites are described to be formed by processes involving the development of mats of multispecies 
microbial communities (proteobacteria, planctomyces, actinobacteria, cyanobacteria), and binding of 
sedimentary grains (Burns et al., 2004; Papineau et al., 2005). b) Scanning electron micrograph (SEM) 
from the multispecies indigenous microbial population present in the mucous layer of the small intestine 
of a mouse (Source: Rozee et al., 1982). c) Coloured scanning electron micrograph (SEM) of a root 
nodule on a pea plant (Pisum sativum) caused by the nitrogen-fixing bacteria Rhizobium leguminosarum. 
The bacteria convert atmospheric nitrogen to ammonia, and make it available to the plant. The plant 
passes carbohydrates to the bacteria as energy source (Credit: Jeremy Burgess/Science Photo Library). d) 
Photograph of a microbial mat floating on a roadside puddle (Credit: John Lennox, Penn State Altoona). 
Microbial mats are usually formed by multispecies microbial communities; among those cyanobacteria 
are common. Images are not shown to scale. 
 
Biofilms as inhabitants of humans: impact on health and disease 
It seems as intimate relationships between microbial communities and eukaryotic organisms 
are a dominant theme of life, as microbial communities frequently can be found living 
together with both animals (e.g. Fig. 4b) and plants (e.g. Fig. 4c). As known for humans, 
communities of bacteria natively populate mucous membranes and epithelial surfaces like 
the gastrointestinal tract, oral cavity, and skin. Each of the body sides is colonized with a 
mixed microbial community of characteristic composition (Wilson, 2005).  
 
The human organism consist of approximately 10 times more prokaryotic cells than 
eukaryotic cells (Savage, 1977) and it has been estimated that alone the genomes of all 
intestinal microorganisms together contain roughly 100 times as many genes as does the 
entire human genome (Gill et al., 2006). Intriguingly, for most of their lifespan humans do 
not suffer from harboring these microbial communities. In fact, they are important and 
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beneficial to their host as they can degrade nutrients and thereby make them accessible to 
humans and synthesize vitamins, which cannot be synthesizes by the human itself. 
Moreover, they play key roles in the development of the immune system and anatomy of 
the mucosal surfaces and exert protective function against exogenous pathogens (Berg, 
1996; Noverr and Huffnagel, 2005; Wilson, 2005).  
 
The relationship between the host and its microbial communities is delicately balanced but 
under certain conditions it can break down and result in infectious diseases. These 
infections can be caused either by members of the indigenous human microbial community 
or by microorganisms from the environment (Costerton et al., 1987; Wilson, 2005). Under 
conditions where the host is impaired, for example immunocompromised, injured, or 
suffering from cancer or cystic fibrosis, harmful biofilms can develop at different body 
sides and cause persistent infections. Among those infections are various device-related 
infections, but also otitis media, osteomyelitis, pulmonary infections, infective endocarditis, 
wound infections, and chronic prostatitis (Costerton et al., 2003; Hall-Stoodley et al., 2004; 
Parsek and Singh, 2003). The most common infections caused by microorganisms of the 
human indigenous microbial community are caries, periodontal diseases and urinary tract 
infections (Wilson, 2005). Bacteria which in general have been found to be involved in 
human biofilm-related infections are Staphylococci, Escherichia coli, Pseudomonas 
aeruginosa, Enterococci, Streptococci, Proteus mirabilis, Klebsiella, Enterobacter, and 
Haemophilus influenza. Some of these persistent infections involve either of these 
opportunistic pathogens, however, it appears that many are polymicrobial infections, since 
various species can be identified from the side of infection (Costerton et al., 2003; Hall-
Stoodley et al., 2004). The significance of single species in a particular persistent infection 
is often unknown.  
 
A general characteristic of persistent infections is, that they evidently cannot be eradicated 
by the host immune system and are difficult to kill by antimicrobial chemotherapy. Various 
reasons have been postulated to be involved in the persistence of these infections: i) biofilm 
matrix compounds may protect the bacteria, ii) bacteria living in biofilms exhibit a biofilm-
specific antibiotic-resistant physiological state, iii) the causative bacteria have a decreased 
growth rate, iv) the biofilm is composed of a heterogeneous population of cells exhibiting 
different physiological states, which renders only some cells vulnerable to attack by 
antimicrobial compounds, v) biofilm-growth per se increases induction of bacterial stress 
response, which protects the cells against antimicrobials, and vi) quorum sensing systems 
might confer protective functions (Fux et al. , 2005; Lewis, 2001; Mah and O’Toole, 2001; 
Stewart, 2002). 
1.2.2 The planktonic mode of life 
It seems that only a minor fraction of all bacteria on Earth are living in the planktonic mode, 
since most bacteria are found to be associated with terrestrial habitats (incl. oceanic 
subsurfaces) compared to the aquatic habitats, such as the global oceans, lakes and rivers 
(Whitmann et al., 1998). Nevertheless, this mode of life can play important roles in bacte-
rial ecology. Whereas some species might be found predominantly in the planktonic mode 
of growth, others exist in both, the planktonic and biofilm mode of life.  
In the global oceans, bacterioplankton lives almost exclusively in the planktonic form. The 
cyanobacteria Prochlorococcus (Fig. 5a) and Synechococcus (Fig. 5b) belong to the most 
abundant bacteria found in the oceans and account for a significant amount of 
photosynthesis carried out in nature. Differences in the composition of their photosynthetic 
light harvesting pigment complexes, and resulting distinct absorptions spectra, but also 
nutrient requirements appear to play role in differentiating their ecological niches in the 
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ocean environment: Whereas Synechococcus seems to be prevalent in almost all areas, 
Prochlorococcus is restricted to the tropical and subtropical regions. In open waters, where 
both species occur, Prochlorococcus has been found to extend deeper in the water column 
than Synechococcus (Partenski et al. 1999; Ting et al., 2002).  
 
Another interesting group of preferentially planktonic living bacteria seem to be 
magnetotactic bacteria. Magnetotactic bacteria are a morphologically and taxonomically 
diverse group of motile aquatic microorganisms (e.g. Fig. 5c). They are found in high 
numbers at the oxic-anoxic transition zone within calm marine and freshwater 
environments. Research indicates, that they organize themselves by flagella-driven motility 
at this particular aquatic zone steered by magnetotaxis and aerotaxis. Magnetotaxis is 
carried out using intracellular, self-synthesized crystals of magnetic minerals, so-called 
magnetosomes. It is assumed that these organisms play role in iron, sulfur and carbon 
cycling (Blakemore, 1982; Bazylinski and Frankel, 2004).  
  
 
                                  
Fig. 5. The planktonic mode of life. a) Colored transmission electron micrograph (TEM) of a section 
through Prochlorococcus cells. The section reveals bands of membranes (green) inside the cells, which 
contain the light harvesting pigment complexes, used for photosynthesis (Credit: Claire Ting/Science 
Photo Library). b) Photomicrograph of Synechococcus cells (Credit: Ralf Wagner, Germany). Both 
Synechococcus and Prochlorococcus are thought to play important roles in regulating carbon dioxide and 
oxygen levels in the atmosphere. c) Transmission electron micrograph (TEM) of a Magnetospirillum 
magnetotacticum cell. The magnetosomes can be seen within the cell as a row of dark square-like objects  
(Credit: R. B. Blakemore and N. Blakemore). d) Transmission electron micrograph (TEM) of Vibrio 
cholerae. (Credit: New York State Department of Health, Wadsworth Center). Images are not shown to 
scale. 
 
Generally, the bacterial planktonic way of living provides the opportunity to rapidly change 
location and penetrate into new ecological niches. This seems to be an attractive strategy in 
cases of nutrient limitation or other external adverse conditions in a particular environment. 
Moreover, the planktonic mode can facilitate the dissemination of bacteria from a biofilm 
community, for example in aging populations or when adverse conditions occur. In relation 
to human infectious diseases it appears that both, the planktonic as well as the biofilm mode 
of growth can be integral parts of pathogenesis. An interesting case is described for Vibrio 
cholerae (Fig. 5d). This organism exists in the environment predominantly in the biofilm 
mode attached to zooplankton. Upon oral digestion by humans, cells detach from biofilms 
in the intestine to become planktonic. Subsequently, cells colonize the intestinal epithelium, 
multiply and form biofilm-like aggregates. In later stages of this infectious process large 
numbers of bacteria emigrate from the epithelial surface, mainly planktonically but also as 
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aggregates, to leave the human environment and enter possibly again aquatic environments 
(Colwell, 2004; Faruque et al., 2006; Nielsen et al., 2006; Zhu and Mekalanos, 2003). 
Another example for dissemination of planktonic bacteria during infectious diseases can be 
observed in cases of bacteremia. In these cases bacteria can be found emigrating from 
biofilms, which had formed on indwelling devices, such as catheters. Bacteremia can lead 
to severe sepsis and multiple organ failure (Eggimann et al., 2004). 
 
1.3 Techniques for cultivation and analysis of biofilms 
Biofilms are intriguing societies of microbes and a great mission is to unravel their 
structural assembly, organization, physiology, evolution and role in nature. However, due to 
their complexity, natural microbial communities have been challenging objects of 
investigation. Various factors impact on biofilm biology and many of those factors are 
interrelated. To reduce complexity and facilitate investigations in the laboratory under 
controlled and reproducible conditions, various ‘simple’ methods for biofilm cultivation 
and examination have been established. Moreover, to discover genetic determinants and 
regulatory pathways impacting on the biofilm mode of life, major focus relies on well 
characterized and genetic tractable microorganisms, such as Pseudomonas spp., 
Staphylococci, Bacillus subtilis, E. coli, V. cholera, Salmonella typhimurium and Candida 
albicans. Generally, research on laboratory-grown biofilms applies combinatorial 
approaches, which can involve different methods of biofilm cultivation, macroscopic 
examinations, microscopic examinations, quantifications, computational modeling, genetic 
engineering and functional genomics. The following section should give an overview about 
the most common tools used to study biofilm biology of these model organisms. 
1.3.1 Flow-chamber-grown biofilms 
Flow-cell technology in combination with confocal laser scanning microscopy (CLSM) and 
fluorescent reporters appears to be the gold standard in biofilm research. It allows getting 
insight into details of developmental processes, spatial organization and function of 
biofilms under continuous and non-invasive conditions up to the single-cell level (e.g. 
Palmer et al., 2006). In flow-chambers, biofilms are cultivated under hydrodynamic 
conditions and parameters such as nutrient composition, flow-rate, temperature and oxygen 
supply can be chosen as required (schematic setup of the system: Fig. 6a). As surface for 
microbial attachment serves glass, however, the surface may be modified by coating. 
CLSM allows the visualization of fully hydrated biofilms on-line in up to four dimensions. 
To be able to detect living cells present in the biofilm via CLSM, the cells need to either 
express a ‘fluorescent tag’ such as the green, cyan, yellow, or red fluorescent protein (Gfp, 
Cfp, Yfp or Rfp) (e.g. Fig. 7a), or be stained with a fluorescent dye (e.g. Syto 9 or Syto 62). 
Moreover, visualization of dead cells is possible using e.g. propidium iodide, and matrix 
components can be visualized using fluorescent dyes (e.g. calcofluor white) or fluorescently 
labeled lectins (e.g. tetramethylrhodamine-wheat germ agglutinin (TMR-WGA)) (Doyle, 
1999; Palmer et al., 2006). To assess the role of particular genes in biofilm formation, 
knock-out mutants can be genetically engineered and the phenotype of these strains 
compared with the phenotype of the isogenic wild type strain (e.g. Fig. 7a). The expression 
of single genes of interest can be studied in situ using fluorescent promotor fusions. In this 
case a gene encoding for a fluorescent protein (e.g. gfp, gfp[AGA]) is placed under 
expression control of the promotor of the gene of interest, and this construct introduced into 
the microbial cell. Only cells in which the expression from the promotor of interest is 
induced will exhibit a fluorescent signal (Andersen, et al., 1998). Fluorescent in situ 
hybridization (FISH) can be applied to target specific nucleic acid sequences of biofilm 
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cells, however, this requires fixation and embedding procedures and removal of the biofilm 
from the flow-chambers. Depending on the equipment of the CLSM (lasers, filter sets) it is 
possible to combine some of the visualization techniques described above (Doyle, 1999; 
Palmer et al., 2006). Certain general features of biofilms can be quantified, such as biofilm 
thickness and roughness, biovolume and substratum coverage (Heydorn et al., 2000). 
Furthermore, the response of biofilms to changes in environmental conditions can be 
studied by exposing the biofilm to e.g. another carbon source, high shear force, 
antimicrobial compounds, or predatory eukaryotic cells (e.g. Palmer et al., 2006).  
 
        
Fig. 6. Cultivation of biofilms. a) To the left: Schematic representation of the flow-cell setup (Credit: K. 
B. Barken and J. A. J. Haagensen). Biofilms are cultivated in individual flow-channels of three-channel-
flow-cells (to the right) (Image: Pamp, unpublished). A peristaltic pump is used to attain a continuous 
flow of media through the flow-chambers and bubble traps are interconnected to catch air bubbles, which 
can accidentally arise in the system. b) Colony biofilms of P. aeruginosa strains on agar plates containing 
Congo red dye. The morphology of the wild type (to the left) appears wrinkly due to production of matrix 
components. The mutant strain (to the right) is defective in matrix synthesis (Source: Branda et al., 2005). 
c) Pellicle biofilms of B. subtilis strains formed at the air/liquid interface of standing cultures. The mutant 
strain (to the right) is defective in matrix production and unable to form a stable pellicle, as formed by the 
wild type strain (to the left) (Source: Branda et al., 2005). d) Biofilms formed in the wells of a microtiter 
dish by E. coli wild type (to the left) and a mutant strain of E. coli (to the right). Biofilms are visualized 
by staining with crystal violet (Source: Branda et al., 2005). e) Biofilms formed by E. coli strains on 
Pyrex glass slides in microfermentors. Strain A harbors two plasmids encoding for conjugative type IV 
pili, whereas strain B does not contain any plasmids (Source: Dudley et al., 2006). Images are not shown 
to scale. 
1.3.2 Other experimental biofilm setups and tools 
The bacterial colony itself has been recognized as a type of biofilm and proven to be a 
useful object for biofilm investigations. Cultivations of colony biofilms do not require any 
specific and costly equipment and they are applicable for screenings, such as transposon-
libraries. Bacteria are allowed to establish a colony biofilm either directly on the surface of 
an agar-plate (Fig. 6b), or on top of a polycarbonate membrane, which is placed on an agar-
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plate (Bokranz et al., 2005; Branda et al., 2004; Werner et al., 2004). The morphology of 
these colonies can vary greatly, dependent on the bacterial species used and the intrinsic 
ability of a particular strain to produce matrix-compounds, such as polysaccharides and 
proteins (Fig. 6b) (Bokranz et al., 2005; Branda et al., 2004). Moreover, environmental 
conditions such as the prevailing media composition, agar concentration, temperature, and 
duration of cultivation can impact on the morphology of the colony biofilm. The presence 
of matrix components can be examined by applying dyes, which specifically bind to these 
components (e.g. Congo red) (Fig. 6b) (Bokranz et al., 2005). Microscopy such as scanning 
electron microscopy (SEM) or transmission electron microscopy (TEM), have also been 
helpful in visualizing cell-to-cell interconnecting components (e.g. Fig. 7b+c). Studying 
dynamics and developmental processes within the colony is difficult as it is not possible so 
far to follow these processes under non-destructive conditions. However, in situ gene 
expression studies are achievable in combination with embedding and cryosectioning 
procedures and subsequent microscopic investigations (Fig. 7d) (Werner et al., 2004). 
Functional genomics approaches, such as transcriptomics (DNA-microarrays) or proteomics 
(e.g. 2D-PAGE) may be applied on these biofilms if desired (e.g. Mikkelsen et al., 2007; 
Waite et al., 2005).  
 
        
Fig. 7. Microscopic examination of biofilms. a) Confocal laser scanning micrographs (CLSM) of flow-
chamber grown P. aeruginosa strains (vertical representation). P. aeruginosa PAO1 wild type (Gfp-
tagged) forms a mushroom-like structured biofilm, whereas P. aeruginosa PAO1 rhlA::Gmr (Yfp-tagged) 
forms a flat-structured biofilm (Images: Pamp, unpublished). b) Scanning electron micrograph (SEM) of 
P. aeruginosa biofilms. The P. aeruginosa wild type strain produces matrix-compounds, whereas the 
mutant strain is defective in matrix-synthesis (Source: Branda et al., 2005). c) Transmission electron 
micrograph (TEM) of P. aeruginosa biofilms. The P. aeruginosa wild type produces matrix-compounds, 
visualized with ruthenium red, whereas the mutant strain is defective in matrix-synthesis (Source: Branda 
et al., 2005). d) Confocal laser scanning micrographs (CLSM) of vertical cryosections of colony biofilms 
formed by P. aeruginosa, visualized with rhodamine B. The P. aeruginosa strain harbors a gfp-gene, 
which expression is inducible by IPTG. Gfp is not expressed in the absence of IPTG (to the left). In the 
presence of IPTG (to the right), Gfp is expressed in the upper layer of the colony biofilm in metabolically 
active cells (Source: Werner et al., 2004). Images are not shown to scale. 
 
Biofilms can also form at air/liquid interfaces. In this regard, so-called pellicle biofilms can 
be established at the air/liquid interface of static cultures. It appears that matrix-production 
is explicitly required for establishment of a pellicle. Strains that are defective in matrix-
production do not form a pellicle at the air/liquid interface or only a fragile layer of cells 
(Fig. 6c) (e.g. Branda et al., 2004). Environmental conditions, such as media composition 
and temperature can effect on pellicle formation. Cell-to-cell interconnecting components 
can be visualized by either scanning electron microscopy (SEM) or transmission electron 
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microscopy (TEM) (e.g. Fig. 7b+c) (e.g. Anriany et al., 2001). This biofilm assay is also 
compatible with high-throughput screenings. For detailed microscopic analysis, aimed at 
learning about structural organization and in situ gene expression, this assay is not well 
suitable. 
 
The microtiter-dish assay is a popular biofilm assay in which also the amount of biofilm can 
be easily quantified. Moreover it can be applied in large scale, such as for screenings of 
transposon-libraries. Commonly cultures with a low inoculum of bacteria are introduced 
into the wells of the microtiter-dish and incubated under static condition. Biofilms can form 
at the walls of the wells and subsequent to washing-steps stained with dyes such as crystal 
violet. The amount of crystal violet bound is assumed to be directly proportional to the 
amount of biofilm, and therefore the amount of biofilm is determined by extraction of the 
crystal violet from the biofilm and subsequent quantitative absorptions measurements (e.g. 
O’Toole and Kolter, 1998a). The effect of environmental conditions on biofilm formation 
can be easily investigated, e.g. by modifying the composition of the media, addition of 
compounds of interest, variation of the incubation temperature or duration. However, this 
assay is not suitable for microscopic investigations concerning biofilm structural 
development. 
 
Biofilms can also be cultivated in microfermentors. Here the biofilm can develop on Pyrex 
glass slides under continuous flow condition and the flow rate can be adapted to minimize 
the amount of planktonic cells. The biofilm biomass can be recovered and quantified, for 
example by measurements of optical densities of resuspensions of biofilm cells. The 
structure of the biofilm can be investigated by microscopy, such as scanning electron 
microscopy (SEM) (e.g. Fig. 7b). Global approaches, like transcriptomics (DNA-
microarrays) or proteomics (e.g. 2D-PAGE) can be applied on these biofilms as well. 
Moreover this setup is applicable for small-scale genetic screenings. The role of 
environmental conditions can be investigated, e.g. by modifying the media composition, 
incubation temperature or addition of antimicrobial compounds (Ghigo, 2001; Dudley et al., 
2006; Valle et al., 2006). 
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2 Cellular differentiation in single species 
bacterial multicellular communities  
  
 
 
 
This chapter aims at providing insight into the organization of multicellular communities at 
the microscopic level. Using examples from various laboratory-grown single species 
multicellular communities, a number of different cell types will be introduced which can 
evolve by cellular differentiation. The phenotypes of the different cell types will be 
described as well as their impact on the development of a multicellular community. 
Thereafter, additional features of some cell types in relation to biofilm cell populations, and 
cell types in relation to planktonic cell populations, will be discussed. 
 
2.1 Cell types in multicellular communities 
The biofilm mode of life is described to be distinct from the planktonic mode of life. 
Comparative analysis of the global transcriptional profiles of planktonic cell populations 
and biofilm cell populations demonstrated that there exist significant differences between 
these two populations (e.g. Beloin et al., 2004; Resch et al., 2005; Whiteley et al., 2001). 
Also at the global proteomic level populations of planktonic cells differ significantly from 
populations of biofilm cells (e.g. Mikkelsen et al., 2007; Resch et al., 2006; Sauer et al., 
2002). Together this suggests, that the physiology of biofilm cells significantly differs from 
the physiology of planktonic cells.  
 
Investigations at a lower level of organization reveal that single species multicellular 
communities by a number of bacteria, such as P. aeruginosa, B. subtilis, Myxococcus 
xanthus, Streptomyces spp., and Staphylococci, consist of a variety of different cell types 
exhibiting various physiological states and distinct phenotypes. Among those cell types can 
be e.g. metabolic active cells, metabolic inactive cells, motile cells, non-motile cells, 
matrix-producing cells, dead cells, spore cells, and genetic variant cells. Some of these cell 
types are mutually exclusive, e.g. spore cells are generally not motile. However, cells might 
also exhibit overlapping phenotypes, e.g. metabolic active cells can be motile. It appears 
that cells of the same type are often found to be spatially co-localized forming confined 
subpopulations within the multicellular community. The following section aims at 
introducing some of the various cell types, which have been found to be present in a 
number of laboratory-grown multicellular communities. 
 
High metabolic active cells / low metabolic active cells  
Microscopic analysis on various laboratory-grown biofilms, e.g. by P. aeruginosa, S. 
epidermidis, Klebsiella pneumoniae, E. coli and P. putida, reveal that biofilm cells exhibit 
differential degrees of metabolic/physiological activity. The biofilm cells appear to fall into 
two major spatially distinct subpopulations: A subpopulation of cells situated proximal to 
the substratum exhibits low metabolic/physiological activity, whereas a subpopulation of 
cells distal to the substratum at the biofilm/air or biofilm/liquid interface exhibits high 
metabolic/physiological activity. The spatial distribution of low and high metabolic/ 
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physiological active cells appear to be a result of prevailing low and high local 
concentrations of oxygen, respectively, however, also local limitations of nutrient 
compounds might result in a lower metabolic activity of cells situated in the deeper layers 
of the multicellular structure (Pamp et al., submitted; Rani et al., 2007; Sternberg et al., 
1999; Wentland et al., 1996; Werner et al., 2004; Haagensen, personal communication). 
 
Motile cells / non-motile cells 
A binary cellular phenotype with respect to cellular migration can be observed in a number 
of multicellular communities, e.g. by P. aeruginosa, M. xanthus, and B. subtilis, as both, 
motile and non-motile cells can be found to co-exist in the respective multicellular 
structures. In the initial phase of flow-chamber-grown biofilms of P. aeruginosa the 
substratum-attached cell population appears to differentiate into a motile (driven by type IV 
pili) and non-motile fraction of cells (Klausen et al., 2003b; Singh et al., 2002; see also 
chapter 3.2). During further developmental steps spatially confined microcolonies are 
formed by clonal proliferation of non-motile cells. A fraction of motile cells can migrate on 
top of the microcolonies to initiate the formation of a spatially confined cap-forming 
subpopulation. Migration of these cells seems to be facilitated by flagella-driven motility 
and the secretion of biosurfactants and depends on the presence of type IV pili and 
extracellular DNA. In aged multicellular communities of P. aeruginosa rapidly swimming 
cells can be observed inside hollows formed in the center of the structures. These cells 
appear to function as offspring as they can leave from the multicellular structures and 
possibly establish in new niches (Barken et al., in prep.; Haagensen et al., 2007; Klausen et 
al., 2003b; Pamp and Tolker-Nielsen, 2007; see also chapter 3.2). Motile and non-motile 
cells appear also to be involved in the formation of multicellular communities (fruiting 
bodies) by M. xanthus. Cells can move along surfaces by means of so-called gliding 
motility, which is driven cooperatively by S-motility (type IV pili, extracellular fibril 
material, LPS) and A-motility (slime secretion). In cases where groups of gliding cells 
collide, small irregular cellular aggregates (‘traffic jams’) are formed and the participating 
cells become non-motile (Fig. 8a). When streams of other gliding cells encounter such an 
aggregate it can serve as a nucleus for enlargement: the stream glides over and around the 
aggregate to produce a hemispherical mound on top of the subpopulation of non-motile 
cells. Here the cells move in cyclic paths dependent on cell-to-cell contact facilitated by the 
C-signal (surface-bound protein). As the mound increases in size motile cells can 
differentiate into non-motile spores (Kaiser, 2003; Sliusarenko et al., 2007; Sozinova et al., 
2006). A distinct subpopulation of motile cells can also be observed in colony biofilms by 
B. subtilis (Fig. 8b). In contrast to the described multicellular communities by P. 
aeruginosa and M. xanthus, the motile cells (driven by flagella) in the B. subilis biofilm are 
predominantly found at the base. It is hypothesized that motile cells might actively move to 
the base attracted by nutrients present in the agar medium. Nevertheless, some motile cells 
were also observed in the top layer of the biofilm (Kolter, 2007; Vlamakis et al., 2007). 
 
Matrix-producing cells 
Matrix synthesis appears to be spatially confined to distinct subpopulations of cells in 
laboratory-cultivated multicellular communities such as P. aeruginosa, M. xanthus, and B. 
subtilis. In P. aeruginosa flow-chamber-grown biofilms, the polysaccharide PEL seems to 
be preferably produced by cells, which are located in the upper layer of microcolonies and 
mushroom-like structures. Extracellular DNA seems to be localized preferably inside and in 
the upper part of microcolonies and at the interface between the stalk-forming and cap-
forming subpopulations of mushroom-like structured biofilms. In early stages of biofilm 
formation the extracellular DNA seems to play role in stabilization of initial microcolonies. 
In subsequent stages the extracellular DNA is important for development of the cap-
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forming subpopulation lifting up from the stalk-forming subpopulation (Allesen-Holm et 
al., 2006; Ma et al., 2007b; Whitchurch et al., 2002). M. xanthus cells produce an 
extracellular fibril matrix, composed of polysaccharide and protein, which is thought to 
surround the single cells. A recent study reports that the polysaccharide component can 
induce retraction of type IV pili and thereby modulate S-motility. In mature multicellular 
structures the polysaccharide component has been found to be present in the outer layers of 
the fruiting bodies, suggesting that cells in the outermost layers exhibit increased 
polysaccharide synthesis (Behmlander and Dworkin, 1994; Li et al., 2003; Lux et al., 
2004). B. subtilis produces a matrix, which is composed of a polysaccharide component 
(EPS) and a protein component (TasA). Recent investigations indicate that in colony 
biofilms by this organism, TasA expression is not uniform throughout the biofilm, instead it 
is confined to certain cell-groups, which are scattered throughout the multicellular structure 
(Aguilar et al., 2007; Kolter, 2007). 
 
Dead cells 
Dead cells and remnants of cells (e.g. extracellular DNA, and cell envelopes devoid of 
cytoplasmic contents) can be found in a number of multicellular communities, such as by P. 
aeruginosa, Staphylococci, and Streptomyces spp. In biofilms of P. aeruginosa some dead 
cells can be found in the stalk-part of the multicellular structure close to the substratum. 
Extracellular DNA seems to be derived from lyzed cells, and can be found in microcolonies 
and as layers between the stalk- and cap-forming subpopulations (see above, matrix-
producing cells). The number of dead cells and amount of extracellular DNA can vary 
dependent on environmental conditions, age of the biofilm and inherent characteristics of a 
particular strain. Factors such as anoxic microenvironments, reactive nitrogen and oxygen 
intermediates, phage induction, flagella, type IV pili, and quorum sensing have been 
implicated with the appearance of dead cells and extracellular DNA in P. aeruginosa 
biofilms. (Allesen-Holm et al., 2006; Barraud et al., 2006; Hunt et al., 2004; Hunter and 
Beveridge, 2005; Webb et al., 2004; Werner et al., 2004; Whitchurch et al., 2002). In 
biofilms by Staphylococci dead cells and extracellular DNA were also observed in the 
interior area of the multicellular structures. In S. aureus cell lysis is suggested to be 
dependent on the cid and lrg genes, which are homologous to genes that encode for proteins 
mediating murein hydrolase-dependent cell lysis. In S. epidermidis the appearance of dead 
cells and extracellular DNA in biofilms appears to be dependent on autolysin (AtlE) (Qin et 
al., 2007; Rice et al., 2007). Dead cells have also been found to be part of mycelial colonies 
by Streptomyces spp. and appear to be important for structural development of these 
colonies. Generally, the mycelial colonies consist of two major cell types: the vegetative 
substrate mycelium present in and on the substratum, and aerial hyphae arising from the 
substratum into the air (Fig. 8c). Development of aerial hyphae is described to be dependent 
on cell death of the substrate mycelium. In early stages of colony development the substrate 
mycelium is formed. In response to nutrient starvation specialized aerial hyphae can arise, 
which grow upwards into the air. Growth of aerial hyphae appears to coincide with cell 
death of the substrate mycelium. It is thought that remnants of these dead cells might serve 
as nutrient supply for aerial hyphae development. Some hyphae die by autolyses, however, 
the majority of hyphae undergo a process termed physiological cell death. This is a slower 
process in which cellular contents such as DNA degrade, whereas the cell envelope 
maintains shape for a while. Eventually the cell contents of dead cells are released leaving 
an empty cell envelope. This is proposed to be advantageous, as remains of cell envelopes 
might provide some mechanical support for aerial hyphae development. Death of the 
substrate mycelium coincides with the release of antimicrobial substances and it is thought 
that this is a mechanism by which possible other invading microorganisms (attracted by the 
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release of nutrients from dying hyphae) are kept away (Chater, 1993; Claessen et al., 2006; 
Miguélez et al., 2000). 
 
Surfactant-producing cells 
Release of surface active agents appears to be confined to distinct areas within multicellular 
communities and facilitates differentiation of distinct cell subpopulations in laboratory-
cultivated multicellular communities such as P. aeruginosa, Streptomyces spp., and B. 
subtilis. In P. aeruginosa flow-chamber-grown biofilms, excretion of biosurfactants seems 
to have various effects. They are preferably produced by cells, which form microcolonies 
during early stages of biofilm formation, and by cells, which constitute the stalk of 
mushroom-like structures during later stages of biofilm formation, suggesting that they 
exert effects during different stages of biofilm development. Consistent with this, a rhlA-
mutant was found to be affected in microcolony formation, possibly because biosurfactants 
are required for cell-to-cell-aggregation in early stages during microcolony formation. 
During later stages biosurfactants appear to be involved in formation of the cap-forming 
subpopulation by facilitating migration of motile cells onto the microcolonies, and by 
keeping the water channels open in between the mushroom-shaped structures. In aging 
biofilms biosurfactants are reported to facilitate the detachment of cells from the 
multicellular structures (Boles et al., 2005; Davey et al., 2003; Lequette and Greenberg, 
2005; Pamp and Tolker-Nielsen, 2007). Surfactant components have also been found to be 
involved in structural development of mycelial colonies by Streptomyces spp, by facilitating 
the differentiation of aerial hyphae from the vegetative substrate mycelium. It appears that 
the surface tension between the aqueous milieu of the colony and the air must be reduced if 
nascent hyphae are to grow into the air. Dependent on the composition of the growth 
medium, this can be accomplished by two classes of surfactant-like molecules: the SapB 
peptide and the chaplin proteins. SapB is a lanthionine-containing peptide, which is thought 
to fold into a three-dimensional structure exhibiting amphiphilic characteristics. 
Observations suggest that SapB is expressed in the substrate mycelium and aerial hyphae, 
but not in spore cells. The chaplins form proteinaceous fibrils that mediate the rigidity of 
aerial hyphae, keep aerial hyphae apart and provide surface hydrophobicity. Expression of 
chaplins is confined to aerial hyphae and spores, however, in contrast to aerial hyphae 
formation chaplins are not required for the formation of spores (Capstick et al., 2007; 
Claessen et al., 2003; Claessen et al., 2006; Elliot et al., 2003; Kodani et al., 2004; 
O’Connor et al., 2002; Tillotson et al., 1998; Willey et al., 2006). Aerial structures, which 
are reminiscent from fruiting bodies of other microorganisms, can also arise from the upper 
layers of colony and pellicel biofilms by B. subtilis (Fig. 8b). Surfactin, a biosurfactant 
produced by B. subtilis, appears to be involved in the formation of the aerial structures. 
Surfactin is thought to either facilitate erection of the aerial structures by lowering surface 
tension, or mediate cell-to-cell signaling and thereby modulate the expression of other 
factors required for structural development of the multicellular community and the aerial 
structures (e.g. TasA) (Branda et al., 2001; Kolter, 2007) 
 
Endospore cells 
Differentiation of spore cells appears to take place in distinct areas of multicellular 
communities by a number of microorganisms, e.g. M. xanthus, B. subtilis, and Streptomyces 
spp. As described above, M. xanthus can undergo a developmental cycle to form fruiting 
bodies (Fig. 8a). In the hemispheric multicellular part, which is lifted up from the 
substratum, cells can differentiate into spore cells. When the C-signal has reached a certain 
threshold, rod-shaped motile cells differentiate into round non-motile spores accumulating 
in the center of the fruiting body. It is thought that spore cells are formed in the outer layer 
of the fruiting body and then passively transported due to encountering moving cells 
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(present in the outer layer) into the center of the multicellular structure (Kaiser, 2003; 
Sliusarenko et al., 2007; Sozinova et al., 2006). Differentiation of spore cells appears to 
take place also in distinct parts of multicellular colony and pellicle structures by B. subtilis 
(Fig. 8b). It has been observed, that sporulation-specific gene expression is confined to the 
top part of the aerial structures erecting from colonies and pellicles, indicating that these are 
the predominant sites of spore formation. Transcriptional regulators, such as Spo0A, sigma 
H and sigma F are found to be required for structural development of the overall 
multicellular community and/or differentiation of spores (Branda et al., 2001). Spores can 
also develop at the top of aerial hyphae of mycelial colonies by Streptomyces spp. (Fig. 8c). 
Upon a complex differentiation process the extension of aerial hyphae stops and hyphal-tips 
undergo multiple septation. This gives rise to compartments in which spores develop. The 
process appears to be dependent on a second round of cell death (see information regarding 
the first round of cell death above), which here affects the basal non-sporulating parts of the 
aerial hyphae (Chater, 1993; Claessen et al., 2006; Miguélez et al., 2000). 
 
Genetic variant cells 
When biofilm cells are harvested and plated onto nutrient agar a diversity of colony 
morphology variants can appear. Biofilm-derived colony variants that differ in morphology 
from their respective wild type ancestor have been described for bacterial species such as P. 
fluorescence, P. aeruginosa, Listeria monocytogenes, Serratia marcescens, S. pneumoniae, 
and S. aureus (Allegrucci and Sauer, 2007; Boles et al., 2004; Kirisits et al., 2005; Koh et 
al., 2007; Monk et al., 2004; Rainey and Travisano, 1998; Yarwood et al., 2007). As the 
phenotype of these variants in many cases is reported to be stable, it is assumed that genetic 
variations (e.g. mutations) in some biofilm cells occurred resulting in the observed altered 
colony phenotypes. However, a direct causal relationship between a genetic variation and 
an altered phenotype is documented in the rare case. At present it is unknown if the genetic 
variant cells are generated and localized in a certain spatial area within the biofilm 
structure, or whether these cells are randomly distributed throughout the multicellular 
structure. A number of different colony variants of P. aeruginosa have recently been 
reported to arise at high frequency in biofilms cultivated in a drip-flow biofilm reactor 
(Boles et al., 2004). Among the most prominent variants were found ‘wrinkly’ and ‘mini’ 
colony morphotypes. Beside their altered colony morphology the various colony variants 
exhibited differential degrees of swimming motility, auxotrophy, pigment production and 
two isolated wrinkly and mini variants exhibiting altered biofilm formation phenotypes in 
flow-chambers. Further analysis indicate that a recA-dependent process is involved in 
generating the diversity of colony variants, as plated biofilm cells by a recA-mutant exhibit 
only wild type colony morphology (Boles et al., 2004). Recent investigations point at the 
involvement of oxidative stress in the generation of genetic variants. It is hypothesized that 
reactive oxygen intermediates prevailing in these biofilms might induce double strand DNA 
breaks and that a mutagenic repair might result in the generation of various genetic variants 
(Singh, 2007). In another study a ‘sticky’ colony morphotype was isolated from P. 
aeruginosa biofilms established in a tube reactor (Kirisits et al., 2005). This variant 
exhibited a strong auto-aggregative phenotype, hyperadherence to abiotic surfaces and 
lower degrees of swimming and twitching motility. In flow-chambers the variant formed 
biofilms with increased biomass compared to the wild type ancestor. Further investigations 
revealed, that the auto-aggregative and hyperadherence phenotypes were partly mediated by 
an increased production of the polysaccharide PSL (Kirisits et al., 2005). 
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Fig. 8. Multicellular communities by Myxococcus xanthus, Bacillus subtilis and Streptomyces spp. a) 
M. xanthus forms multicellular communities (fruiting bodies) in which different phenotypic cell types 
(e.g. motile cells and non-motile cells) participate in development of the multicellular structure. Spore 
cells are differentiated in mature multicellular structures (see main text) (Images, modified from: Kaiser, 
2003). b) In colony biofilms by B. subtilis various phenotypic cell types have been observed, e.g. motile 
cells, non-motile cells, matrix-producing cells, spore cells (see main text). To the left: colony formed by a 
wild type B. subtilis (Credit: Claudio Aguilar, HMS, Boston). In the middle: schematic representation of a 
vertical section through a colony. Some cell types can predominantly be found in distinct areas within the 
multicellular structure (see main text). To the right: Image from a fruiting body, which is found at the 
biofilm/air interface of wild type B. subtilis colonies. Blue dye present at the tip originates from 
conversion of X-Gal by β-galactosidase, expressed from the sporulation-specific promotor PsspE 
(Source: Branda et al., 2001). c) On nutrient agar Streptomyces form mycelial colonies, which contain 
various cell types (see main text). To the left: colony formed by Streptomyces coelicolor A3(2) on a 
nutrient agar (Credit: John Innes Centre, Norwich, UK). In the middle: Vertical section through a 
Streptomyces colony (Credit: Jamie Ryding, Norwich, UK). To the right: schematic representation of the 
vertical section: chains of black circles represent spore cells, black hyphae represent live cells, white 
hyphae represent dead cells, red area represents the zone of antimicrobial compounds released into the 
immediate environment (Source, with modifications: Chater, 2006). 
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2.2 Characteristics of cell types in relation to cell 
populations 
As described in the section above (and chapter 3), when laboratory-grown multicellular 
communities are looked at through a microscope, supported by advanced techniques, a 
remarkable spatial organization is apparent. Not all cells inhabiting the clonal multicellular 
community are alike. Instead, cells situated in one area of the multicellular structure differ 
significantly from cells that are present in another area. Their phenotype can differ with 
respect to metabolic/physiological activity, gene expression profiles, productivity of 
extracellular (macro-)molecules, responsiveness to various environmental stimuli, and 
sensitivity to toxic compounds (see also chapter 3). Cells, which exhibit the same 
phenotype are often found to be spatially co-localized resulting in the formation of distinct 
subpopulations. Nevertheless, it seems as that dependencies between the different cell 
subpopulations in a microbial community exist, presumably also at the level (or because) of 
metabolic interactions, which impact on the differentiation of subpopulations and 
organization of the entire community. Metabolic interactions and their effect on spatial 
organization of a microbial community have been described for laboratory-grown mixed 
two-species microbial communities. In these mixed communities the two species were 
found to organize spatially to optimize metabolic interaction. Moreover, differentiation into 
phenotypic subpopulations was observed for one of the two species driven by metabolic 
interaction with the second species (Christensen et al., 2002; Nielsen et al., 2000). Similar 
and even more complex differentiation processes and spatial organizations are likely to 
occur in natural multi-species microbial communities.  
 
Differentiation into phenotypic cell types implicates that these processes are reversible, and 
that cells can switch between different phenotypes as a result of an adaptation response to 
changes occurring in their immediate surrounding environment. In some cases, however, 
differentiation into another cell type is manifested due to genetic variations that occurred in 
cells. Various factors are assumed to play role in causing and maintaining a genetic 
variation in a (sub-) population, but the general notion is that stress factors play a major role 
(Rosenberg, 2001; Tenaillon et al., 2004). These stress factors might either i) be generated 
by the participating members of a microbial community themselves due to unbalanced 
metabolic interactions, so that toxic metabolic intermediates accumulate as they are not 
processed further, or ii) act from the environmental surrounding on the cells, such as 
compounds of the innate immune defence, or antimicrobial agents. Therefore, one could 
speculate that in microbial communities, in which the interactions between the participating 
cells and/or the interactions of the cells with their immediate environmental surroundings 
are unbalanced so that stress acts on the microbial cells, genetic variations are likely to 
occur and to maintain (e.g. P. aeruginosa cell populations during chronic lung infection in 
CF patients). However, in adapted microbial communities in which the interactions and 
dependencies between the participating microbial cells and their surroundings are well 
regulated and balanced, the occurrence and maintenance of genetic variations can be 
expected to be lower (e.g. in mutually beneficial microbial communities inhabiting the 
human host).  
 
The co-existence of a variety of different phenotypic cell types and their spatial 
organization into confined subpopulations might be characteristic for all microbial 
multicellular communities. This does, however, not imply that the factors and processes that 
modulate cellular differentiation, assembly, and structural organization of the various 
multicellular communities are the same ones. For example, the development of fruiting 
bodies by Myxobacteria is commonly described to follow a confined genetic program under 
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a variety of environmental (starvation) conditions. The formation of mushroom-like 
structured biofilms by P. aeruginosa, or wrinkly colony biofilms by B. subtilis on the other 
hand, appear to be strongly dependent on environmental conditions and therefore might 
reflect more an optimized adaptation process to establish in a particular ecological niche. It 
can be assumed that also the formation and composition of various microbial communities 
in nature are largely driven by the prevailing environmental factors and in addition depend 
on the inherent metabolic capacities of the participating cells. Nevertheless, local 
microenvironments within multicellular structures, generated by the participating cells 
themselves, will impact on structural organization of all multicellular communities. Overall, 
it seems as that the spatial assembly and organization of microbial multicellular 
communities is driven by the prevailing environmental conditions in a particular niche, the 
inherent characteristic traits of the participating cells and local microenvironments within 
the multicellular structure.  
 
As mentioned in the beginning of this chapter, global analysis on populations of biofilm 
cells and populations of planktonic cells revealed significant differences between these 
populations at the transcriptomic and proteomic levels. Can these differences be explained 
by supposing that results obtained from planktonic cell populations reflect one 
physiological status (e.g. exponential or stationary phase), whereas results obtained from 
biofilm cell populations represent averages of various physiological states? I assume in the 
main this might be the case, however, an increasing number of investigations reveal that 
also in planktonic cell populations not all cells are alike. For example, planktonic 
exponential phase cell populations of B. subtilis contain at least two distinct phenotypic cell 
types: non-motile chains of cells (‘sessile cells’) and motile cells (Fig. 9a). Moreover, 
planktonic stationary phase cell populations of B. subtilis can contain mixed populations 
either of motile cells, endospore cells, and cannibal cells, or motile cells and competent 
cells, dependent on the composition of the cultivation medium (Gonzalez-Pastor et al., 
2003; Kearns and Losick, 2005; Maamar and Dubnau, 2005; Msadek, 1999). Another 
example is persister cells of E. coli that can be formed in exponential phase cell popu- 
 
                        
 
Fig. 9. Cell types in planktonic exponential phase cell populations. a) In exponential phase 
populations of B. subtilis laboratory strains two major cell types can be found: chains of cells (also called 
‘sessile cells’) and motile single (doublet) cells. All cells here contain the reporter fusion Phag-gfp. The 
hag-gene encodes for the flagellin protein and can be regarded as marker gene for motile cells. Consistent 
with this only the single (doublets of) cells exhibit a green fluorescent signal. All cells were stained with 
the membrane stain FM4-64 (red) (Source, with modifications: Kearns and Losick, 2005). b) Exponential 
phase E. coli cell population examined via microfluidic technique and microscopy. Most cells of an 
exponential phase E. coli cell population are lyzed by the action of ampicillin (target: peptidoglycan 
synthesis) within 4 hours. However, one subpopulation of cells, so-called ‘persisters’, survive the 
ampicillin-treatment, because these cells had arrested growth prior to ampicillin-exposure. Once the 
antibiotic agent vanishes, the persister cells resume growth (to the right) (Source, with modifications: 
Balaban et al., 2004). 
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lations (type II persisters). These cells enter a state of slow or no growth, in which they are 
tolerant to sudden employed antibiotic agents such as ampicillin. Once the antibiotic 
vanishes, the cells resume growth (Fig. 9b) (Balaban et al., 2004). These are just a few of 
the many examples providing evidence that planktonic cell populations are by no means 
homogeneous cell populations as they can consist of a number of different phenotypic cell 
types. However, in well-shaken planktonic cell cultures all cells will experience the same 
environmental conditions; therefore the diversity of cell types can be expected to be lower 
compared to biofilm cell populations where numerous micro-environments can exist. 
Overall, global analysis on planktonic cell populations will represent average profiles of 
cells living in one niche and which under these conditions exhibit stochastic expression 
rates (also referred to as ‘noise’, e.g. Rao et al., 2002), which can lead to the differentiation 
of distinct cell subpopulations. Global analysis on biofilm cell populations will represent 
average profiles of cells living in various niches and which under these conditions will 
exhibit different expression profiles. In addition, also possible stochastic fluctuations in 
gene expression will impact on the overall expression profile of biofilm cell populations. 
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3 P. aeruginosa – a biofilm model organism 
 
 
 
 
This chapter aims at introducing the organism P. aeruginosa and to provide insights into the 
biofilm life style of P. aeruginosa. At first, the principal constituents of P. aeruginosa will 
be presented, which allow this organism to interact with its environment and form distinct 
microbial communities. Thereafter, the development of the mushroom-shaped biofilm by P. 
aeruginosa will be described. At last, knowledge derived from studies involving 
antimicrobial treatments on P. aeruginosa biofilms will be presented. 
 
3.1 P. aeruginosa and its basic elements 
P. aeruginosa has become a model organism in microbiology and in particular in biofilm 
biology. It belongs to the γ-Proteobacteria and is a Gram-negative polar flagellated and 
piliated rod-shaped bacterium with a high GC-content of about 67%. In nature, P. 
aeruginosa can be isolated from various environmental habitats, such as terrestrial and 
aquatic niches as well as from animal and plants (e.g. Ramos, 2004). It is easily cultivable 
in the laboratory because it has no special nutritional requirements and it can multiply in 
reasonable time at temperatures ranging from ~14-42ºC. Cultures of P. aeruginosa have a 
typical green-bluish color due to the production of phenazines. For this trait it has been 
named P. aeruginosa, for the Latin aerugo, which refers to the blue-green rust of copper 
(Price-Whelan et al., 2006). 
 
P. aeruginosa as opportunistic pathogen 
P. aeruginosa has raised increasing attention as it can cause a wide range of opportunistic 
human infections. People afflicted with cystic fibrosis or individuals suffering from cancer, 
AIDS, burn wounds and patients in intensive care units frequently acquire infectious 
diseases caused by P. aeruginosa. Among those infections are pulmonary infections, 
medical-device-related infections, urinary tract infections, wound infections, and 
bacteremia (Bodey et al., 1983; Ramos, 2004). In particular pulmonary infections in cystic 
fibrosis patients, medical-device associated infections and wound infections have been 
associated with the biofilm lifestyle of P. aeruginosa. (e.g. Høiby et al., 2001; Hall-
Stoodley et al., 2004; Harrison-Balestra et al., 2003). Generally it appears as the pathogenic 
trait of P. aeruginosa is not restricted to humans, since this organism can cause disease in a 
great variety of eukaryotic organisms, e.g. Mus spp., Arabidopsis thaliana, Caenorhabditis 
elegans, Drosophila melanogaster, Dictyostelium discoideum, Canis spp., Lactuca spp., and 
Galleria mellonella (D'Argenio et al., 2001; Elsinghorst, 2003; Mahajan-Miklos et al., 
2000; Pukatzki et al., 2002; Rahme et al., 2000). 
 
The genome  
The genome size of P. aeruginosa can vary and range from 5.2 to 7 Mbp (Tümmler, 2006). 
It appears that the genomes of P. aeruginosa clones are made up of clonal typical core 
genome segments and accessory genome segments as well as of blocks in the core genome, 
which originate from unrestricted gene flow within the population (Tümmler, 2006; Shen et 
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al., 2006; Spencer et al., 2003; Wiehlmann et al., 2007; Wolfgang et al., 2003). The 
accessory genome consists of a variable set of genomic islets and genomic islands (e.g. 
PAPI-1, PAGI-2). Moreover the genome can harbor the sequences of prophages. A finished 
genome sequence for one P. aeruginosa strain, namely PAO1 (6.3 Mbp), is available 
(Stover et al., 2000) and deep draft genome assemblies for several other strains (e.g. PA14).  
 
Cell surface appendages  
The flagellum is a striking proteinaceous organell localized at one pole of the bacterial cell 
(Fig. 10). About 40 proteins are involved in flagella formation, either directly as structural 
components of the flagellum or as assembly components. Flagella-driven motility allows P. 
aeruginosa to actively transport itself to other locations such as in liquid environments and 
under laboratory conditions of semi-solid agar plates (swimming and swarming). Moreover, 
the flagellum has been found to be involved in adhesion and structural biofilm formation 
(e.g. O’Toole and Kolter, 1998b; Klausen et al., 2003a; McEachran and O’Toole, 2007; see 
also chapter 3.2). The flagella can also be recognized by eukaryotic hosts through Toll-like 
receptor 5 (TLR5) and elicit an immune response (Dasgupta et al., 2004). Another kind of 
surface appendages of P. aeruginosa are type IV pili (Fig. 10). PilA is the main structural 
component of type IV pili and about 20 further proteins are assumed to be involved in type 
IV pili structure and assembly (Mattick, 2002; Mattick et al., 1996). Type IV pili can 
mediate adhesion to various kinds of surfaces and molecules (e.g. epithelial cells, plastic, 
glas and DNA) and translocation across surfaces via so-called twitching motility and 
swarming motility (Köhler et al., 2000; Mattick, 2002; Mattick et al., 1996; Skerker and 
Berg, 2001). Moreover they are involved in structural biofilm formation by P. aeruginosa 
(e.g. Klausen et al., 2003a; Klausen et al., 2003a; see also chapter 3.2). P. aeruginosa 
appears to produce a third kind of proteinaceous surface appendages, called cup-fimbria, 
which were found to be involved in biofilm formation by this organism (Vallet et al., 2001). 
 
                         
Fig. 10. Transmission electron micrograph (TEM) of a P. aeruginosa PAO1 cell (marked with 
asterisk). The white arrow points to the flagella and black arrows indicate type IV pili (Source, with 
modifications: O’Toole et al., 2000). Type IV pili are proteinaceous filaments of about 5-6 nm in 
diameter, ranging from 2-5 μm in length (Folkhard et al., 1981; Semmler et al., 1999). Flagella can be 
around 4.5-9.0 μm in length and have a diameter of about 16 nm (e.g. Suzuki and Lino, 1980). 
 
Extracellular products  
P. aeruginosa can synthesize and export a variety of compounds that can be found in 
culture supernatants of this organism or in clinical specimens in which P. aeruginosa is 
present. Among those are small chemical molecules, as well as proteins, and 
polysaccharides. P. aeruginosa produces a mixture of molecules which exhibit surfactant-
like properties. The most abundant compounds are hydroxyalkanoic acids (HAAs), and 
mono- and di-rhamnolipids (Fig. 11a) (Deziel et al., 1999; Rendell et al., 1990). Their 
biosynthesis is derived from central metabolic pathways, such as fatty acid biosynthesis and 
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dTPD-activated sugars synthesis (Fig. 11b) (Maier and Soberon-Chavez, 2005). The 
production of these biosurfactants was found to promote biodegradation by P. aeruginosa 
of slightly soluble organic compounds, such as aliphatic and aromatic hydrocarbons (Al-
Tahhan, et al., 2000; Herman, et al., 1997; Miller, 1995; Zhang and Miller, 1994). Due to 
their ability in reducing surface tension the biosurfactants can also facilitate the 
translocation along surfaces by P. aeruginosa such as can be observed under laboratory 
conditions in semi-solid agar plates (swarming and twitching) (Caiazza et al., 2005; Köhler 
et al., 2000; Pamp and Tolker-Nielsen, 2007). In case of swarming motility the various 
compounds of biosurfactans can exert different effects on cellular migration and thereby 
modulate the structural pattern of the swarm zone (Caiazza et al., 2005; Tremblay et al., 
2007). Furthermore, biosurfactants appear to have multiple roles in structural biofilm 
development by P. aeruginosa (see chapter 3.2). With regard to human infections the 
biosurfactants are found to possess effects on the respiratory tract by perturbing 
mucocilliary clearance and releasing mucus glycoconjugates (Read, et al., 1992; 
Somerville, et al., 1992). Moreover, biosurfactants seem to affect host cells, e.g. by priming 
oxidative burst response and phagocytic response of monocytes but also by inducing 
necrosis of polymorphonuclear leukocytes (PMNs) (Jensen et al., 2007; Kharami et al., 
1989; McClure and Schiller, 1992). Furthermore, the biosurfactants were shown to increase 
the solubility and bioactivity of another exported molecule produced by P. aeruginosa, 
namely Pseudomonas quinolone signal (PQS) (Calfee et al., 2005). PQS together 
 
 
Fig. 11. Biosurfactants produced by P. aeruginosa. a) P. aeruginosa produces a mixture of 
ith the N-acylhomoserine lactones 3-oxo-C12-HSL and C4-HSL mediate intercellular 
biosurfactant-like molecules of three major structural groups: 3-(3-hydroxyalkanoyloxy)alkanoic acids 
(HAAs), mono-rhamnolipids, and di-rhamnolipids. The alkyl-chains of these congeners can range from 
C8 to C12, however, the most abundant congeners under laboratory conditions have C10-alkyl-chains. b) 
The biosynthesis of these molecules is derived from central metabolic pathways, such as fatty acid 
biosynthesis and deoxythymidine diphosphate (dTPD)-activated sugars synthesis. RhlA is the enzyme 
responsible for the synthesis of HAAs. The rhamnosyltransferase RhlB uses dTDP-L-rhamnose and 
HAAs as precursors and synthesizes mono-rhamnolipids. The mono-rhamnolipids together with HAAs 
are the substrates for RhlC, which synthesizes di-rhamnolipids (Source, with modifications: Maier and 
Soberon-Chavez, 2005). 
 
w
signalling (quorum sensing) by P. aeruginosa. Other small chemical molecules, which can 
be found in the extracellular milieu of P. aeruginosa, and which can be produced in 
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he cell envelope 
mprising inner and outer membrane and the peptidoglycan layer, 
response to intercellular signalling, are hydrogen cyanide and the phenazines (e.g. 
pyocyanin). Moreover, quorum sensing-regulated proteins such as LasA protease, alkaline 
protease, exotoxin A, LasB elastase, together with the lectins LecA and LecB can be 
released by P. aeruginosa into the extracellular environment (e.g. Diggle et al., 2006; Price-
Whelan et al., 2006; Schuster and Greenberg, 2006). P. aeruginosa has been found to 
produce at least three different polysaccharides: PEL, PSL and alginate. Whereas PEL and 
PSL have been found to be involved in in vitro biofilm formation by P. aeruginosa, alginate 
predominantly is involved in in vivo biofilm formation by P. aeruginosa during chronic 
colonization of lungs of cystic fibrosis patients (e.g. Branda et al., 2005; Ma et al., 2006; 
Pamp et al., 2007; Ramsey and Wozniak, 2005). 
 
T
The cell envelope, co
separates the inside from the outside of the cell and functions as a permeability barrier. 
Lipopolysaccharide (LPS) is the major component of the outer membrane and can be 
recognized through Toll-like receptor 4 (TLR4)-MD2-CD14 complex in humans resulting 
in elicitation of an immune response. Dependent on environmental conditions the structural 
composition of LPS can be modulated. It has been observed that the lipid A part of LPS 
molecules of clinical cystic fibrosis (CF) isolates of P. aeruginosa predominantly is hexa- 
or hepta-acetylated, compared to lipid A of environmental P. aeruginosa isolates, which 
predominantly is penta-acetylated (Miller et al., 2005). Under conditions of low 
concentrations of divalent cations (e.g. Mg2+, Ca2+), or in the presence of antimicrobial 
peptides (e.g. polymyxins) or polyamines (e.g. spermidine), LPS can be modified by 
addition of aminoarabinose to the phosphate moietys of lipid A (Fig. 12a). This 
modification decreases the overall negative net charge of the bacterial outer surface, and 
e.g. hence the interaction with antimicrobial peptides (Ernst et al., 1999; Kwon and Lu, 
2006; McPhee et al., 2003). The cell envelope contains various proteins of which many are 
involved in the transport of molecules in or out of the cell. Porins, located in the outer 
membrane, mediate the uptake of a number of compounds ranging from small nutrient 
molecules to larger iron-siderophore complexes. Among these are general porins such as 
OprF and OprG as well as specific porins, such as OprB (transport of glucose and other 
monosaccharides), OprP (transport of phosphate), and OprD (transport of arginine and 
lysine) or gated porins, such as FpvA (a pyoverdine receptor) (Tamber and Hancock, 2003; 
Tamber and Hancock, 2004). Many antibiotics enter the cell through porins as well. A 
number of efflux and secretion systems are responsible for exporting a variety of small 
molecules from the cell, which might have toxic effects. Multidrug efflux systems of all 
known families have either been described or homologues identified in P. aeruginosa, 
though examples of the resistance-nodulation-division (RND)-efflux pumps (e.g. MexAB-
OprM, MexCD-OprJ, MexGHI-OpmD) are the best described ones (e.g. Fig 12b). Together 
these efflux-pumps are able to export a great variety of substrates such as β-lactams, 
fluoroquinolones, triclosan, ethidium bromide, macrolides, chloramphenicol, tetracycline, 
or N-acylhomoserine lactones (Evans et al., 1998; Poole, 2005; Schweizer, 2003). A recent 
study indicates that also tolerance to an antimicrobial peptide (polymyxin E) can be 
mediated by MexAB-OprM under conditions when P. aeruginosa is living as biofilm 
(Pamp, et al., submitted). As is basic to all bacteria proteins are present in the inner 
membrane, which participate in generating the proton motive force (PMF). The inner 
membrane is also the location where external signals can be received and transferred to 
signal transduction systems (see next section) inside the cell. P. aeruginosa is able to 
degrade a wide range of organic compounds and consistent with this observation it has been 
found that P. aeruginosa is attracted to a great variety of different compounds, such as 
amino acids, sugars, phospholipids, organic acids, aromatic acids and oligopeptides (e.g. 
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Parales et al., 2004). Signal-reception of small molecules occurs for example through 
methyl accepting proteins (MCPs) involved in chemotaxis. Environmental signals can also 
be received through histidine-sensor kinases (HisKin), which are members of phosphor-
transfer signal transduction systems. The genome of P. aeruginosa PAO1 encodes for 26 
MCPs (e.g. McpA, McpB, PilJ) and 63 HisKin (e.g. PmrB, PhoQ) (Galperin, 2005).  
 
 
  
F al ig. 12. Components of the cell envelope, which can confer resistance or tolerance to antimicrobi
ntracellular components  
y networks control basic cellular processes such as 
compounds. a) Chemical structure of lipopolysaccharide (LPS) with 4-amino-4-deoxy-L-arabinose 
(marked with asterisk) bound to one phospate residue of lipid A (hier: LPS from Salmonella enterica 
serovar Thyphimurium as example) (Source, with modifications: Miller et al., 2005). b) Model of an 
assembled efflux pump of the resistance-nodulation-division (RND) family. ArcB (homologous to MexB 
from P. aeruginosa) (green) constitutes the energy-providing, substrate-binding component in the inner 
membrane. MexA (blue) is a periplasmatic ‘adaptor’, linking the inner and outer membrane components. 
TolC (homologous to OprM from P. aeruginosa) (red) constitutes an exit duct for the substrates (Source, 
with modifications: Eswaran et al., 2004). 
 
I
Remarkable complex regulator
replication and metabolism as well as processes, which govern flagella- and type IV pili-
driven motility, the synthesis and export of small chemical compounds and proteins, the 
production of polysaccharides, and modifications of cell-surface compounds. All these 
processes occur as a result of an adaptation in response to local environmental stimuli such 
as nutrients, temperature, O2, oxidative stress, secondary metabolites and other chemical 
molecules. The genome of P. aeruginosa PAO1 contains a high proportion of genes, which 
can be assigned regulatory functions. Around 517 (~9%) of all genes encode for proteins 
with motifs of transcriptional regulators or members of two-component systems 
coordinating phosphotransfer signal transduction (Kulasekara and Lory, 2004; Stover et al., 
2000). Genome sequence analysis also revealed the presence of 33 GGDEF-motifs and 21 
EAL-motifs in proteins of P. aeruginosa, which are thought to be involved in regulating 
intracellular levels of the signal-messenger molecule c-di-GMP. In addition 24 genes have 
been identified which encode for putative sigma (σ) factors (Kulasekara and Lory, 2004; 
Stover et al., 2000). Five homologues of chemotaxis gene clusters (cluster I-V) have been 
identified in the genome sequence of P. aeruginosa. Chemotaxis gene clusters encode for 
proteins, which mediate signal transduction such as CheA (sensor kinase), CheY (response 
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3.2 The development of a biofilm 
films are most suitable for detailed 
ontacting the substratum 
nosa is able to live planktonically and move around by 
indicate that the following initial developmental 
regulator), CheW (coupling protein), CheB (methylesterase), CheR (methyltransferase), 
CheZ (phosphatase) and some MCPs. Cluster I and cluster V appear to be involved in 
regulating flagella-driven motility. Cluster IV has been found to regulate type IV pili-driven 
motility, however, a recent study provides data, which indicate that this cluster might also 
modulate flagella-driven motility. Cluster III has been found to regulate the production of 
the polysaccharides PEL and PSL via c-di-GMP-signaling. The role of the chemotaxis 
cluster II is not yet clear, however, it seems as it might be involved in chemotactic 
processes of stationary phase growth by P. aeruginosa. With the exception of cluster II, all 
other four clusters have been found to be involved in biofilm formation by P. aeruginosa 
using different experimental setups (Caiazza et al., 2007; Ferrandez et al., 2002; Hickman 
et al., 2005; Parales et al., 2004; Whitchurch et al., 2004; Barken et al., in prep.). Quorum 
sensing is well known to orchestrate the production of extracellular chemical molecules and 
proteins (e.g. biosurfactants, cyanide, LasA protease, alkaline protease, exotoxin A, LasB 
elastase). The direct impact of quorum sensing on cellular motility and biofilm formation 
appears to be controversial and might be dependent on environmental conditions (e.g. 
Shrout et al., 2006). 
 
As described in chapter 1.3.1, flow-chamber-grown bio
studies concerning biofilm development, anatomy and physiology. In this section an 
overview of the developmental processes and biology of P. aeruginosa flow-chamber-
grown biofilms will be presented. It will be focused on the mushroom-like shaped biofilm, 
which is preferably formed under low shear force conditions when glucose is provided as 
carbon source. Where indicated, knowledge derived from studies on flat-structured flow-
chamber-grown biofilms and colony-grown biofilms by P. aeruginosa will be presented. 
The observed phenotype of the mature P. aeruginosa biofilm, at a glance, is depicted as 
color-coded graphical fingerprint at the end of this section (Fig. 14). 
 
C
In liquid environments P. aerugi
flagella-driven motility. Contact to the substratum by a fraction of planktonic cells can be 
initiated either passively, due to gravity or Brownian motion, or actively, by flagella-driven 
motility (McEachran and O’Toole, 2007). Within the first ~4 hours, at least two major 
phenotypic cell types at the air/liquid interface can be observed: cells that stay attached and 
cells that had attached but detach again. Little is known about the detached planktonic cells, 
but it seems as that many of those cells will be transported away by the liquid flow. Some 
of the attached cells can be observed bound to the surface via the cell-pole and rotating 
around their polar axis (e.g. Caiazza and O’Toole, 2004; Sauer et al., 2002). Microscopic 
observations, comparing wild type strain and mutant strains, indicate that flagella and SadB 
might be involved in this phenotypic behavior (Caiazza and O’Toole, 2004; Sauer et al., 
2002). However, after ~5 hours most cells are attached to the substratum via the 
longitudinal side (Sauer et al., 2002; Singh et al., 2002; Pamp, unpublished observation). 
Recent research indicates that the polysaccharide PSL, which was found to surround single 
cells, can facilitate firm attachment of cells to the substratum (Ma et al., 2006; Ma et al., 
2007a; Matsukawa and Greenberg, 2004). 
Observations involving time-lapse CLSM 
step at the substratum involves two classes of phenotypic cell types: non-motile cells and 
motile cells. Moreover, cell division is initiated. Non-motile cells can divide and the 
progeny cells can either be non-motile as well or induce surface-associated migration. 
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nitiation of structural biofilm formation 
cells can give rise to clonal microcolony 
ithin the same time frame of initial microcolony formation, an increasing number of 
Motile cells can slow-down surface-associated migration and induce cell division. The 
progeny cells can then move along the surface or stay at the location of their origin (Fig. 
13a) (Klausen et al., 2003b; Shrout et al. 2006; Singh et al., 2002; Pamp, unpublished 
observation). It appears that the relative abundance of these cell types and processes of cell 
division are delicately balanced and that a shift in favor of a certain cell type can have 
profound impact on the following developmental steps and the final three-dimensional 
structure of the biofilm. However, little is known about the cellular differentiation processes 
that lead to these different phenotypic cell types and their exact relative abundance. 
Detailed research, resolved at the single-cell level, is required to understand the intrinsic 
and extrinsic factors that govern these cellular differentiation processes.  
 
I
High local abundance of non-motile and dividing 
formation (Fig. 13b), as can be observed by studying the behavior of cells (e.g. Gfp-tagged 
cells or mixtures or Yfp- and Cfp-tagged cells) by time-lapse CLSM (Fig. 13c) (Klausen et 
al., 2003b; Singh et al., 2002). Factors that facilitate firm attachment between the cells 
within these microcolonies appear to be extracellular DNA, biosurfactants, and the 
polysaccharide PSL. Treatment of initial microcolonies with DNase I was found to dissolve 
the microcolonies and it was suggested that the extracellular DNA might function as cell-to-
cell interconnecting component (Whitchurch et al., 2002). Cells, which are unable to 
produce biosurfactants (e.g. rhlA-mutant cells), are unable to establish firm cell-to-cell 
association upon local cell proliferation (Pamp and Tolker-Nielsen, 2007). The supporting 
effect of biosurfactants on microcolony formation might be explained by changes in cell-
surface hydrophobicity, which can evidently be caused by the surface-active agents 
produced by P. aeruginosa and which might increase the adhesiveness between cells (Al-
Tahhan et al., 2000; Herman et al., 1997; Zhang et al., 1994). In support of the involvement 
of biosurfactants in microcolony formation it has been observed that expression of rhlA is 
induced in microcolonies of wild type P. aeruginosa (Lequette and Greenberg, 2005). In 
addition, the polysaccharide PSL appears to be involved as well as a mutant defective in 
PSL-production was affected in microcolony formation (Jackson et al., 2004; Matsukawa 
and Greenberg, 2004). Using a fluorescently labeled lectin and CLSM, the polysaccharide 
PSL was found to be located in the upper layers of microcolonies formed by the wild type 
and it is thought that PSL functions as a scaffold, holding the biofilm cells together in the 
microcolony (Ma et al., 2007b). The production of PSL in biofilms seems to be regulated 
via the intracellular messenger c-di-GMP, which relative amounts appear to be modulated 
by gene products of the chemosensory cluster III (Wsp-cluster) (Hickman et al., 2005). 
 
W
motile cells can be observed migrating along the surface of the substratum (Fig. 13b). This 
process appears to be facilitated by type IV pili, as mutant cells defective in type IV pili 
formation or function (e.g. pilA-, chpA-, pilJ-, pilK-mutants) exhibit no or decreased 
surface-associated motility, as can be observed by time-lapse CLSM (Klausen et al., 2003b; 
Pamp, unpublished observation). In contrast, these strains exhibit somewhat prematurely 
microcolony formation relative to the wild type, presumably due to the absence or low 
number of motile cells (Pamp, unpublished observation). The opposite is true in cases 
where surface-associated motility is stimulated, such as under conditions of low 
concentrations of iron or the presence of citrate as carbon source instead of glucose. Singh 
et al. (2002) showed that in the presence of iron-chelating lactoferrin, surface associated 
type IV pili-driven motility is increased and microcolony formation prevented. Klausen et 
al. (2003a) observed that when citrate is present, cells spread out from initial microcolonies 
resulting in a flat-structured biofilm. Comparative analysis involving the wild type strain, 
 
3  P. aeruginosa – a biofilm model organism 
 
 
 28
tructural biofilm maturation 
crocolonies formed by non-motile cells, and the cells 
ime-lapse FRAP-CLSM analysis on a 2-day-grown biofilm by the wild type strain 
o examine the impact of biosurfactants produced by P. aeruginosa on facilitating 
pilA- and fliM-mutants suggested that cells spread largely driven by type IV pili and to a 
minor degree by flagella-driven motility (Klausen et al., 2003a). 
 
S
Both subpopulations of cells, the mi
exhibiting surface-associated motility, are originators for further steps in development of 
the mushroom-like structured biofilm. Biofilm analysis involving single strains (e.g. Gfp-
tagged) or mixed strains (e.g. Cfp-tagged + Yfp-tagged strains), in combination with 
CLSM, time-lapse CLSM and/or FRAP (fluorescence recovery after photobleaching)-
CLSM revealed that formation of the mushroom-shaped biofilm occurs by climbing of 
motile cells and proliferation of these cells on top of microcolonies formed by non-motile 
cells (Fig. 13c). The microcolony-forming subpopulation is thereafter also referred to as 
‘stalk’ and the subpopulation on top has been referred to as ‘cap’.  
 
T
revealed the presence of motile cells surrounding the microcolony formed by non-motile 
cells (Haagensen et al., 2007). Mixed color-coded time-lapse CLSM involving non-motile 
cells (e.g. Cfp-tagged pilA-mutant) and motile cells (e.g. Yfp-tagged wild type) revealed, 
that microcolonies are largely formed by the pilA-mutant whereas wild type cells are 
migrating along the substratum and colonize the top of the microcolonies to form the cap-
forming subpopulation (Klausen et al., 2003b). Generally, three factors have been found to 
be involved in surface associated motility by P. aeruginosa: type IV pili, biosurfactants and 
flagella. Recent studies indicate that all three factors contribute to different degrees in 
facilitating migration of cells up on the microcolonies. As pilA-mutant cells are not able to 
climb up on a microcolony it has been thought that type IV pili-driven cellular migration is 
the main factor involved in establishment of a cap-forming subpopulation (Klausen et al., 
2003b). In support of this, pilA-gene expression was found induced in the fraction of cells 
that colonize the top of microcolonies (Barken et al., unpublished observation). However, 
studies involving mutants, which express to some degree type IV pili, but are affected in 
function of type IV pili, such as chemotaxis cluster IV-mutants (e.g. ΔchpA, ΔpilJ, ΔpilK) 
or a fimL-mutant were found to be able to climb on microcolonies formed by a pilA-mutant 
(Whitchurch et al.,2005; Barken et al., in prep.; Pamp, unpublished observation). This 
suggests a minor role for type IV pili-driven motility in cap-formation. But as the caps 
formed by these mutant strains were irregular-shaped compared to the smooth cap formed 
by wild type cells, it seems that type IV pili-driven motility and/or chemotaxis might be 
involved in modulating the three-dimensional structure of the cap-forming subpopulation 
(Whitchurch et al.,2005; Barken et al., in prep.; Pamp, unpublished observation). Since type 
IV pili are essential for formation of a cap-forming subpopulation (Klausen et al., 2003b), it 
is hypothesized that the type IV pili are rather required for attachment and binding of motile 
cells to the microcolony, than required for facilitating cellular migration. This idea is 
originated from the observation that type IV pili can bind DNA, and extracellular DNA has 
been found to cover microcolonies of the wild type strain (Allesen-Holm et al., 2006; Van 
Schaik et al., 2005).  
 
T
migration of the motile cells to the top of the microcolonies, investigations have been 
performed on biofilms initiated with Cfp-tagged pilA-mutant cells and Yfp-tagged rhlA-
mutant cells. In these experiments some rhlA-mutant cells were able to climb onto the 
microcolonies, but the final cap-forming subpopulation was significantly reduced in size 
compared to the caps formed by the wild type cells (Pamp and Tolker-Nielsen, 2007). This 
suggests, that biosurfactants can facilitate migration of motile cells on the microcolonies, 
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ecent investigations aimed at determining the role of flagella in facilitating cellular 
uring all stages of biofilm maturation the cells in the upper layer of the 
issemination from the biofilm 
multicellular structures and 
presumably by mechanisms that reduce surface tension. An additional role is suggested for 
biosurfactant production during later stages of structural biofilm maturation. In this case 
biosurfactants seem to be responsible for keeping the water channels in between the 
mushroom-like structures open (Davey et al., 2003).  
 
R
migration and colonization of microcolonies indicate that these surface appendages play a 
major role in cap-formation. Experiments carried out on mixed-strain biofilms involving 
Cfp-tagged pilA-mutant cells and Yfp-tagged fliM-mutant cells revealed that the fliM-
mutant is affected in development of a cap-forming subpopulation. Only a few cells were 
able to colonize on top of the microcolonies (Barken et al., in prep.). Together this suggests 
that in initial stages of the maturation phase motile cells might attach to the microcolonies 
via type IV pili and that the colonization of cells on top of the microcolonies is facilitated 
by flagella-driven motility supported by the secretion of surface-active agents. It is not clear 
whether in later stages of the maturation phase the cells forming the cap are still actively 
migrating, as this is difficult to examine due to technical limitations of CLSM. Initial 
attempts to address this issue, however, suggest that most cells of the cap-forming 
subpopulation are not moving during late stages of biofilm maturation (Pamp, unpublished 
observation).  
 
D
microcolony/mushroom-like structure exhibit a higher metabolic activity compared to the 
cells inside these structures (Pamp et al., submitted). This can be explained by the fact that 
concentrations of dissolved O2 (and nutrients) are high in the bulk-liquid, and therefore 
easily accessible to the cells situated in the upper layer of the biofilm structure. High 
concentrations of O2 (and nutrients) in the bulk liquid are likely to be the driving-force for 
cells to colonize the top of initial microcolonies, and the ability of motile cells, in contrast 
to non-motile cells, to transport themselves to new areas seems to be advantageous in 
conquering the top of microcolonies. The idea seems to be supported by a result obtained 
from a mixed three-color-coded experiment involving wild type cells, rhlA-mutant cells, 
and pilA-mutant cells: Only the wild type cells, which have the full capacity to migrate, 
were able to establish in the most upper layer of the multicellular structure, in contrast to 
the mutant cells which were affected in cellular migration, and established in the lower 
areas (Pamp and Tolker-Nielsen, 2007). Limited amounts of O2 within the deeper areas of 
flow-chamber-grown biofilms can be expected as has been shown by microelectrode 
oxygen measurements on colony biofilms by P. aeruginosa (Werner et al., 2004; Xu et al., 
1998). That the cells in the deeper layers of flow-chamber-grown biofilms have access to 
only very low amounts or no O2 can be concluded from the observation that nirS (nitrite 
reductase), required for anaerobic respiration, is induced in cells situated in the deeper 
layers of the multicellular structures. In addition, reactive nitrogen intermediates (RNI) such 
as nitric oxide (NO), resulting from denitrification, were found to be present in the deeper 
areas of the biofilm (Barraud et al., 2006). The cells in the deeper layers of mushroom-
shaped biofilms appear also to experience iron-limiting conditions, as pvdA-expression is 
induced in these cells (Kaneko et al., 2007).  
 
D
In aging biofilms some cells can be observed to leave the 
become planktonic (Fig. 13d). This process is commonly termed dispersion and in P. 
aeruginosa it can follow the so-called hollowing pattern. The term ‘hollowing’ results from 
observations in which void spaces (hollows) in the center of multicellular structures 
appeared. The hollows are usually filled with a great number of rapidly moving cells, which 
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eventually can find a way out of the hollows and become planktonic. In addition, dead cells 
have also been observed inside the void spaces (Barraud et al., 2006; Boles et al., 2005; 
Hunt et al., 2004; Purevdorj-Gage et al., 2005; Sauer et al., 2002; Webb et al., 2002; Webb 
et al., 2004).  
 
 
Fig. lik 13. Schematic representation of the structural biofilm development of the mushroom- e 
ifferent factors are reported to trigger hollowing, however, generally it appears that a 
gests that generally changes in environmental conditions might be sufficient to 
could be a result of phage-induced cell lysis. Investigations carried out using motility-plate 
structured biofilm by P. aeruginosa. a) Cells get in contact with the substratum and establish firm 
attachment. Differentiation of the cell population into two phenotypic subpopulations: motile cells 
(yellow) and non-motile cells (blue). Motility is facilitated by type IV-pili-driven motility. Moreover, cell 
proliferation takes place. b) High local abundance of non-motile and dividing cells gives rise to 
microcolony-formation (blue). Appearance of extracellular DNA in the microcolonies (red). In addition, a 
second cell population migrates along the substratum (yellow). c) A motile subpopulation of cells 
(yellow) climbs up on the microcolonies (blue). Motility requires flagella, biosurfactants, type IV pili and 
extracellular DNA. The mature mushroom-like structured multicellular communities are composed of 
two major spatially distinct subpopulations: the ‘cap’ (yellow) and the ‘stalk’ (blue). d) In aging biofilms 
some cells can detach from the multicellular structures to enter the planktonic mode of life. 
 
D
certain threshold diameter of the mushroom-like structures is required (e.g. Purevdorj-Gage 
et al., 2005). This could indicate that low local concentrations of O2 or nutrients in the 
deeper areas of the multicellular structures might impact on induction of hollowing. A 
recent study showed that under glucose-starved continuous flow conditions hollowing and 
dispersion is induced (Hunt et al., 2004). Sauer and colleagues describe that an increase in 
carbon source or shift to another carbon source could induce dispersion (Sauer et al., 2002).  
             
This sug
induce dispersion. In favor of the hypothesis that low anoxic local environments could 
trigger hollowing, Barraud and colleagues recently described that reactive nitrogen 
intermediates (RNI), arising from anaerobic respiration, can induce cell-death and 
dispersion (Barraud et al., 2006). These processes also occurred concurrently with an 
increased number of phages in the effluent, which might indicate that hollowing formation 
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g. 14
raphical fingerprint. It is striking that the various described phenotypic characteristics of P. aeruginosa 
 speculated that NO therefore could induce motility in the surviving cells in the deeper 
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Fi
g
. Phenotype of mature P. aeruginosa biofilms presented schematically as color-coded 
biofilms (flow-chamber-grown and colony) exhibit a distinct binary structural distribution: a phenotype is 
expressed in cells situated closer to the substratum but not in the cells situated in the upper area of the 
multicellular structure, or vice versa (see main text of this chapter). Also, macromolecules as well as 
small molecules appear to be present in high amounts in one area and present in low amounts in the other 
area. These observations provide the basis for this schematic representation. The square represents a 
vertical section through a biofilm, divided into two parts representing the upper and lower area of a 
biofilm, respectively (not to scale). Black: the phenotype is expressed preferably in this area / the amount 
of a molecule is highest in this area. Grey: the phenotype is not well expressed in this area / the amount of 
a molecule is low in this area. The representation is a simplification of the described observations from 
the various studies and should be regarded as such.   
 
assays indicate, that low concentrations of NO can also stimulate swarming motility and it 
is
layers of biofilms resulting in dispersion (Barraud et al., 2006). In support of these 
observation, Sauer and colleagues observed by global transcriptomic analysis on separated 
dispersed and biofilm cells, that flagella and phage genes were induced in dispersed cells, 
whereas genes involved in denitrification were induced in biofilm cells (Sauer et al., 2002). 
A mechanism of dispersion independent of flagella-driven motility was described recently. 
In this study an MCP (BdlA) and changes in intracellular levels of c-di-GMP were reported 
metabolic/physiological activity
cellular motiliy
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rhlA-expression
nirS-expression
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.3 Antimicrobial action in biofilms 
ciated with animals and plants or 
sed to antimicrobial compounds, 
films are composed of two major 
ubpopulations, a subpopulation situated close to the substratum and a subpopulation on 
ilms to colistin, EDTA, SDS, novispirin G10, chlorhexidine 
luconate or gallium 
, 
 gallium, the cell subpopulation situated in the interior area close 
e, which is administered as treatment against infections 
aused by Gram-negative bacteria, e.g. pulmonary infections caused by P. aeruginosa in CF 
to be required for dispersion (Morgan et al., 2006). Boles et al. (2005) observed, that 
induction of rhlAB-expression and resulting biosurfactant production in biofilms leading to 
induction of hollowing and dispersion of cells from the biofilms. Moreover they showed 
that also biosurfactants provided from the outside had a similar effect on biofilms, 
indicating that cells in the interior part of the biofilm exhibited sensitivity to the surface-
active agent, in contrast to the surrounding cells. Purevdorj-Gage et al. (2005) reported, that 
biofilms formed by a rhlA-mutant also induced hollowing and dispersion similar to the wild 
type strain, indicating that biosurfactants can trigger hollowing and dispersion but are not 
essentially required. 
 
3
Biofilms living in the environment as well as those asso
present in man-made environments are frequently expo
both of natural and synthetic origin. Flow-chamber-grown biofilms appear to be a useful 
model system to study antimicrobial action in biofilms, e.g. as the spatial appearance and 
distribution of dead and surviving cells in a biofilm upon antimicrobial attack can be 
followed in real-time. This section will give an overview of the spatial antimicrobial 
susceptibility and tolerance phenotypes of P. aeruginosa biofilms living in flow-chambers. 
Moreover, extrinsic and intrinsic determinants that can lead to these phenotypes will be 
discussed. As summary, the observed phenotypes are depicted at a glance as color-coded 
graphical fingerprint at the end of this section (Fig. 16). 
 
As described in the previous section, P. aeruginosa bio
s
top. Interestingly, all antimicrobial compounds tested by now, seem to exert their 
antimicrobial effects on either of the two subpopulations, the subpopulation close to the 
substratum or the subpopulation on top, whereas the other subpopulation survives the 
treatment. In most cases the surviving subpopulation of cells exhibits phenotypic tolerance 
and not resistance. 
 
Exposure of biof
g
If P. aeruginosa biofilms were exposed either to colistin, EDTA, SDS, novispirin G10
chlorhexidine gluconate or
to the substratum was killed, whereas the cells situated in the upper area of the multicellular 
structure survived the treatment.  
 
Colistin is an antimicrobial peptid
c
patients. This compound is thought to exert its primary antibacterial effect through 
interactions with the membrane, resulting in leakage and eventually death of the bacterial 
cell (Hancock and Chapple, 1999; Storm et al., 1977). The spatial distribution of live and 
dead cells appears to be independent of the actual three-dimensional structure of the biofilm 
and the carbon source used for biofilm-growth, e.g. as mushroom-shaped as well as 
irregular-shaped glucose-grown biofilms, and flat-structured wild type biofilms grown on 
citrate exhibited a subpopulation of dead cells close to the substratum and a subpopulation 
of live cells on top (Haagensen et al., 2007; Pamp et al., submitted; Haagensen, 
unpublished observation). In premature glucose-grown wild type biofilms, development of 
colistin tolerance in cells situated in the upper area appeared to be dependent on type IV 
pili-mediated cellular migration (Haagensen et al., 2007). The mechanism by which type IV 
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exes with metal ions, such as Mg2+, Ca2+ and Fe3+. 
xposure of proteobacterial cells with EDTA has been reported to result in removal of 
 and its derivatives can be found in 
any household products (e.g. soaps). Due to its amphiphilic characteristics SDS interferes 
pili-dependent cellular migration mediates the development of colistin tolerance in 
premature biofilms is unknown at present. In mature glucose-grown wild type biofilms, 
development of colistin tolerance in cells situated in the upper area was linked to high 
metabolic activity, and found to be independent of cellular migration (Pamp et al., 
submitted). Experiments involving fluorescent in situ gene expression under control of a 
growth-rate-dependent promotor (P1rrnB) revealed, that colistin targets preferably biofilm 
cells exhibiting low metabolic activity, whereas biofilm cells exhibiting high metabolic 
activity survive the treatment (Pamp et al., submitted). Further experiments involving 
fluorescent in situ gene expression, under control of PpmrH or PmexA, and the comparison 
of wild type and mutant strains, e.g. ΔpmrF, ΔpmrB , ΔmexAB-oprM suggested, that 
tolerance development to colistin in these biofilm cells is dependent on LPS-modification 
mediated by the pmr-operon, and efflux of colistin mediated by mexAB-oprM (Haagensen 
et al., 2007; Pamp et al., submitted).  
 
EDTA has the ability to form compl
E
divalent cations (Mg2+, Ca2+) from LPS of the outer membrane and consequently in 
disruption of the outer membrane (Hancock, 1984; Tamber and Hancock, 2004). Exposure 
of mature wild type biofilms does not only induce cell death in the subpopulation of cells 
close to the substratum, it also results in dispersal of a fraction of viable cells from the 
multicellular structures (Banin et al., 2006; Pamp, unpublished observation). Induction of 
cell death and dispersal by EDTA could be inhibited by the addition of Mg2+, Ca2+ or Fe3+ 
ions, supporting the notion, that EDTA exerts its effects on biofilm cells by complex-
formation with metal ions, which are present in the outer membrane of the cells and 
possibly also part of the stabilizing extracellular matrix (Banin et al., 2006). The reason for 
why the upper subpopulation of cells survived the EDTA treatment is unclear at present. 
The fact that expression of the pmr-operon is induced in the cell subpopulation in the upper 
layer suggested that tolerance to EDTA was conferred by pmr-mediated LPS-modification. 
However, the observation that pmr-mutants (e.g. ΔpmrF, ΔpmrB) exhibit wild type 
phenotype upon EDTA exposure indicate, that the tolerance mechanisms is independent of 
pmr-mediated LPS-modification (Pamp et al., in prep.). 
 
SDS is a synthetic anionic surfactant, and this compound
m
with biological membranes and is also known for its ability to denature proteins. High 
concentrations of SDS (0.01%) induce cell death in the cell subpopulation close to the 
substratum in premature as well as mature wild type biofilms within 30-60 minutes 
(Haagensen et al., 2007; Pamp, unpublished observation). Lower concentrations of SDS 
(0.003%) can induce cell death in the cell subpopulation close to the substratum in mature 
wild type biofilms within 13 hours (Pamp et al., in prep.). Another study reported disruption 
of P. aeruginosa biofilm via hollowing by exposure with 0.2% SDS for 1.5 hours (Boles et 
al., 2005). However, as the reported experiment was performed in the absence of a 
fluorescent indicator for dead cells (e.g. propidium iodide) it is unknown whether cells from 
the interior area of the biofilm detached or were killed. The genetic determinants and 
mechanisms, which facilitate tolerance development of the surviving fraction of cells is 
unknown at present. Tolerance development to SDS in the cells situated in the upper area 
appears to be independent of pmr-mediated LPS-modification, as pmr-mutants exhibit wild 
type phenotype upon exposure and the pmr-operon is not induced in the surviving fraction 
of cells (Pamp et al., in prep.).  
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he antimicrobial peptide novispirin G10 is a synthetic alpha-helical octadecapeptide with 
hlorhexidine gluconate is a synthetic antiseptic predominantly used as treatment against 
allium nitrate (Ga(NO3)3) is used as treatment in cancer therapy. It can inhibit growth of 
xposure of biofilms to ciprofloxacin, tetracycline, tobramycin, imipinem, 
 biofilms were exposed either to ciprofloxacin, tetracycline, tobramycin or 
T
structural similarities to sheep myeloid antimicrobial peptide 29, and its target appears to be 
the bacterial membrane. This peptide and its derivatives are considered as a novel potential 
therapeutic against infections, e.g. caused by P. aeruginosa (Eckert et al., 2006; Jacobsen et 
al., 2007; Sawai et al., 2000; Song et al., 2005; Steinstraesser et al., 2002). If mature P. 
aeruginosa wild type biofilms were exposed to novispirin G10, the cells situated in the 
interior area were killed, whereas the cells situated in the upper area of the multicellular 
structure survived the treatment (Pamp et al., in prep.). Preliminary observations suggest, 
that pmr-mediated LPS-modification is involved in tolerance development to novispirin 
G10, as expression of the pmr-operon is induced in the cells in the upper area of the biofilm 
upon exposure, and biofilms formed by pmr-mutants exhibit increased sensitivity to 
novispirin G10 (Pamp, unpublished observation). 
 
C
plaque and oral infections. It can interfere with microbial membranes, which can lead to 
perturbations and eventually death of the microbial cell (e.g. Vitkov et al., 2005). If mature 
P. aeruginosa wild type biofilms were exposed to chlorhexidine gluconate, the cells 
situated in the interior area were killed, whereas the cells situated in the upper area of the 
multicellular structure survived the treatment (Pamp et al., in prep.). The genetic 
determinants and molecular mechanisms, which are required for tolerance development to 
chlorhexidine gluconate in this particular subpopulation of cells is unknown at present. 
 
G
various lymphoma cell lines by interfering with cellular iron metabolism. The Ga3+-ion 
strongly resembles the Fe3+-ion and many biological systems are unable to distinguish Ga3+ 
from Fe3+. Iron is an essential component for functioning of key enzymes by mediating 
redox reactions, but in contrast to Fe3+, Ga3+ cannot be reduced to the divalent oxidation 
state (Jakupec and Keppler, 2004; Perabo and Müller, 2007). The approach of interfering 
with cellular iron metabolism using gallium has been recently applied in treatment of P. 
aeruginosa biofilms (Kaneko et al., 2007). If mature P. aeruginosa mushroom-shaped 
biofilms were exposed to 10 μM Ga(NO3)3 the interior part of the multicellular structure 
was killed within 72 hours, whereas cells in the upper area survived the treatment. If mature 
P. aeruginosa mushroom-shaped biofilms were exposed to 100 μM Ga(NO3)3 the interior 
part of the multicellular structure was killed within 48 hours. In addition a thin layer of the 
outermost area of the cap-forming subpopulation was killed (Kaneko et al., 2007). Using in 
situ gene expression analysis, the authors provide evidence, that expression of pvdA 
(encoding for an enzyme required for synthesis of the iron siderophore pyoverdine) is 
induced in the interior part of the structure, indicating iron-limiting conditions in this area. 
Therefore killing by gallium of the interior subpopulation is thought to occur by increased 
uptake of gallium by these cells due to iron starvation and subsequent induced cell death. 
Gallium was found not to be taken up by the major iron-uptake systems, as pyoverdine as 
well as pychelin and ferric citrate receptor mutants all exhibit wild type phenotype when 
grown in the presence of gallium in a flow-chamber setup (Kaneko et al., 2007). 
 
E
or lysozyme 
If P. aeruginosa
imipinem, the cell subpopulation situated in the interior area close to the substratum 
survived the treatment, whereas the cells situated in the upper area of the multicellular 
structure were killed.  
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he fluoroquinolone ciprofloxacin has bactericidal effects and induces cell death by 
etracycline is an antimicrobial agent, which originates from secondary metabolites 
he aminoglycosid tobramycin is a secondary metabolite derived from Streptomyces spp. 
T
interfering with bacterial replication due to inhibition of the DNA gyrase. Ciprofloxacin is 
administered for treatment of various infections caused by Gram-negative and Gram-
positive bacteria. Using in situ gene expression analysis, involving a growth activity-
dependent fluorescent reporter, it was found that ciprofloxacin specifically targets the 
biofilm cells exhibiting high metabolic activity in the upper area. By contrast, biofilm cells 
in the deeper layers exhibiting low metabolic activity survive ciprofloxacin treatment 
(Pamp et al., submitted). A similar phenotype with respect to the distribution of growth 
activity and ciprofloxacin-induced cell death was observed for a colony biofilm by P. 
aeruginosa (Walters et al., 2003). The fact that the effect of killing in flow-chamber grown 
biofilms is found to be restricted to the cells in the upper layer exhibiting high metabolic 
activity prompted to examine if metabolic activity of the cells in the deeper layers could be 
increased by e.g. providing an alternative electron acceptor (nitrate) which could 
subsequently make the cells susceptible to ciprofloxacin. However, when mature P. 
aeruginosa wild type biofilms were exposed simultaneously to ciprofloxacin and nitrate, 
severe hollowing was induced (Fig. 15a). The hollowing was a result of merging of the cap-
forming subpopulations of neighboring mushroom-like structures and dissolution of the 
stalk. Inside the hollows cells were present, which exhibited increased motility. The cells 
forming the shell of the hollows were killed to a large degree (Fig. 15a). Another combined 
treatment, in this case with ciprofloxacin and colistin was found to eradicate almost all cells 
of the flow-chamber-grown P. aeruginosa biofilm (Pamp et al., submitted).  
 
T
produced by Streptomyces spp. It can inhibit bacterial protein synthesis by preventing 
attachment of aminoacyl-tRNA to the ribosomal acceptor site (A-site) and thereby induce 
cell-death. If mature P. aeruginosa wild type biofilms were exposed to tetracycline, the 
cells situated in the upper area of the multicellular structures were killed, whereas the cells 
situated in the deeper areas survived the treatment (Pamp et al., submitted). An experiment 
involving treatment of a biofilm formed by a strain, which harbors a growth activity-
dependent fluorescent reporter fusion, indicates that tetracycline specifically kills the cells 
in the upper area, which exhibit high metabolic activity. By contrast, cells in the deeper 
areas of the biofilm, which exhibit a lower metabolic activity, are not killed by tetracycline 
(Pamp, unpublished observation). A combined treatment with colistin, which preferably 
kills the biofilm cells in the interior area, and tetracycline, which preferably kills the biofilm 
cells in the upper area, enables eradication of almost all cells of the flow-chamber-grown P. 
aeruginosa biofilm (Pamp et al., submitted). 
 
T
and it can inhibit protein synthesis in Gram-negative bacteria by preventing translocation of 
peptidyl-tRNA from the A-site to the P-site of the ribosome, and thereby inducing cell-
death. If mature P. aeruginosa biofilms were exposed to tobramycin, the cells situated in 
the upper area of the multicellular structures were killed, whereas the cells situated in the 
deeper areas survived the treatment (Bjarnsholt et al., 2005; Henzer et al., 2003; Kaneko et 
al., 2007). The efficiency of tobramycin-induced killing in P. aeruginosa biofilms was 
increased by co-administration of furanone C-30, a compound, which was identified to 
inhibit quorum sensing regulated gene expression (Henzer et al., 2003). Also, a biofilm 
formed by a mutant strain, which is defective in las- and rhl-mediated cell-to-cell-
communication showed increased sensitivity to tobramycin, indicating a possible role for 
quorum sensing in tolerance towards tobramycin (Bjarnsholt et al., 2005). Mah and 
colleagues presented results, which indicate that in biofilm cells of strain PA14 
periplasmatic glucans might sequester tobramycin and hence prevent the interaction of 
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tobramycin with its target. An ndvB-mutant, which is deficient in the synthesis of 
periplasmatic glucans, exhibited increased sensitivity to tobramycin in biofilms  (Mah et al., 
2003). 
 
 
Fig. 15. Antimicrobial treatment of mature P. aeruginosa biofilms. P. aeruginosa (Gfp) was grown 
ipenem is derived from a secondary metabolite produced in nature by Streptomyces spp. 
e is an enzyme, which is present in human fluids (e.g. tears, saliva and respiratory 
the multicellular structure were seemingly unaffected (Pamp, unpublished observation). 
for 4 days on glucose minimal medium in flow-chambers and was then continuously exposed to a) 60 
μg/ml ciprofloxacin + 7.5 mM nitrate (KNO3), b) 60 μg/ml imipenem, or c) 64 μg/ml lysozyme. Images 
were aquired a) 24 hours, b) 24 hours and c) 13 hours subsequent to the beginning of the treatment. Life 
cells appear green (Gfp) and dead cells appear red, due to staining with propidium iodide (Pamp, unpubl.). 
 
Im
It has increased stability towards degradation by β-lactamases compared to e.g. penicillin, 
and is used for treatment of various infections caused by both Gram-negative and Gram-
positive bacteria. As penicillin it interferes with bacterial cell wall synthesis by inhibiting a 
transpeptidase enzyme that links peptidoglycan molecules, and thereby induces bacterial 
cell lysis. If mature P. aeruginosa biofilms were exposed to 60 μg/ml imipenem (15×MIC) 
almost all cells in the upper part of the multicellular structures, were killed (lysed), whereas 
the cells situated in the deeper areas survived the treatment (Fig. 15b). Examination of the 
upper area of treated biofilms at a higher magnification revealed the presence of large 
spherical structures, which could be spheroplasts generated by disruption of the cell wall 
(Pamp, unpublished observation). If mature P. aeruginosa biofilms were exposed to 
subinhibitory concentrations of imipenem (0.5 μg/ml, 1/8×MIC) cells in the upper part of 
the multicellular structures exhibited increased expression of ampC (encoding for a 
chromosomal encoded β-lactamase), as examined through the use of a fluorescent reporter-
fusion (Bagge et al., 2004a). By contrast, cells in the deeper area did not express ampC. If 
mature P. aeruginosa biofilms were exposed to 10 μg/ml (2.5×MIC) all cells of the biofilm 
exhibited expression of ampC (Bagge et al., 2004a). Interestingly, exposure of mature P. 
aeruginosa biofilms to subinhibitory concentrations of imipenem for extended periods 
could increase the biofilm biomass compared to unexposed biofilms. This effect was 
described to be a consequence of overproduction of the polysaccharide alginate, induced by 
the low concentrations of imipenem (Bagge et al., 2004b). 
             
Lysozym
secretions) as well as in cells of the innate immune system (e.g. neutrophils, macrophages). 
It can degrade bacterial peptidoglycan by hydrolyzing the glycosidic bonds between N-
acetylmuramic acid and N-acetylglucosamine, leading to cell lysis. In contrast to imipinem, 
which inhibits peptidoglycan synthesis and induces lysis of the cells, which are situated in 
the upper layer of the biofilm, treatment of mature P. aeruginosa wild type biofilms with 
lysozyme appears to have a different effect. P. aeruginosa biofilms exposed to lysozyme, 
induced hollowing in the interior area of the biofilm, which is situated closest to the 
substratum (Fig. 15c). Inside the hollows single cells were observed, which exhibited 
extensive motility. In addition, a few single dead cells were present. The remaining cells of 
 
3  P. aeruginosa – a biofilm model organism 
 
 
 37
colistin
EDTA
SDS
novispirin G10
chlorhexidine
gallium (Ga3+)
ciprofloxacin +
nitrate
ciprofloxacin +
colistin
tetracycline
tetracycline +
colistin
tobramycin
imipenem
lysozyme
pmr-operon mexABoprM
pmr-operon
pmr-operon
pmr-operon
ampC
15xMIC 1/8xMIC
ampC
2.5xMIC
Haagensen et al., 2007
Pamp et al., submitted
Banin et al., 2006
Pamp et al., in prep.
Haagensen et al., 2007
Pamp et al., in prep.
Pamp et al., in prep.
Pamp et al., in prep.
Kaneko et al., 2007
ciprofloxacin Walters et al., 2003
Pamp et al., submitted
Pamp, unpublished
Pamp et al., submitted
Pamp et al., submitted
Pamp et al., submitted
Hentzer et al., 2003
Bjarnsholt et al., 2005
Kaneko et al., 2007
Bagge et al., 2004a
Pamp, unpublished
Pamp, unpublished
survival
death
expression
no expression
hollowing
s/d/h      gene expression
antimicrobial agent            phenotype phenotype reference
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig
p
. 16. Antimicrobial tolerance & susceptibility phenotype of mature P. aeruginosa biofilms 
resented schematically as color-coded graphical fingerprint. For explanations regarding the 
representation please see the information provided in the figure legend to figure 13. Red: most cells in 
this area exhibit sensitivity towards the antimicrobial compound. Green: most cells in this area survive 
the treatment of the antimicrobial compound. White: the ‘hollowing’ pattern is induced in this area. Black: 
the gene/operon is expressed in cells present in this area. Grey: the gene is not (or marginal) expressed in 
cells present in this area. The representation here is a simplification of the described observations from 
the various studies and should be regarded as such. 
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d cells are not 
ndomly distributed. Instead, the effect of antimicrobial compounds is confined to one of 
One explanation for the different effects of imipinem and lysozyme on P. aeruginosa 
biofilms could be, that imipinem might exert its effects preferentially on proliferating cells, 
whereas the effect of lysozyme might not be dependent on cell proliferation.  
 
It is striking that upon exposure of P. aeruginosa biofilms, surviving and dea
ra
the two physiological distinct subpopulations, which have been identified to be prevailing 
in P. aeruginosa biofilms (see chapter 3.1). The observations suggest, that the effect of 
antimicrobial agents, which interfere with basic cellular metabolic processes, such as 
replication, transcription, translation, or peptidoglycan synthesis, appears to a major part to 
depend on the metabolic/physiological activity of the prevailing biofilm cells. Therefore, 
the efficiency of a conventional antimicrobial compound to induce cell death in a 
population of biofilm cells might depend on the number of biofilm cells, which reflect the 
active state of a particular target, such as those cells undergoing replication will be more 
vulnerable to compounds interfering with replication processes than cells that do not 
replicate. This is in agreement with observations showing that antimicrobial agents, which 
interfere with peptidoglycan synthesis, replication or translation, effectively induce cell 
death in exponential phase cells, whereas their efficiency is relatively low on stationary 
phase cells (Spoering and Lewis, 2001). In comparison, biofilm populations of cells 
exhibited an overall median sensitivity to these compounds (Spoering and Lewis, 2001), 
which is in agreement with observations showing that biofilm cell populations consists of a 
mixture of both, cells exhibiting high and cells exhibiting low metabolic/physiological 
activity (e.g. Pamp et al., submitted; Rani et al., 2007; Sternberg et al., 1999; Wentland et 
al., 1996; Werner et al., 2004; Haagensen, personal communication). Other factors such as 
the inherent characteristics of a particular antimicrobial agent (e.g. hydrophobicity) and 
inherent characteristics of biofilms (e.g. matrix synthesis), might impact on the rate of 
diffusion of a particular compound through the multicellular structure as well. In addition, 
some cells might reflect a certain cell type in which they are inherently invulnerable 
towards a particular antimicrobial agent. The reason why membrane-targeting compounds 
and gallium preferentially kill cells in the deeper areas of the biofilm is unknown at present. 
Also the factors, which confer tolerance to the cells in the upper layer of the biofilm 
towards these compounds, are not entirely uncovered. Regarding tolerance development to 
colistin it appears that the metabolic active cells are able to adapt to colistin by LPS-
modification, mediated by the pmr-operon and antimicrobial efflux, mediated by mexAB-
oprM. However, at least with respect to pmr-mediated LPS-modification it appears that this 
mechanism does not confer tolerance to the membrane-targeting compounds EDTA and 
SDS. It will be interesting to investigate, if one common determining factor is responsible 
for the spatial distribution of live and dead cells upon exposure with membrane-targeting 
compounds and gallium, or if various mechanisms specific for each antimicrobial agent 
exist.
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4 Concluding remarks 
 
 
 
 
The majority of microbial cells on Earth live in intimate relationship with other microbial 
cells to jointly form communities, also called biofilms. Biofilms exist in a great variety of 
shapes, sizes and composition and most of the microbial communities are associated with 
animals, plants, and abiotic matter. One challenge among microbiologist is to unravel 
possible common themes among microbial communities, and to learn about interactions 
taking place between the participating biofilm cells and/or between the biofilm cells and 
their environment. 
 
Studies involving laboratory-grown biofilms have provided intriguing insight into the 
fundamental capacities of microorganisms to assemble into multicellular communities. 
Model systems such as flow-chamber-grown biofilms and colony biofilms, reveal a set of 
inherent elements of microorganisms that can facilitate their organization into multicellular 
communities. Among those elements can be e.g. the production of matrix compounds, the 
secretion of surfactants, cell-surface bound proteins, cellular migration, and regulatory 
elements such as signal transduction systems, and intra- and extra-cellular signal messenger 
molecules. In this experimental thesis work biosurfactants, flagella-driven motility and 
chemotaxis signal transduction were found to be elements involved in certain steps of the 
organization of cells into multicellular communities by the model-organism P. aeruginosa. 
A number of studies, including this thesis work, indicate that cells differentiate into 
different cell types during the process of development of a multicellular structure. These 
cell types express a phenotype, which distinguishes them from other cells and suggest that 
the different cell types exert different functions during biofilm development. A common 
theme seems to be that cells of the same type spatially co-localize and take up similar 
positions in space, suggesting that environmental factors impact on the differentiation 
process. Mature multicellular structures reveal a spatial organization that can reflect the 
developmental process of assembly. Confined subpopulations can be distinguished with 
respect to their ability to migrate, their metabolic/physiological state, gene expression, 
productivity of extracellular (macro-) molecules, responsiveness to various environmental 
stimuli and sensitivity to toxic compounds. These insights are supported by various 
observations from this experimental thesis work on P. aeruginosa biofilms, such as the 
observations that i) secreted biosurfactants facilitate migration of cells to form cap-
subpopulations, ii) the cap-forming cell subpopulation is susceptible to ciprofloxacin, 
tetracycline and imipinem, and iii) expression of the pmr-operon and mexAB-oprM in 
metabolic active cells confers tolerance to colistin.  
 
Future studies, facilitated by sophisticated approaches and new technologies, will increase 
the understanding of the microbial life in multicellular communities. Research studies with 
focus at a lower level of organization will be able to uncover expression profiles of single 
cells within the community and reveal dependencies between single members of a 
multicellular community. Research studies with focus at a higher level of organization will 
be able to uncover the actual species diversity within a microbial community in a given 
ecological niche in nature, and reveal dependencies between the various species within a 
community and dependencies between a microbial community and its environment. 
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Recent studies have indicated that biosurfactants produced by Pseudomonas aeruginosa play a role both in
maintaining channels between multicellular structures in biofilms and in dispersal of cells from biofilms.
Through the use of flow cell technology and enhanced confocal laser scanning microscopy, we have obtained
results which suggest that the biosurfactants produced by P. aeruginosa play additional roles in structural
biofilm development. We present genetic evidence that during biofilm development by P. aeruginosa, biosur-
factants promote microcolony formation in the initial phase and facilitate migration-dependent structural
development in the later phase. P. aeruginosa rhlA mutants, deficient in synthesis of biosurfactants, were not
capable of forming microcolonies in the initial phase of biofilm formation. Experiments involving two-color-
coded mixed-strain biofilms showed that P. aeruginosa rhlA mutants were defective in migration-dependent
development of mushroom-shaped multicellular structures in the later phase of biofilm formation. Experi-
ments involving three-color-coded mixed-strain P. aeruginosa biofilms demonstrated that the wild-type and
rhlA and pilA mutant strains formed distinct subpopulations on top of each other dependent on their ability
to migrate and produce biosurfactants.
Evidence is accumulating that many infections display ele-
vated tolerance towards antimicrobial attack because the caus-
ative bacteria reside in biofilms (8, 15, 51). The opportunistic
human pathogen Pseudomonas aeruginosa has become a model
organism for studying biofilm development. When P. aerugi-
nosa is grown as a biofilm in flow chambers, it often develops
mushroom-shaped multicellular structures separated by liquid-
filled channels (9, 26, 32). The cap-forming subpopulation and
the stalk-forming subpopulation of these mushroom-shaped
structures in many cases display differential tolerance to anti-
microbial compounds. For example, the antibiotic tobramycin
was shown to kill preferentially bacteria in the cap portion of
the mushroom-shaped structures, whereas the antibiotic colis-
tin, the detergent sodium dodecyl sulfate, and the chelator
EDTA were shown to kill preferentially bacteria in the stalk
portion of the mushroom-shaped structures (3, 5, 19, 21).
Knowledge about subpopulation development in biofilms, and
the way the subpopulations interact and change during struc-
tural biofilm development, may be useful for creating strategies
to control biofilm formation and eradicate persistent infec-
tions.
Studies of liquid flow and molecular diffusion in flow cham-
ber-grown biofilms have led to the proposal that the channels
and interstitial voids between the microcolonies may function
as a circulation system for efficient nutrient supply and waste
product removal (11, 52). Biosurfactants produced by P.
aeruginosa via the RhlA gene product were shown to be im-
portant for maintenance of the water channels between the
mushroom-shaped multicellular structures in biofilms (10). A
study which employed fluorescent reporter genes indicated
that biosurfactant synthesis preferentially takes place in mi-
crocolonies during early stages of biofilm development and
in the stalk portion of the mushroom-shaped structures in
more mature P. aeruginosa biofilms (33). In addition, evi-
dence has been presented that the biosurfactants produced
by P. aeruginosa are involved in the dispersion of cells from
biofilms (5, 24, 47).
P. aeruginosa produces a number of biosurfactants, of which
the three most abundant are 3-(3-hydroxyalkanoyloxy)alcanoic
acid (HAA), L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate
(mono-rhamnolipid), and L-rhamnosyl-L-rhamnosyl-3-hydroxyde-
canoyl-3-hydroxydecanoate (di-rhamnolipid) (13, 14, 44, 46).
HAA is synthesized via the RhlA enzyme and is converted to
mono-rhamnolipid by the RhlB enzyme (14, 39). Mono-rham-
nolipid is converted to di-rhamnolipid by the RhlC enzyme
(44). The rlhAB operon and rhlC gene are induced by acyl
homoserine lactone-activated RhlR and are thus under quo-
rum-sensing control (39–42, 44). In addition, phosphate limi-
tation and the presence of nitrate have been shown to promote
the synthesis of rhamnolipids, while ammonium and high
amounts of iron have been shown to repress the production of
rhamnolipids (18, 37, 38).
The formation of the mushroom-shaped multicellular
structures in P. aeruginosa biofilms under some conditions
occurs in a sequential process which involves a nonmotile
bacterial subpopulation that forms the mushroom stalks by
clonal cell proliferation in certain foci on the substratum
and a migrating bacterial subpopulation that forms the
mushroom caps via a process which requires type IV pili
(26). Type IV pili have been implicated in two kinds of
surface-associated motility in P. aeruginosa. One form of
surface-associated translocation of P. aeruginosa which re-
quires functional flagella and biosurfactant production, and
under some conditions type IV pili, has been termed swarm-
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ing motility (29, 45, 49). Another form of surface-associated
translocation of P. aeruginosa, which requires type IV pili,
has been termed twitching motility (20, 34, 48). Presently, it
is not known whether the type IV pili-driven motility that
plays a role in mushroom cap formation in P. aeruginosa
biofilms should be regarded as twitching, swarming, or an-
other kind of surface-associated motility.
Because surface-associated motility and biosurfactant pro-
duction evidently both have roles in structural biofilm forma-
tion by P. aeruginosa, we found it of interest to investigate
whether the biosurfactants produced by P. aeruginosa might
play a role in structural biofilm development by facilitating
surface-associated motility. We present evidence that migra-
tion-dependent formation of the cap portion of the mushroom-
shaped structures in P. aeruginosa biofilms is facilitated by
biosurfactant production. In addition, we present evidence that
biosurfactant production is necessary for initial microcolony
formation in P. aeruginosa biofilms.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. Escherichia coli strains were
cultured in Luria broth (LB) medium at 37°C. P. aeruginosa strains were cultured
in LB medium at 37°C during the procedure of genetic manipulation. In motility
plate assays, orcinol assays, and for cultivation of biofilms, AB minimal medium
supplemented with glucose as indicated was used. AB medium consists of
(NH4)2SO4 (15.1 mM), Na2HPO4  2H2O (33.7 mM), KH2PO4 (22.0 mM), NaCl
(0.051 M), MgCl2 (1 mM), CaCl2 (0.1 mM), and trace metals (100 l/liter). The
trace metal solution contained CaSO4  2H2O (200 mg/liter), FeSO4  7H2O
(200 mg/liter), MnSO4  H2O (20 mg/liter), CuSO4  5H2O (20 mg/liter),
ZnSO4  7H2O (20 mg/liter), CoSO4  7H2O (10 mg/liter), NaMoO4  H2O, and
H3BO3 (5 mg/liter). Antimicrobial agents were used where appropriate at the
following concentrations: for E. coli, ampicillin (Vepidan ApS, Denmark) at 100
g/ml; for P. aeruginosa, gentamicin sulfate (Biochrome AG, Germany) at 30
g/ml, streptomycin sulfate (Sigma) at 300 g/ml, potassium tellurite (Sigma) at
150 g/ml, and carbenicillin (Sigma) at 200 g/ml. The P. aeruginosa PAO1 (23)
strain from John Matticks’ laboratory and an isogenic pilA::Telr derivative (27)
were used in this study. The rhlA mutant strain was obtained by transferring the
mutated rhlA gene from P. aeruginosa PAO1 rhlA::Gmr (44) (kindly provided by
G. A. O’Toole) into P. aeruginosa PAO1, using the transducing phage E79tv2
TABLE 1. Strains, plasmids, and primers used in this study
Strain, plasmid, or primer Relevant characteristics or sequence Source and/or reference
P. aeruginosa strains
PAO1 Wild type 23; obtained from J. S.
Mattick, University of
Queensland Brisbane
PAO1 Gfp PAO1 tagged with EGFP in a mini-Tn7 construct; Gmr 27
PAO1 Yfp PAO1 tagged with EYFP in a mini-Tn7 construct; Gmr 27
PAO1 rhlA rhlA::Gmr 44; kindly provided by
G. O’Toole, Dartmouth
Medical School
PAO1 rhlA Yfp rhlA inactivated by transferring rhlA::Gmr from strain PAO1 rhlA via
transduction into PAO1 wild type; tagged with EYFP in a mini-Tn7
construct; Gmr Smr
This study
PAO1 rhlA Cfp rhlA inactivated by transferring rhlA::Gmr from strain PAO1 rhlA via
transduction into PAO1 wild type; tagged with ECFP in a mini-Tn7
construct; Gmr Smr
This study
PAO1 pilA pilA inactivated by allelic displacement with a tellurite resistance cassette
using pTTN80; Telr
27
PAO1 pilA Cfp PAO1 pilA tagged with CFP; Telr Smr This study
PAO1 pilArhlA Cfp pilA inactivated by allelic displacement in strain PAO1 rhlA CFP using
pTTN80; Telr Gmr Smr
This study
E. coli HB101 recA thi pro leu hsdRM; Smr; strain used for maintenance and
proliferation of pTTN80 and the plasmids used for fluorescent tagging
25
Plasmids
pTTN80 pCK318 with pilA::Telr cassette cloned in the NotI site; Apr Telr; used for
allelic displacement
27
pUX-BF13 mob ori-R6K; Apr; helper plasmid providing the Tn7 transposition
functions in trans
4
pBK-mini-Tn7(Km,
Sm)PA1/04/03-eyfp-a
mob; Apr Smr Kmr; delivery plasmid for mini-Tn7(Km, Sm)PA1/04/03-eyfp 31
pBK-mini-Tn7(Km,
Sm)PA1/04/03-ecfp-a
mob; Apr Smr Kmr; delivery plasmid for mini-Tn7(Km, Sm)PA1/04/03-ecfp 31
pEX1.8 pEX1 carrying ori (P. aeruginosa) as 1.8-kb PstI fragment from pRO1614
in StyI site
41
pEX1.8-rhlAB pEX1.8 carrying rhlAB including the rhlA promoter 5
Primers
Tn7-GlmS 5-AATCTGGCCAAGTCGGTGAC-3
Tn7-R109 5-CAGCATAACTGGACTGATTTCAG-3
rhlA-fw 5-CCGCTGAGTTACTTGTCTGC-3
rhlA-rev 5-TGCGTTATGCAACCGCAAAG-3
pilA-fw 5-GAAGTACGCGGTCACCTG-3
pilA-rev 5-CGGAGATGCCTACAAAGAGC-3
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(36). The P. aeruginosa PAO1 pilA rhlA double mutant strain was derived from
the rhlA mutant by allelic displacement of pilA with pilA::Telr using the knockout
plasmid pTTN80. The strains were fluorescently tagged at an intergenic neutral
chromosomal locus downstream of the glmS gene with ecfp, eyfp, or egfp in
mini-Tn7 constructs as described previously (31). Plasmids were transformed
into P. aeruginosa strains using electroporation (25 F, 200 , 5 ms, 2.5 kV).
Rhamnolipid assay. The concentration of rhamnolipids in culture superna-
tants was determined by the orcinol method as previously described (5, 28, 47),
with modifications. Briefly, P. aeruginosa strains were grown at 30°C for 4 days in
AB minimal medium supplemented with 10 mM glucose. A 0.5-ml aliquot of
culture supernatant was extracted twice with 2 volumes of diethyl ether (high-
performance liquid chromatography grade; Sigma). The ether fractions were
pooled, evaporated to dryness, and reconstituted in 0.25 ml distilled H2O. A
100-l aliquot of each sample was diluted 1:10 in orcinol reagent and heated at
80°C for 30 min. Orcinol reagent was prepared immediately prior to use and
consisted of 7.5 volumes of 60% (vol/vol) sulfuric acid and 1 volume of 1.6%
(wt/vol) orcinol in distilled water. After heating, the samples were allowed to cool
at room temperature for 15 min, and absorbance (A421) was measured and
compared with rhamnose standards. The concentration of rhamnolipids was
determined by the relation that 1.0 mg of rhamnose corresponds to 2.5 mg of
rhamnolipid (41).
Twitching motility plate assay. Twitching motility was assayed on plates com-
posed of AB minimal medium supplemented with 10 mM glucose and solidified
with 1.0% agar. The plates were dried overnight at room temperature and point
inoculated through the agar surface with 2.5-l aliquots taken from overnight
cultures of P. aeruginosa. Overnight cultures of P. aeruginosa were grown in AB
minimal medium, supplemented with 30 mM glucose, at 30°C under vigorous
shaking. All plates were incubated at 30°C for 48 h. Twitching motility was
visualized by staining with Coomassie brilliant blue R250 (Sigma) as described by
Semmler et al. (48). To complement the twitching motility-deficient phenotype
of the rhlA mutant, 0.0005% Tween 20 was added to the agar medium where
indicated. Twitching motility of P. aeruginosa rhlA containing either pEX1.8 or
pEX1.8-rhlAB was examined in the presence of carbenicillin.
Cultivation of biofilms. Biofilms were cultivated in three-channel flow cells
with individual channel dimensions of 1 by 4 by 40 mm and covered with a glass
coverslip serving as substratum for biofilm formation. The flow system was
assembled and prepared as described elsewhere (50). AB minimal medium
supplemented with 0.3 mM glucose as carbon source was used as growth me-
dium. Individual flow chambers were inoculated with 300-l aliquots taken from
overnight cultures of P. aeruginosa, adjusted to an optical density at 500 nm of
0.005. Overnight cultures of P. aeruginosa strains were grown in AB minimal
medium supplemented with 30 mM glucose at 30°C under vigorous shaking. P.
aeruginosa rhlA strains containing either pEX1.8 or pEX1.8-rhlAB were grown as
overnight cultures in the presence of carbenicillin. After inoculation, flow cham-
bers were left without flow for 1 h to allow bacterial attachment. The flow system
was incubated at 30°C, and a laminar flow with a mean flow velocity of 0.2 mm
s1 was achieved using a Watson Marlow 205S peristaltic pump. P. aeruginosa
rhlA strains harboring either pEX1.8 or pEX1.8-rhlAB were cultivated as biofilms
without supplementation of carbenicillin. Loss of plasmid during 4 days of
growth in biofilms was not observed as examined by plating of cells derived from
biofilms on LB agar medium with and without carbenicillin.
Microscopy and image processing. Image acquisition was performed by the
use of a Zeiss LSM 510 confocal microscope (Carl Zeiss, Jena, Germany)
equipped with an argon laser and with detectors and filter sets for simultaneous
monitoring of cyan fluorescent protein (CFP) and yellow fluorescent protein
(YFP). Spectral imaging of mixed three-color-coded biofilms (CFP, green fluo-
rescent protein [GFP], and YFP) was carried out using the Zeiss META module.
Lambda stacks within a spectral range from 453.5 to 549.8 nm were recorded
using laser excitation at 458, 488, and 514 nm. Reference emission spectra from
single-color-coded biofilms were used for linear unmixing of the mixed color-
coded biofilms. Images were obtained using a 40/1.3 Plan-Neofluar oil objec-
tive. Simulated three-dimensional images, shadow projections, and vertical cross-
sections were generated using the Imaris software package (Bitplane AG).
RESULTS
In order to examine the effect of biosurfactant production on
biofilm development by P. aeruginosa, we constructed isogenic
P. aeruginosa strains with and without the capability to produce
biosurfactants. We inactivated the rhlA gene in our P. aerugi-
nosa PAO1 strain by the use of transduction with phages that
had been propagated on a P. aeruginosa rhlA::Gmr strain. In-
sertion of the rhlA::Gmr cassette in our PAO1 strain was con-
firmed by PCR, and deficiency of biosurfactant production was
confirmed by a drop-collapsing assay (data not shown). In
addition, an orcinol assay showed that the wild-type PAO1
produced 50.9 g rhamnolipid/ml (n  3; standard deviation
[SD], 7.1) when it was grown in the medium used to cultivate
biofilms, compared to 0.58 g rhamnolipid/ml (n  3; SD, 1.1)
measured in cultures of the rhlA mutant. As biosurfactants
have been described to facilitate swarming motility (25), we
examined the ability of the PAO1 rhlA mutant and wild type to
swarm on semisolid glucose minimal medium and found that
the rhlA mutant was deficient in swarming, as expected (data
not shown). Subsequently, we tested the ability of the rhlA
mutant to perform twitching motility and found that the rate of
expansion at the interstitial phase between a plastic surface
and agar was significantly reduced for the rhlA mutant com-
pared to the wild type (Fig. 1A and Table 2), suggesting that
biosurfactants can also facilitate twitching motility. The P.
aeruginosa pilA mutant (which does not produce type IV pili)
was included as a nontwitching control (Fig. 1A). The twitch-
ing defect of the rhlA mutant was complemented in P. aerugi-
nosa PAO1 rhlA(pEX1.8-rhlAB), which contains a plasmid-
FIG. 1. Twitching motility plate assays. Glucose minimal medium
agar plates were point inoculated with P. aeruginosa PAO1 strains and
incubated at 30°C for 48 h. The twitching zones were visualized by
staining with Coomassie brilliant blue after incubation. (A) Twitching
zones of P. aeruginosa PAO1 Yfp wild type, P. aeruginosa PAO1
pilA::Telr (Cfp), and P. aeruginosa PAO1 rhlA::Gmr Yfp. (B) Twitching
zones of P. aeruginosa PAO1 rhlA::Gmr Yfp harboring either the
vector control plasmid pEX1.8 or the plasmid pEX1.8-rhlAB express-
ing rhlAB in trans. (C) Twitching zones of P. aeruginosa PAO1 Yfp wild
type and P. aeruginosa PAO1 rhlA::Gmr Yfp on medium containing
0.0005% Tween 20.
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borne rhlAB operon (Fig. 1B and Table 2). To further
substantiate that surfactants can facilitate twitching motility,
we investigated if the presence of the surfactant Tween 20
could restore twitching motility of the rhlA mutant in the plate
assay. In the presence of very low concentrations of Tween 20,
the rhlA mutant was able to migrate by twitching motility at the
plastic-agar interstitial surface to the same extent as the wild
type (with or without Tween 20) (Fig. 1C and Table 2).
We have previously found that when P. aeruginosa was
grown in flow chambers with glucose as carbon source, the
bacteria differentiated into a nonmotile and a motile subpopu-
lation and formed mushroom-shaped multicellular structures
with the nonmotile subpopulation in the stalk portion and the
motile subpopulation eventually settling in the cap portion
(26). When a biofilm was initiated with a mixture of P. aerugi-
nosa wild type and P. aeruginosa pilA mutant, the nonmotile
pilA mutant cells formed mushroom stalks only, whereas the
motile wild-type bacteria were able to form mushroom caps on
top of the mushroom stalks formed by the pilA mutants (26).
To address whether biosurfactants may facilitate cap formation
by the motile subpopulation in P. aeruginosa biofilms, we in-
oculated glucose minimal medium-perfused flow chambers
with 1:1 mixtures of CFP-tagged pilA mutant and either YFP-
tagged wild type or YFP-tagged rhlA mutant and investigated
structural biofilm development in the flow chambers by the use
of confocal laser scanning microscopy (CLSM). After 4 days,
the wild type had formed cap-shaped structures on top of the
stalk-shaped structures formed by the pilA mutant (Fig. 2A), as
has been shown previously by Klausen et al. (26). By day 4 the
rhlA mutant also had formed cap-shaped structures on top of
the stalk-forming pilA mutant, but the caps formed by the rhlA
mutant were significantly smaller than those formed by the
wild type (Fig. 2). The defect of the rhlA mutant in cap struc-
ture formation could be complemented by introducing the
plasmid pEX1.8-rhlAB, expressing the rhlAB operon in trans.
The rhlA(pEX1.8-rhlAB) strain formed caps on top of the
stalk-forming pilA mutant which were similar to those formed
by the wild type, whereas the rhlA(pEX1.8) strain formed caps
similar to those formed by the rhlA mutant (Fig. 2). Analysis of
50 randomly chosen mushroom-shaped structures in each of
TABLE 2. Quantification of twitching motility
P. aeruginosa strain and supplementation
Median
diama
(cm) 	 SD
P. aeruginosa PAO1 Yfp .........................................................3.25	 0.12
P. aeruginosa PAO1 rhlA Yfp.................................................1.60	 0.11
P. aeruginosa PAO1 rhlA Yfp pEX1.8 ..................................1.60	 0.21
P. aeruginosa PAO1 rhlA Yfp pEX1.8-rhlAB .......................2.85	 0.16
P. aeruginosa PAO1 Yfp  0.0005% Tween 20 ..................3.30	 0.19
P. aeruginosa PAO1 rhlA Yfp  0.0005% Tween 20..........3.15	 0.21
a Based on 10 replicates for each strain/supplement combination.
FIG. 2. Confocal laser scanning micrographs of 4-day-old biofilms, initiated with a 1:1 mixture of either P. aeruginosa pilA::Telr Cfp and P.
aeruginosa Yfp wild type (A), P. aeruginosa pilA::Telr Cfp and P. aeruginosa PAO1 rhlA::Gmr Yfp (B), P. aeruginosa pilA::Telr Cfp and P. aeruginosa
PAO1 rhlA::Gmr Yfp(pEX1.8-rhlAB) (C), or P. aeruginosa pilA::Telr Cfp and P. aeruginosa PAO1 rhlA::Gmr Yfp(pEX1.8) (D). The images show
top-down shadow projections (230 m by 230 m) with two flanking images representing sections in the x-z and the y-z planes. Bar, 40 m.
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the 4-day-old mixed-strain biofilms showed that the wild type
formed caps with an average height of 65.34 m (SD, 9.80),
while the rhlA mutant formed caps with an average height of
31.30 m (SD, 5.99). The complemented strain rhlA(pEX1.8-
rhlAB) formed caps with an average height of 65.71 m (SD,
10.37), whereas the vector control strain rhlA(pEX1.8) formed
caps with an average height of 27.02 m (SD, 5.28). The experi-
ment therefore suggested that biosurfactants produced by P.
aeruginosa have a role in facilitating mushroom cap formation.
The experiments indicating that biosurfactants may facilitate
cap formation by facilitating bacterial migration also imply that
a putative effect of the biosurfactants to a high degree is con-
fined to the biosurfactant-producing subpopulation, as the
stalk-forming pilA subpopulation in the experiments described
above was capable of synthesizing biosurfactants. If biosurfac-
tant production (i) facilitates colonization of the upper part of
P. aeruginosa biofilms by facilitating bacterial migration, and
(ii) exerts an effect which to a large extent is confined to the
biosurfactant-producing subpopulation, then a mixed biofilm
formed by P. aeruginosa pilA, rhlA, and wild-type strains should
form multicellular structures with the pilA mutant at the base,
the rhlA mutant on top of the pilA mutant, and the wild type on
top of the rhlA mutant. To investigate this hypothesis we in-
oculated flow chambers with a 1:1:1 mixture of CFP-tagged
pilA mutant, YFP-tagged rhlA mutant, and GFP-tagged wild
type. As shown in Fig. 3, in support of the hypothesis, (i) the
pilA mutants, which can produce biosurfactants but are unable
to migrate, formed microcolonies at the substratum, (ii) the
rhlA mutants, which cannot produce biosurfactants and in a
twitching motility assay showed reduced ability to migrate,
were able to colonize on top of the microcolonies formed by
the pilA mutants, and (iii) the wild-type bacteria, which are
capable of producing biosurfactants and have no migration
deficiency, were able to colonize on top of the rhlA mutants.
Because the fluorescence emission peaks of CFP, GFP, and
YFP are close to each other, simultaneous detection of these
three fluorescent proteins is not possible by the use of conven-
tional CLSM. Therefore, simultaneous detection of the YFP-,
GFP-, or CFP-tagged cells in the biofilm was carried out by the
use of a special detector system mounted on the microscope
(as described in Materials and Methods) which, as apparent in
Fig. 3, has diminished signal detection compared to conven-
tional CLSM.
Although the effect of the biosurfactants apparently to a
high degree is confined to the biosurfactant-producing sub-
population, we could not exclude that biosurfactants produced
by the pilA or wild-type subpopulations in the mixed-strain
biofilms to some extent could facilitate migration of the rhlA
mutant. If biosurfactants were necessary for the motile sub-
population to migrate on the pilA microcolonies, we would
expect that the rhlA mutant would not be able to colonize pilA
microcolonies which are not capable of providing biosurfac-
tants. To address this, we knocked out the pilA gene in the rhlA
mutant by the use of allelic exchange, inoculated a flow cell
with a 1:1 mixture of CFP-tagged pilA rhlA double mutant and
YFP-tagged rhlA mutant, and investigated biofilm develop-
ment in glucose minimal medium. We expected that the pilA
rhlA double mutant would form mushroom stalks and that we
would be able to investigate the ability of the rhlA mutant to
form mushroom caps in a biofilm entirely devoid of biosurfac-
tants. Surprisingly, however, microcolonies did not develop in
the biofilm containing the mixture of the pilA rhlA double
mutant and the rhlA mutant. Instead, the bacteria formed a flat
biofilm, as shown in Fig. 4, which depicts a CLSM micrograph
acquired in a 4-day-old pilA rhlA-rhlA mixed biofilm.
Because our experiments with mixed-strain P. aeruginosa
biofilms surprisingly had indicated that biosurfactants, in ad-
dition to their role in the formation of mature biofilm struc-
FIG. 3. Confocal laser scanning micrographs of biofilms initiated with a 1:1:1 mixture of P. aeruginosa pilA::Telr Cfp, P. aeruginosa rhlA::Gmr
Yfp, and P. aeruginosa PAO1 Gfp wild type. Representative vertical sections acquired at three different locations in 3- (left) or 4-day-old (right)
biofilms are shown.
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tures, might also play a role in the formation of the initial
microcolonies, we found it of interest to examine the role of
biosurfactant production on biofilm development in more sim-
ple model systems consisting of mono-strain P. aeruginosa bio-
films. While the wild type and the pilA mutant after 4 days of
development had formed a biofilm with mushroom-shaped
structures (Fig. 5A) and irregular protruding structures (Fig.
5C), respectively, the rhlA mutant and the pilA rhlA double
mutant both formed flat biofilms (Fig. 5B and D), supporting
the hypothesis that biosurfactants are necessary for initial
microcolony formation.
To examine further the role of biosurfactants in initial mi-
crocolony formation, we examined young P. aeruginosa bio-
films. After 16 h of development in glucose minimal medium-
perfused flow chambers, the wild type had formed small
microcolonies (Fig. 6A), whereas the rhlA mutant had formed
a flat thin biofilm (Fig. 6B). When the rhlA mutant and the wild
type were present in the flow chamber in a 1:1 mixture, the rhlA
mutant was able to form initial microcolonies of the same size
as those formed by the wild type (Fig. 6C), suggesting that
biosurfactant produced by the wild type enabled microcolony
formation by the rhlA mutant.
DISCUSSION
Because previous studies had indicated that surface-associ-
ated motility and biosurfactant production both play roles in
structure formation in P. aeruginosa biofilms (10, 26), we found
it of interest to investigate if the role of biosurfactants in
structural P. aeruginosa biofilm formation can be attributed to
FIG. 4. Confocal laser scanning micrograph of a 4-day-old biofilm,
initiated with a 1:1 mixture of P. aeruginosa rhlA::Gmr Yfp and P.
aeruginosa pilA::Telr rhlA::Gmr Cfp. The image shows a top-down
shadow projection (230 m by 230 m) with two flanking images
representing sections in the x-z and the y-z planes. Bar, 20 m.
FIG. 5. Confocal laser scanning micrographs of 4-day-old biofilms formed by P. aeruginosa PAO1 Yfp wild type (A), P. aeruginosa rhlA::Gmr
Yfp (B), P. aeruginosa pilA::Telr Cfp (C), and P. aeruginosa pilA::Telr rhlA::Gmr Cfp (D). The images show top-down shadow projections (230 m
by 230 m) with two flanking images representing sections in the x-z and the y-z planes. Bar, 40 m.
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facilitation of bacterial migration. As discussed below, our
results indicate that biosurfactants produced by P. aeruginosa
indeed do play roles in migration-mediated structure forma-
tion in the later stages of biofilm development and, in addition,
have an impact on microcolony formation in the early phase of
P. aeruginosa biofilm development.
Initial studies to determine the capability of an rhlA mutant
to migrate in conventional motility plate assays suggested that
biosurfactants promote twitching motility of P. aeruginosa. The
P. aeruginosa rhlA mutant used in the present study and other
P. aeruginosa rhlA mutants of different PAO1 sublines were
found to be impaired in twitching motility compared to their
isogenic wild type (Fig. 1A and data not shown). The defect of
the rhlA mutant strains in migration in the twitch plate assay
could in each case be complemented by either introducing the
biosurfactant biosynthesis genes rhlAB in trans or by providing
the surfactant Tween 20 (Fig. 1B and C and data not shown).
The observed defect of P. aeruginosa rhlA mutants in migration
in twitch plate assays was to some extent surprising, since so far
biosurfactants have only been reported to facilitate motility by
P. aeruginosa in swarm plate assays (14, 29). However, it ap-
pears that the ability of biosurfactants to reduce surface ten-
sion and act as wetting agents may facilitate different kinds of
surface-associated translocation of P. aeruginosa. In addition, it
has been reported that biosurfactants may affect the composi-
tion of lipopolysaccharide (LPS) on the outer membrane of P.
aeruginosa (2) and that a change in the LPS composition of P.
aeruginosa may cause a significant reduction in the capability of
the bacterium to migrate in both twitch plate and swarm plate
assays (1). An effect of changes in cell surface LPS composition
on migration in motility plate assays has been observed for
several species, including Salmonella enterica, Proteus mirabilis,
and Myxococcus xanthus (6, 17, 35, 53, 55). In the case of S.
enterica, it was shown that the defect in motility due to changes
in the LPS composition could be restored by providing a
surfactant (53).
To investigate the impact of biosurfactants on migration-
mediated structural biofilm development, we performed exper-
iments with mixed-strain color-coded biofilms. Our results pro-
vide evidence that biosurfactants produced by P. aeruginosa
indeed facilitate bacterial migration and colonization of the
upper part of the biofilm. The rhlA mutant developed mush-
room caps of reduced size on top of mushroom stalks formed
by the pilA mutant, compared to the mushroom caps devel-
oped by the wild type in an analogous setup. In addition,
experiments with three-strain color-coded biofilms suggested
that, unlike the wild-type strain, the motility-impaired rhlA
mutant was not able to colonize the top of the mushroom-
shaped structures. These experiments also indicated that the
possible effects of biosurfactant on cellular migration and
structure formation are largely confined to the subpopulations
that produce the biosurfactants. It is likely that, due to their
inherent amphipathic characteristics, the biosurfactants will
adhere directly to the cell surfaces of the producing cells or to
a cell surface in close proximity and exert their effect on cel-
lular migration, leading to the spatial distribution of distinct
subpopulations within the multicellular structures. Because
biosurfactant production evidently may facilitate both swarm-
ing and twitching motility, the involvement of biosurfactants in
facilitating migration-dependent structural development in P.
aeruginosa biofilms does not provide information regarding the
type of surface-associated motility occurring.
In agreement with our observations, Davey et al. (10) re-
ported that a P. aeruginosa rhlA mutant formed a flat biofilm.
Contrary to our suggestion, however, Davey et al. (10) sug-
gested that the biosurfactants are not required for the forma-
tion of initial microcolonies but that they participate in the
maintenance of the channels between the microcolonies once
they are formed. When we used the same P. aeruginosa rhlA
mutant as was used by Davey and colleagues we got essentially
the same results as reported by them. That is, this P. aeruginosa
rhlA strain indeed formed microcolonies and the channels be-
tween the microcolonies were subsequently colonized (data
not shown). However, when we moved the rhlA mutation via
phage transduction to a number of different PAO1 sublines,
the newly constructed rhlA mutants were all deficient in mi-
crocolony formation as reported here. This suggests that the
rhlA mutant used by Davey et al. (10) carries additional mu-
tations that enable it to form microcolonies in the absence of
biosurfactants. However, differences in media and experimen-
tal setup may also be the cause of these seemingly divergent
results.
A role of P. aeruginosa biosurfactants in initial microcolony
formation appears to be contrary to the established roles of
FIG. 6. Confocal laser scanning micrographs of 16-h-old biofilms formed by P. aeruginosa PAO1 Cfp wild type (A), P. aeruginosa rhlA::Gmr Yfp
(B), and a 1:1 mixture of P. aeruginosa PAO1 Cfp wild type and P. aeruginosa rhlA::Gmr Yfp (C). The images show top-down shadow projections
(230 m by 230 m) with two flanking images representing sections in the x-z and the y-z planes. Bar, 30 m.
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biosurfactants in maintaining channels between microcolonies
(10) and in dispersal of biofilm (5, 24, 47). However, in support
of the proposed role of P. aeruginosa biosurfactant in initial
microcolony formation, it has been shown that low concentra-
tions of rhamnolipid enhance the cell surface hydrophobicity
of P. aeruginosa by causing a release of LPS from the cell
surface (2, 56). An increase in cell surface hydrophobicity
could increase the adhesiveness of the bacteria to a level which
is critical for initial microcolony formation in biofilms. In sup-
port of this suggestion, Herman et al. (22) showed that addi-
tion of low concentrations of rhamnolipid induced the forma-
tion of multicellular aggregates in P. aeruginosa suspensions. It
is possible that the bacteria in wild-type P. aeruginosa biofilms
produce low amounts of biosurfactants, sufficient to facilitate
microcolony formation, in the early phase of biofilm develop-
ment when the cell concentration is still not high enough to
constitute a quorum. When the cell concentration reaches
higher levels, the production of high concentrations of P.
aeruginosa biosurfactants is expected to be induced via quorum
sensing, and these high concentrations of P. aeruginosa biosur-
factants might have the proposed effects on cellular migration,
channel maintenance, and biofilm dispersal. At present we
cannot explain why the effect of biosurfactants on structure
formation in developed biofilms seemed to be confined largely
to biosurfactant-producing subpopulations, whereas biosurfac-
tant production by the wild type in young wild-type–rhlA mixed
biofilms apparently could facilitate microcolony formation of
both the wild type and the rhlA mutant. However, this might be
related to differences in the amount and composition of bio-
surfactants required in the different processes. Caiazza and
coworkers recently described that the various biosurfactant
compounds produced by P. aeruginosa have different effects on
cell surface hydrophobicity and cellular migration (7).
Due to the occurrence of nutrient and oxygen gradients in
biofilms, the top of the mushroom-shaped structures is be-
lieved to be a favored location, because the cells present there
will receive more substrate from the bulk liquid than the cells
situated within the multicellular structures or close to the sub-
stratum (12, 16, 30, 43, 54). It appears that only cells which are
fully capable of type IV pilus-driven migration succeed in
reaching the favorable top of the mushroom-shaped structures.
Experiments to investigate a possible role of chemotaxis in
coordinating the cellular migration involved in cap formation
are under way in our laboratory.
In conclusion, the present study together with the studies of
others suggest that P. aeruginosa biosurfactants have multiple
roles in P. aeruginosa biofilm development: (i) they are neces-
sary for initial microcolony formation, (ii) they facilitate sur-
face-associated bacterial migration and thereby the formation
of mushroom-shaped structures, (iii) they prevent colonization
of the channels between the mushroom-shaped structures (10),
and (iv) they play a role in biofilm dispersion (5, 47).
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Bacteria living as biofilm are frequently reported to exhibit inherent tolerance to antimicrobial compounds, and 
might therefore contribute to the persistence of infections. Antimicrobial peptides are attracting increasing 
interest as new potential antimicrobial therapeutics, however, little is known about potential mechanisms, which 
might contribute to resistance or tolerance development towards these compounds in biofilms. Here we provide 
evidence that a spatially distinct subpopulation of metabolically active cells in Pseudomonas aeruginosa biofilms 
is able to develop tolerance to the antimicrobial peptide colistin. On the contrary, biofilm cells exhibiting low 
metabolic activity were killed by colistin. We demonstrate that the subpopulation of metabolically active cells is 
able to adapt to colistin by inducing a specific adaptation mechanism mediated by the pmr-operon, as well as an 
unspecific adaptation mechanism mediated by the mexAB-oprM-genes. Mutants defective in either pmr-mediated 
LPS-modification or in mexAB-oprM-mediated antimicrobial efflux were not able to develop a tolerant 
subpopulation in biofilms. In contrast to the observed pattern of colistin-mediated killing in biofilms, 
conventional antimicrobial compounds such as ciprofloxacin and tetracycline were found to specifically kill the 
subpopulation of metabolically active biofilm cells, whereas the subpopulation exhibiting low metabolic activity 
survived the treatment. Consequently, targeting the two physiologically distinct subpopulations by combined 
antimicrobial treatment with either ciprofloxacin and colistin or tetracycline and colistin almost completely 
eradicated all biofilm cells.  
 
Introduction 
 
In nature, bacteria are constantly exposed to a 
variety of small bioactive natural products, also 
referred to as secondary metabolites. Secondary 
metabolites are produced by virtually all living 
organisms on earth. The ecological role of these 
chemical compounds is still a matter of debate, and 
might range from waste product removal, to 
signalling or defence. Some of these compounds 
can exhibit bacteriocidal or bacteriostatic activities 
and are now frequently used in medical settings as 
antibiotics to treat bacterial infections. However, 
bacteria have evolved different strategies to sense, 
respond and adapt to these small chemical 
compounds. In the present study we investigate the 
spatiotemporal-dependent effects and mechanisms 
taking place in an established microbial community 
of P. aeruginosa upon exposure to the antimicrobial 
peptide colistin. 
      P. aeruginosa is a metabolically versatile Gram-
negative bacterium, which can be found as natural 
inhabitant of terrestrial and aquatic environments as 
well as associated with animals and plants (Ramos, 
2004). In humans it can frequently cause life-
threatening infections under conditions where the 
host is injured, the immune system is compromised, 
or in individuals who are afflicted with cystic 
fibrosis (CF) (Bodey et al., 1983; Lyczak et al., 
2002).    
      It is assumed that the majority of bacteria in 
nature are living in spatially distinct communities, 
also referred to as biofilms (Davey and O’Toole, 
2000). A number of human infectious diseases have 
been associated with the bacterial biofilm mode of 
living (Høiby et al., 2001; Parsek and Singh, 2003; 
Hall-Stoodley et al., 2006).  It is believed that these 
infections are difficult to treat with conventional 
antimicrobial therapy, because the causative bacteria 
reside in biofilms and are intrinsically tolerant to 
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antimicrobial attack (Costerton et al., 1999; Stewart 
and Costerton, 2001; Donlan and Costerton, 2002). 
Several reasons have been suggested to explain this 
phenomenon, such as i) poor penetration of the 
antimicrobial compound, ii) slow growth, or iii) the 
presence of specialized persister cells or phenotypic 
variants (Mah and O’Toole, 2001; Lewis, 2001; 
Stewart, 2002; Drenkard, 2003; Fux et al., 2005). 
However, recent observations indicate that, 
dependent on the antimicrobial compound used, 
biofilm cells do not necessarily exhibit higher 
tolerance than planktonic cells (Brooun et al., 2000, 
Spoering and Lewis, 2001). Therefore detailed 
knowledge on biofilm physiology, and on bacterial 
adaptation responses in biofilms towards particular 
antimicrobial compounds is required to design new 
treatment strategies against persistent infections. 
      Antimicrobial peptides (AMPs) are attracting 
increasing interest as new potential antimicrobial 
therapeutics, because i) resistance to antimicrobial 
peptides has rarely been observed (Boman, 1995; 
Hancock, 2001; Peschel and Sahl, 2006) and 
moreover ii) due to their ability to modulate innate 
immune response (Boman, 1995; Hancock and 
Sahl, 2006). Antimicrobial peptides are a struc-
turally diverse group of molecules, which share 
cationic and amphipathic properties and are found 
throughout all domains of life (Boman, 1995; 
Hancock and Chapple, 1999; Zasloff, 2002; Peschel 
and Sahl, 2006). It is generally assumed that the 
primary target of AMPs is the microbial membrane. 
However, there is increasing evidence that 
antimicrobial peptides can also have intracellular 
targets (Otvos, 2005; Brogden, 2005). It is still 
somewhat of an enigma why highly effective 
resistance mechanisms towards AMPs have not 
evolved so far, since microorganisms have been 
exposed to these peptides presumably for millions 
of years (Peschel and Sahl, 2006). 
      The antimicrobial peptide colistin (Polymyxin 
E) has recently received raising attention due to its 
significant effect on multi-drug resistant Gram-
negative bacteria (Falagas and Kasiakou, 2005; Li 
et al., 2006). Colistin belongs to a group of peptide 
antibiotics, the polymyxins, which are synthesized 
in nature by strains of Paenibacillus spp., (e.g. 
Paenibacillus polymyxa) (Ainsworth et al., 1947; 
Benedict and Langlykke, 1947; Stansly et al., 1947; 
Suzuki et al., 1965; Storm et al., 1977). In clinical 
settings these compounds are administered for 
treatment of various infections caused by Gram-
negative bacteria, e.g. sepsis, wound infections, 
urinary tract infection, pneumoniae, catheter-related 
infections and otitis media (Levin et al., 1999; 
Garnacho-Montero et al., 2003; Markou et al., 2003; 
Karabinis et al., 2004). However, the primary use of 
colistin is in treatment of lung infections caused by 
P. aeruginosa in patients afflicted with CF (Jensen 
et al., 1987; Johansen et al., 2004; Littlewood et al., 
1985; Littlewood et al., 2000). Tolerance-
development to polymyxins (and other antimicrobial 
peptides) in Gram-negatives appears to be con-
ditional and involves modifications of lipopoly-
saccharide (LPS) that decrease the overall negative 
net charge of the bacterial outer surface, and hence 
the interaction with AMPs. Among those modi-
fications is the addition of aminoarabinose to 
negatively charged phosphate groups of lipid A 
(Helander et al., 1994; Ernst et al., 1999; Zhou et 
al., 2001; Trent et al., 2001). The modification is 
mediated by the gene products of the pmrHFIJKLM-
operon (or homologues), present in Gram-negative 
bacteria such as Salmonella typhimurium, P. aeru-
ginosa and Escherichia coli (Gunn et al., 1998; 
Trent et al., 2001; McPhee et al., 2003). In P. 
aeruginosa the expression of pmrHFIJKLME 
(PA3552-3559) can be induced under conditions of 
low Mg2+, and in the presence of antimicrobial 
peptides (such as polymyxins) or polyamines (such 
as spermidine) (McPhee et al., 2003; Kwon and Lu, 
2006). Two two-component systems, namely PhoPQ 
and PmrAB, have been identified to regulate the 
expression of pmrHFIJKLME under these environ-
mental conditions (Ernst et al., 1999; Mcfarlane et 
al., 2000; McPhee et al., 2003; Moskowitz et al., 
2004). However, the reported data suggested that 
other determinants might play a role in peptide-
mediated tolerance-development as well (McPhee et 
al., 2003).  
      Haagensen et al. (2007) recently presented 
evidence that the pmr-operon is involved in the 
development of a colistin-tolerant subpopulation of 
cells in P. aeruginosa PAO1 flow-chamber-grown 
biofilms. In addition to colistin tolerance, the cells 
of this particular subpopulation were found to 
exhibit surface associated motility. However, 
whether there was a link between tolerance 
development to colistin and motility, or whether the 
apparent correlation was indirect was not clear. Here 
we provide evidence that development of tolerance 
to colistin in mature P. aeruginosa biofilms is 
dependent on cellular metabolic activity but 
independent of cellular motility. The metabolically 
active cells are able to adapt to colistin treatment by 
inducing a specific adaptation mechanism mediated 
by the pmr-operon, as well as an unspecific 
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adaptation mechanism mediated by mexAB-oprM. 
Moreover, we show that by specifically targeting 
physiologically distinct subpopulations present in a 
biofilm, it is possible to eradicate most of the cells 
in the biofilm. 
 
Experimental procedures 
 
Bacterial strains and growth conditions 
 
The bacterial strains used in this study are listed in 
table 1. For routine strain manipulations P. 
aeruginosa and E. coli strains were grown in LB 
medium at 37ºC. For batch culture experiments with 
P. aeruginosa AB minimal medium (Pamp and 
Tolker-Nielsen, 2007) supplemented with 1 μM 
FeCl3 and 10 mM glucose was used. The clinical 
non-mucoid isolates P. aeruginosa CFSJ208 and 
CFSJ234 were isolated from sputum obtained from 
23 and 25 years old patients respectively, who are 
afflicted with cystic fibrosis. Isolation was carried 
out using Pseudomonas isolation agar (PIA) and the 
strains verified using phenotypic analysis and PCR. 
Where appropriate, antibiotics were used for 
bacterial cultures at the following concentrations: 
for P. aeruginosa, gentamycin (Biochrome AG, 
Germany) at 30 μg/ml, streptomycin (Sigma, 
Germany) at 300 μg/ml, potassium tellurite (Sigma, 
Germany) at 150 μg/ml and carbenicillin (Sigma, 
Germany) at 200 μg/ml; for E. coli, ampicillin 
(Vepidan ApS, Denmark) at 100 μg/ml, chloram-
phenicol (Sigma, Germany) at 25 μg/ml, kanamycin 
(Sigma, Germany) at 50 μg/ml, and gentamycin at 
15 μg/ml. 
 
DNA manipulations 
 
Plasmids and primers used in this study are listed in 
table 1. DNA restriction enzyme digestions and 
modifications were performed according to the 
manufacturer’s instructions (Fermentas, Invitrogen). 
Plasmids were transformed using electroporation if 
not otherwise stated: for P. aeruginosa, 25 mF, 200 
Ω, <5 ms, 2.5 kV; for E. coli, 25 mF, 400 Ω, <5 ms, 
2.5 kV. P. aeruginosa strains were fluorescently 
tagged at an intergenic neutral chromosomal locus 
(25 bp downstream of the glmS gene) in miniTn7 
constructs, as described previously (Lambertsen, et 
al., 2004). The insertion was verified by PCR using 
the primers Tn7-GlmS and Tn7-R109, as described 
previously (Lambertsen, et al., 2004). The strain P. 
aeruginosa PAO1 ΔmexAB-oprM::Gmr was con-
structed as follows: A knockout fragment of 
ΔmexAB-oprM containing a gentamycin (Gm) 
resistance cassette was generated by PCR overlap 
extension essentially as described by Choi and 
Schweizer (2005); shortly, primers MexA-UpF-GW, 
MexA-UpR-Gm, OprM-DnF-Gm, OprM-DnR-GW 
were used to amplify chromosomal regions of mexA 
and oprM respectively, and primer Gm-F and Gm-R 
were used to amplify the Gm cassette using plasmid 
pPS856 (Hoang et al. 1998) as template. The PCR 
fragments were fused together and amplified with 
primers GW-attB1 and GW-attB2 incorporating the 
attB1 and attB2 recombination sites at either end of 
the knockout cassette. Using the Gateway cloning 
system (Invitrogen) the resulting knockout fragment 
was first transferred via BP reaction into 
pDONR221 generating entry plasmid pDONR211-
mexA-oprM and subsequently transferred via LR 
reaction into pEX18ApGW generating the knockout 
plasmid pEX18ApmexA-oprM. The knockout 
fragment ΔmexAB-oprM::Gmr was transferred into 
P. aeruginosa PAO1 by triparental mating using 
helper strain E.coli HB101 pRK600. The resulting 
double crossover in strain P. aeruginosa ΔmexAB-
oprM::Gmr was confirmed by PCR and the 
phenotype regarding sensitivity to conventional 
antimicrobial agents compared with the known 
phenotype of strain P. aeruginosa PAO200. The 
strains P. aeruginosa PAO1 ΔmexPQ-oprE::Gmr, P. 
aeruginosa PAO1 ΔmexGHI-oprD::Gmr, and P. 
aeruginosa PAO1 ΔyegMNO-opmB::Gmr were 
constructed in exactly the same way, with the 
exception that the following gene-specific primers 
were used: MexP-UpF-GW + MexP-UpR-Gm and 
OprE-DnF-Gm + OprE-DnR-GW for the con-
struction of the mexPQ-oprE mutant, MexG-UpF-
GW + MexG-UpR-Gm and OprD-DnF-Gm + 
OprD-DnR-GW for the construction of the mexGHI-
oprD mutant, and YegM-UpF-GW + YegM-UpR-
Gm and OpmB-DnF-Gm + OpmB-DnR-GW for the 
construction of the yegMNO-opmB mutant. 
 
Cultivation of biofilms 
 
Biofilms were cultivated in flow-cells with 
individual channel dimensions of 1 x 4 x 40 mm, 
covered with a glass coverslip (Knittel Gläser, 
Germany) as substratum for biofilm formation. The 
biofilm flow-cell system was assembled and 
prepared as described elsewhere (Sternberg and 
Tolker-Nielsen, 2005). AB minimal medium (Pamp  
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and Tolker-Nielsen, 2007) supplemented with 0.3 
mM glucose as carbon source was used as growth 
medium. Individual flow-cells were inoculated with 
300 μl aliquots of overnight growth cultures of P. 
aeruginosa, which were adjusted to an optical 
density at 500 nm of 0.005. Overnight cultures of P. 
aeruginosa were grown in AB minimal medium 
supplemented with 30 mM glucose at 30ºC under 
vigorous shaking. To allow attachment of the 
bacterial cells to the substratum, flow-cells were left 
without flow for 1 hour after inoculation at 30ºC. 
Afterwards, a laminar flow with a mean flow 
velocity of 0.2 mm/s was achieved using a Watson 
Marlow 205S peristaltic pump. The P. aeruginosa 
strain containing plasmid pmexA-gfp was cultivated 
as biofilm without supplementation of carbenicillin 
to avoid any possible secondary effects during 
treatment with other antimicrobial compounds. Loss 
of plasmid during 4 days of biofilm growth was 
observed in a minor fraction of non-treated biofilms 
on average in less than 4 percent of cells, as 
examined by plating of dilutions of cells derived 
from biofilms on LB agar medium with and without 
carbenicillin. 
 
Exposure of biofilms to antimicrobial and other 
compounds 
 
Mature biofilms were exposed to the following 
compounds where indicated: 25 μg/ml colistin 
(Colimycin, colistin methanesulfonate; Lundbeck 
A/S, Denmark); 60 μg/ml ciprofloxacin (Bayer, 
Germany); 200 μg/ml tetracycline (Sigma, 
Germany); 30 μM carbonyl cyanide 3-chlorophe-
nylhydrazone (CCCP) (Sigma, Germany). This was 
achieved by supplementing biofilm media with the 
required compounds at appropriate final concen-
trations and addition of the fluorescent dead-cell 
indicator propidium idodide (Sigma, Germany) at a 
final concentration of 0.3 μM. In non-treated 
control experiments 0.3 μM propidium iodide was 
added alone to the biofilm media. The colistin used 
here is colistin methanesulfonate, which is a 
compound undergoing hydrolysis in aqueous 
solutions to form the active compound colistin 
sulfate (CS) in a time-dependent manner (Bergen, et 
al., 2006). In control experiments CS (Sigma, 
Germany) was added in concentrations raging from 
0.5 μg/ml to 8.0 μg/ml instead of colistin (i.e. 
colistin methanesulfonate). In these experiments the 
same spatial distribution of dead and alive cells was 
observed after 24 hours of exposure, compared to 
biofilms treated with 25 μg/ml colistin (colistin 
methanesulfonate). We used colistin (colistin 
methanesulfonate) in this study, since this is the 
actual compound, which is mainly used in medical 
settings for treatment of infections, in particular for 
treatment of P. aeruginosa lung infections in CF 
patients (Høiby et al., 2005; Littlewood et al., 2000; 
Li et al., 2006). In some experiments 2.5 μM Syto 9 
was added for counterstaining of living cells. To 
determine the survival rate upon antimicrobial 
treatment, cells were harvested from treated and 
non-treated biofilms and the number of surviving 
cells determined as follows: The bulk liquid was 
carefully removed from the flow-chambers and the 
biofilm cells recovered by pumping 1 ml 0.9% NaCl 
solution containing 50 μg glass beads (size ≤ 106 
μm) (Sigma, Germany) rapidly back and forth 
through the flow-chamber until all cells were 
removed from the substratum as examined by 
microscopic inspection. The cell-suspension was 
mixed by vortexing and the number of living cells 
determined by plating dilutions of cells on LB agar 
medium and determination of the number of colony 
forming units (CFU) upon incubation. 
 
Microscopy and image processing 
 
Image acquisition was performed with a Zeiss LSM 
510 confocal laser scanning microscope (Carl Zeiss, 
Germany) equipped with an argon and a NeHe laser 
and detectors and filter sets for simultaneous 
monitoring of Gfp (excitation, 488 nm; emission, 
517 nm) and propidium iodide (excitation, 543 nm; 
emission, 565 nm). Images were obtained using a 
40x/1.3 Plan-Neofluar oil objective. Simulated 
multichannel cross-sections were generated using 
Imaris software package (Bitplane AG, Switz-
erland). 
 
Results 
 
When P. aeruginosa PAO1 is grown under 
continuous culture conditions in flow-chambers for 
four days with glucose as carbon source, it can form 
mature multicellular structures of mushroom-like 
shape (e.g. Fig 1A, and Klausen et al., 2003a). If 
this biofilm is exposed to 25 μg/ml colistin for 24 
hours, only part of the biofilm is eradicated, as can 
be visualized by staining of dead cells with the 
fluorescent indicator propidium iodide: cells in the 
interior part close to the substratum are killed by 
colistin, whereas cells in the upper layer survive the 
treatment (Fig 1B, and Haagensen et al., 2007).  
  6
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laboratory and clinical strains of P. aeruginosa 
exhibit a similar colistin tolerance phenotype in 
biofilms 
 
Bacterial strains, which have been repeatedly 
passaged in the laboratory (as the strain used here), 
can under some conditions exhibit different 
phenotypes compared to environmental or clinical 
isolates (Velicier et al., 1998; Branda et al., 2001, 
Lee et al., 2005). In order to investigate, whether 
the PAO1 strain differed from clinical isolates with 
respect to colistin tolerance in biofilms, we 
investigated a number of P. aeruginosa strains, 
which had been isolated from sputum of young 
patients afflicted with cystic fibrosis, with respect to 
their sensitivity to colistin when grown as biofilm.  
The clinical isolates exhibited the same phenotype 
as the laboratory strain, namely a colistin-sensitive 
subpopulation close to the substratum and a colistin-
tolerant subpopulation on top (two examples are 
shown in Fig. 1C-F). Because genetic variants 
evidently can arise at high frequency in some 
biofilms (Rainey and Travisano, 1998; Boles et al., 
2004) it might be speculated that the cells, which 
survive the colistin treatment under our 
experimental conditions, are genetic variants 
inherently resistant to colistin. However, when 
tested on agar plates, cells harvested from colistin-
treated biofilms formed by the laboratory strain or 
the clinical isolates did not exhibit any change in 
sensitivity to colistin compared to the cells used to 
initiate a biofilm (data not shown). This provides 
evidence that neither laboratory nor clinical strains 
develop inherent resistance to colistin during 
biofilm-growth in the flow-chamber system. Instead 
some cells exhibit phenotypic tolerance to colistin in 
biofilms and apparently only under circumstances 
when they are situated in the upper part of the 
biofilm. 
 
Cellular migration per se is not involved in 
tolerance development towards colistin in mature 
biofilms 
 
Studies employed to unravel the developmental 
stages and genetic determinants involved in for-
mation of the mushroom-like structured P. 
aeruginosa biofilm have shown, that this biofilm is 
composed of at least two distinct subpopulations: a 
stalk-forming subpopulation situated at the substra-
tum, and a cap-forming subpopulation on top (Haag-
ensen et al., 2007; Klausen et al., 2003b; Pamp and 
Tolker-Nielsen, 2007). The studies demonstrated 
that the stalk-forming subpopulation is composed of 
non-motile cells, whereas the cap-forming subpopu-
lation is formed by motile cells. In addition, the 
previous study on colistin tolerance in P. aeruginosa 
biofilms suggested, that the colistin-sensitive 
subpopulation spatially corresponds to the sub-
population of non-motile cells, whereas the colistin-
tolerant subpopulation spatially corresponds to the 
subpopulation of motile cells (Haagensen et al., 
2007). This suggests that cellular migration might 
Fig. 1. Distribution of dead and live cells in colistin-treated P. 
eruginosa biofilms. Biofilms of P. aeruginosa PAO1 Gfp 
A+B), P. aeruginosa CFSJ208 Gfp (C+D) and P. aeruginosa 
FSJ234 (E+F) were grown for 4 days and then continuously 
xposed to 25 μg/ml colistin and propidium iodide for 24 
ours (B, D, F), or as control only to propidium iodide. The 
onfocal laser scanning micrographs show a horizontal section 
ith two flanking images representing sections in the xz and 
z planes, respectively. Live cells appear green due to 
xpression of Gfp (A, B, C, D) or due to staining with the 
luorescent indicator dye Syto 9, specific for live cells (E+F). 
ead cells appear red, due to staining with the dead-cell 
ndicator propidium iodide. 
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be involved in tolerance development to colistin. To 
test this hypothesis, we examined a number of 
motility-defective isogenic P. aeruginosa mutant 
strains with respect to tolerance development 
towards colistin in 4-day-grown biofilms. However 
all motility-defective mutants exhibited the same 
phenotype as the wild type: a sensitive sub-
population close to the substratum, and a tolerant 
subpopulation on top (Fig. 2, and data not shown). 
This suggests that, although bacterial migration is 
involved in structural development of the 
mushroom-like structured biofilm, it is not per se 
required for tolerance development to colistin in 
mature biofilms.  
 
Metabolic/physiological activity is highest in cells 
situated in the upper layer of the biofilm 
 
The observations described above suggested, that 
the physiology of cells situated in the upper layer of 
the flow-chamber-grown biofilm (cap-forming 
subpopulation) significantly differs from the physio-
logy of the cells situated in the area closer to the 
substratum (stalk-forming subpopulation). To learn 
more about the physiology of P. aeruginosa cells 
grown in flow-chambers, we examined their 
metabolic/physiological activity by the use of a 
fluorescent reporter. Similar to as previously de-
scribed (Andersen et al., 1998; Sternberg et al., 
1999), we introduced the growth rate-dependent 
fluorescent reporter fusion rrnBP1-gfp[AGA] into 
our P. aeruginosa strain. In this case the gfp[AGA]-
gene, encoding for a Gfp-protein with a short half-
life, is placed under the transcriptional control of the 
ribosomal promotor rrnBP1. From cells of P. 
aeruginosa rrnBP1-gfp[AGA], which exhibit a high 
metabolic/physiological activity one can therefore 
expect a high fluorescent signal, whereas cells 
exhibiting a low metabolic/physiological activity 
would give no or a low fluorescent signal. As 
control we used P. aeruginosa rrnBP1-gfp, a strain 
expressing a stable version of Gfp, which should 
give an equal high fluorescent signal from all cells 
independent of the actual physiological state. When 
P. aeruginosa rrnBP1-gfp[AGA] was grown as a 
biofilm and CLSM images were acquired at 
intervals over a course of time of four days, a high 
fluorescent signal from cells situated in the upper 
layer could be detected at any time point (Fig. 3A). 
This suggests that the cells in the upper layer of the 
biofilm exhibited high metabolic/physiological 
activity. In contrast, cells located in the interior part 
of the multicellular structure exhibited a lower fluor- 
Fig. 2. Distribution of dead and live cells in colistin-treated 
biofilms formed by P. aeruginosa strains, which are impaired 
in cellular migration. Biofilms of P. aeruginosa PAO1 
pilA::Telr Gfp (A+B), P. aeruginosa PAO1 fliM::Tetr Gfp 
(C+D), P. aeruginosa PAO1 pilA::Telr fliM::Tetr (E+F) and P. 
aeruginosa PAO1 rhlA::Gmr (G+H) were grown for 4 days 
and then continuously exposed to 25 μg/ml colistin and 
propidium iodide for 24 hours (B, D, F, H), or as control to 
propidium iodide (A, C, E, G).  The confocal laser scanning 
micrographs show a horizontal section with two flanking 
images representing sections in the xz and yz planes, 
respectively. Live cells appear green due to expression of Gfp 
and dead cells appear red, due to staining with the dead-cell 
indicator propidium iodide. 
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escent signal (Fig. 3A), indicating lower cellular 
metabolic/physiological activity. In some cases, a 
small fraction of cells exhibiting a high fluorescent 
signal could be observed in the stalk-part close to 
the substratum. The exact reason for this high signal 
is unknown at present. One reason could be that a 
high fluorescent signal is detected from this area 
because particularly here the cells are situated in 
very close proximity, resulting in a higher average 
number of cells compared to the rest of the 
structure, as can be seen using a higher magni-
fication (data not shown; Fig. 1 in Haagensen et al., 
2007) As expected, an almost homogenous 
fluorescent signal from the entire biofilms of the 
control-strain P. aeruginosa rrnBP1-gfp was 
detected (Fig. 3B). 
To get supporting evidence for the result involving 
the growth activity reporter, suggesting that 
specifically the biofilm cells in the upper layer of 
the biofilm are metabolically active, we chose to 
treat the biofilm with a compound that acts 
specifically on metabolically active cells. Cipro-
floxacin was chosen, since it was shown to be 
significantly more effective on growing than non-
growing planktonic cells of P. aeruginosa, and 
because penetration of this compound was shown 
not to be restricted in a colony biofilm of P. 
aeruginosa (Davey et al. 1988; Walters et al., 
2003). We exposed a 4-day-grown biofilm of P. 
aeruginosa rrnBP1-gfp[AGA] to 60 μg/ml 
ciprofloxacin in the presence of the dead cell 
indicator propidium idodide, and followed the effect 
over 13 hours. As shown in Fig. 4A, ciprofloxacin 
killed only the cells in the upper layer of the 
biofilm, which exhibited high fluorescent signal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Visualization of metabolic/physiological active cells in P. aeruginosa biofilms. P. aeruginosa PAO1 Tn7-rrnBP1-
gfp[AGA] (A) and P. aeruginosa PAO1 Tn7-rrnBP1-gfp (B) were grown as biofilm and confocal laser scanning micrographs 
acquired every 24 hours for 4 days. Cells appear green either due expression of the unstable variant of the green fluorescent 
protein, Gfp[AGA] (A), or the stable version Gfp (B), both expressed under control of the ribosomal promotor rrnBP1. The images 
show vertical sections, respectively. 
 
 
Ciprofloxacin killed neither the cells exhibiting a 
low fluorescent signal, nor the small fraction of cells 
close to the substratum, which exhibited a higher 
fluorescent signal. Also, prolonged exposure to 
ciprofloxacin did not lead to a killing-effect in the 
stalk-forming subpopulation of cells (data not 
shown). This provides evidence that only the cells in 
the upper layer of the flow-chamber-grown biofilm 
exhibit high metabolic/physiological activity. 
 
Colistin kills preferably biofilm cells exhibiting low 
metabolic/physiological activity 
 
To investigate if the killing-effect of colistin is 
confined to a distinct metabolic/physiological 
subpopulation of biofilm cells, a biofilm of the 
strain harbouring the growth activity reporter, P. 
aeruginosa rrnBP1-gfp[AGA], was grown for 4 
days and subsequently exposed to 25 μg/ml colistin 
in the presence of the dead cell indicator propidium 
idodide. CLSM image acquisition showed that 
colistin specifically targeted the cells exhibiting low 
fluorescent signals, indicating that it preferably 
killed cells with low metabolic activity (Fig. 4B). In 
contrast, cells exhibiting high fluorescent signals 
survived the colistin treatment, indicating that 
biofilm cells with high metabolic activity exhibited 
tolerance towards colistin (Fig 4B). 
 
Biofilm cells depleted of metabolic/physiological 
energy are sensitive towards colistin 
 
The results described above suggested that an 
energy-driven active process might be involved in 
tolerance development towards colistin of the 
distinct upper subpopulation of cells in biofilms. To  
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obtain additional evidence for this proposition we 
chose to deplete the biofilm cells of metabolic 
energy using the uncoupler of oxidative phos-
phorylation CCCP. Biofilm cells treated with CCCP 
should not be able to develop tolerance towards 
colistin in the upper layer. When a 4-day-grown 
biofilm of P. aeruginosa was simultaneously ex-
posed to 30 μg/ml CCCP and 25 μg/ml colistin (in 
the presence of propidium iodide), all cells in the 
biofilm were killed within 13 hours (Fig. 5A). 
However, no cells were killed in a 4-day-grown 
biofilm of P. aeruginosa when solely exposed to 30 
μg/ml CCCP (and propidium iodide) (Fig. 5B). This 
finding substantiates the suggestion, that an active 
cellular process is required to develop tolerance 
towards colistin in P. aeruginosa biofilms. 
 
Biofilm cells exhibiting high metabolic activity 
induce pmrHFIJKLME-expression upon colistin 
treatment and hence survive 
 
It is known that pmrHFIJKLME-mediated LPS-
modification is involved in tolerance towards 
colistin, and using the fluorescent promotor fusion  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PpmrH-gfp Haagensen and colleagues have recently 
shown, that this operon was induced in a 4-day-
grown biofilm of P. aeruginosa, which had been 
exposed to colistin for 24 hours (Haagensen et al., 
2007). However, it was not investigated, when and 
where induction is initiated in the biofilm im-
mediately upon exposure to colistin, and how this 
correlated to the appearance of dead cells in the 
interior part of the multicellular community in a 
spatiotemporal-dependent manner. In order to in-
vestigate spatiotemporal pmrH-induction and cell-
death in more detail, we exposed a 4-day-grown 
biofilm of P. aeruginosa PpmrH-gfp to 25 μg/ml 
colistin in the presence of the dead-cell indicator 
propidium iodide, and followed the effect over 13 
hours. In agreement with the previous study (Haa-
gensen et al., 2007), the pmr-operon was not 
expressed in the absence of colistin (Fig. 6A t0). The 
pmr-operon was induced after 4 hours but only in 
the subpopulation of cells comprising the upper 
layer of the biofilm, which had just been identified 
to exhibit high metabolic activity (Fig. 6A). No 
induction was observed in the interior part of the 
biofilm. Instead, cells in this part, which were not  
F
o
ig. 4. Targeting distinct metabolic/physiological subpopulations in P. aeruginosa biofilms by ciprofloxacin and colistin. Biofilms 
f P. aeruginosa PAO1 Tn7-rrnBP1-gfp[AGA] were grown for 4 days and then continuously exposed to either 60 μg/ml 
iprofloxacin and propidium iodide (A), or to 25 μg/ml colistin and propidium iodide (B). Confocal laser scanning micrographs 
ere acquired at time point t0 (prior to exposure) and 4, 9, and 13 hours subsequent to the beginning of treatment. The images show 
 horizontal section with two flanking images representing section  in the xz and yz planes, respectively. Metabolic active cells 
ppear green due to expression of Gfp[AGA] under control of the ribosomal promotor rrnBP1 and dead cells appear red, due to 
taining with the dead-cell indicator propidium iodide. 
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Fig. 5. Biofilm cells exposed to CCCP become sensitive to colistin. Biofilms of P. aeruginosa PAO1 Gfp were grown for 4 days 
and then continuously exposed to either 25 μg/ml colistin, 30 μM CCCP and propidium iodide (A), or, as control, to 30 μg/ml 
CCCP and propidium iodide (B). Confocal laser scanning micrographs were acquired at time point t0 (prior to exposure) and 4, 9, 
and 13 hours subsequent to the beginning of treatment. The images represent vertical sections of biofilms, respectively. Live cells 
appear green due to expression of Gfp and dead cells appear red, due to staining with the dead-cell indicator propidium iodide. 
 
 
ba le to induce the pmr-operon during the first hours 
pon colistin exposure, were killed by the colistin 
subsequently (Fig. 6A). To verify that all cells in the 
stalk-part were killed by colistin, we exposed the 
biofilm to Syto 9, a fluorescent indicator-dye 
visualizing live cells. However, no living cells were 
detected in the stalk part of the biofilm (data not 
shown), which is in agreement with the similar  
u 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
experiment presented in Fig. 1B. According to the 
results described in the previous sections, biofilm 
cells depleted of metabolic energy should not be 
able to induce the pmr-operon. And indeed, when a 
4-day-grown biofilm of P. aeruginosa PpmrH-gfp 
was exposed simultaneously to 30 μg/ml CCCP and 
25 μg/ml colistin in the presence of propidium 
iodide, no induction of the pmr-operon was observed  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Expression of the pmr-operon and cell-death upon colistin exposure in P. aeruginosa biofilms takes place in a 
spatiotemporal-dependent manner. Biofilms of P. aeruginosa PAO1 Tn7-PpmrH-gfp (A + B) and P. aeruginosa PAO1 pmrF (Gfp) 
(C) were grown for 4 days and then continuously exposed to either 25 μg/ml colistin and propidium iodide (A + C), or to 25 μg/ml 
colistin, 30 μM CCCP and propidium iodide (B). Confocal laser scanning micrographs were acquired at time point t0 (prior to 
exposure) and 4, 9, and 13 hours subsequent to the beginning of treatment. The images represent vertical sections of biofilms, 
respectively. Live cells appear green due to inducing expression of the pmr-operon (A + B) or constitutively expression of Gfp (C) 
and dead cells appear red, due to staining with the dead-cell indicator propidium iodide. 
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(Fig. 6B). Consequently, the cells in the upper layer 
of the biofilm, as well as in the interior part were 
killed (Fig. 6B). In agreement with the previous 
report by Haagensen et al. (2007), also a mutant, 
which has a defect in the pmr-operon (such as a 
pmrF-mutant), was not able to develop tolerance 
towards colistin in biofilms, and therefore almost all 
cells were killed within 13 hours (Fig. 6C).  
 
mexAB-oprM is required for tolerance towards 
colistin 
 
The uncoupler of oxidative phosphorylation CCCP 
was used in the experiments described above to 
interfere with energy-driven cellular metabolic/ 
physiological processes by disrupting the proton 
motive force (PMF). However, a disruption of PMF 
in bacterial cells does not only inhibit the 
regeneration of redox equivalents, it also interferes 
with the energy-driven transport of small molecules 
across the membrane such as the transport mediated 
by some efflux pumps. CCCP is therefore also 
frequently used as efflux pump inhibitor to study 
the role of efflux pumps in resistance to anti-
microbial compounds (e.g. Takiff et al., 1996; 
Bogdanovich, et al., 2006). P. aeruginosa is known 
for its intrinsic resistance to antimicrobials, to a 
large degree mediated by efflux pumps (Schweizer, 
H.P., 2003; Poole, K., 2005). However, although so 
far no efflux pump has been described to confer 
tolerance towards colistin in P. aeruginosa, we 
wanted to assess this. Consequently, we constructed 
a number of RND-efflux-pump knock-out mutants, 
namely mexPQ-oprE (PA3521-3523), mexAB-oprM 
(PA0425-0427), mexGHI-oprD (PA4205-4208), 
and yegMNO-opmB (PA2525-2528), and tested  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. P. aeruginosa cells devoid of MexAB-OprM exhibit increased sensitivity to colistin in biofilms. Biofilms of P. aeruginosa 
PAO1 ΔmexAB-oprM::Gmr Gfp were grown for 4 days and then continuously exposed to 25 μg/ml colistin and propidium iodide. 
Confocal laser scanning micrographs were acquired at time point t0 (prior to exposure) and after 4, 9, and 13 hours subsequent to 
treatment. The images show a horizontal section with two flanking images representing sections in the xz and yz planes, respectively. 
Live cells appear green due to expression of Gfp and dead cells appear red, due to staining with the dead-cell indicator propidium 
iodide. 
 
 
their ability to develop tolerance to colistin when 
grown as biofilms. We found that specifically the 
mexAB-oprM mutant exhibited a significant 
decrease in tolerance to colistin in biofilms. When a 
4-day-grown biofilm of the P. aeruginosa mexAB-
oprM mutant was exposed to 25 μg/ml colistin, it 
was unable to develop tolerance towards colistin 
(Fig 7). Already after 4 hours of exposure to 
colistin, some cells within the upper layer of the 
biofilm were killed, and within 13 hours of exposure 
almost all cells of the biofilm were eradicated (Fig. 
7). To verify this finding we tested the inde-
pendently created mexAB-oprM-mutant P. aeru-
ginosa PAO200, which has been used in several 
laboratories, and found that it also exhibited a 
significant decrease in tolerance towards colistin in 
biofilms compared to its isogenic wild type strain 
(data not shown). This indicates that the MexAB-
OprM efflux pump is involved in tolerance 
development to colistin in P. aeruginosa biofilms.  
 
Expression of mexAB-oprM is increased in the 
upper layer of a biofilm upon colistin exposure 
 
To assess, whether mexAB-oprM is constitutively 
expressed in our biofilm, or induced upon colistin 
exposure, we introduced the fluorescent reporter 
fusion pmexA-gfp into the P. aeruginosa wild type 
strain and followed expression of the reporter in 
biofilms formed by this strain. A 4-day-grown 
biofilm of P. aeruginosa pmexA-gfp exhibited a 
homogenous low fluorescent signal, indicating a 
weak basal expression of mexAB-oprM in the 
biofilm (Fig. 8). However, upon exposure to 25 
μg/ml colistin, the fluorescent signal of the cells  
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situated in the upper layer of the biofilm increased 
over time (Fig. 8). Cells in the interior part of the 
biofilm did not exhibit an increased expression of 
mexAB-oprM and were killed within 13 hours upon 
exposure to colistin (Fig. 8). Biofilms of the wild 
type strain, harbouring the same vector, but 
expressing gfp from the mexC-promotor (regulating 
expression of the efflux pump MexCD-OprJ) 
instead, exhibited a lower basal expression 
compared to P. aeruginosa pmexA-gfp, and no 
induction of mexC upon colistin exposure (data not 
shown). Altogether, this indicates that colistin is a 
signal for up-regulation of mexAB-oprM expression, 
and that MexAB-OprM contributes to tolerance 
development towards colistin in P. aeruginosa 
biofilms. 
 
Specifically targeting distinct physiological sub-
populations in biofilms enables eradication of most 
biofilm cells using combined antimicrobial trea-
tment 
 
The observations described so far indicate that the 
biofilm is composed of at least two distinct 
physiological subpopulations. The subpopulation of 
cells situated close to the substratum exhibited low 
metabolic activity and sensitivity to the 
antimicrobial peptide colistin. The subpopulation of 
cells comprising the upper layer within the biofilm 
exhibited high metabolic activity and sensitivity to 
ciprofloxacin, which preferably targets replicating 
cells. It was therefore of interest to investigate, if a 
combined treatment using the two compounds 
ciprofloxacin and colistin, would eradicate all cells 
in the biofilm. To examine this, 4-day-grown 
biofilms of P. aeruginosa were established and 
exposed to colistin or ciprofloxacin alone, or 
simultaneously to ciprofloxacin and colistin for 24 
hours (in the presence of propidium iodide 
respectively). As shown in fig. 9, a combined 
treatment with ciprofloxacin and colistin was able to  
 
 
 
 
 
 
 
 
 
 
 
 
kill almost all cells in the biofilm: Less than 10+1 
cells/ml survived the combined antimicrobial 
treatment, compared to 3.80*10+5 cells/ml and 
2.25*10+7 cells/ml on average in separately colistin- 
or ciprofloxacin-treated biofilms (Fig. 9) (details 
regarding the determination of the number of 
surviving biofilm cells are described in the 
Experimental procedures section). To get additional 
evidence, that it is possible to specifically target the 
two different subpopulations dependent on their 
metabolic activity, we chose to treat biofilms with 
another antimicrobial agent, which is supposed to 
act specifically on active cells. We exposed 4-day-
grown biofilms to tetracycline, a compound 
interfering with bacterial translation, for 24 hours 
(in the presence of propidium iodide). As expected, 
tetracycline alone only killed the subpopulation of 
cells in the upper layer of the biofilm, leaving 
1.90*10+8 cells/ml on average surviving (Fig. 9). 
However, a combined treatment with tetracycline 
and colistin was able to eradicate most cells in the 
biofilm, with a surviving fraction of 9.60*10+2 
cells/ml (Fig. 9). This indicates, that by combined 
antimicrobial treatment, using compounds that 
target separate physiological subpopulations within 
biofilms, it is possible to kill the majority of the 
cells in a biofilm. 
 
Discussion 
 
Bacteria grown as biofilms are frequently reported 
to exhibit inherent tolerance to antimicrobial 
compounds, and might therefore contribute to the 
persistence of some human infections (Costerton, et 
al., 1999, Hall-Stoodley et al., 2004). Antimicrobial 
peptides can be produced by humans as part of the 
innate immune defence system and are increasingly 
administered as treatment against microbial 
infections in humans (Falagas and Kasiakou, 2005; 
Hancock, 2001; Hancock and Sahl, 2006; Li et al., 
2006; Zasloff, 2002). So far, however, little is 
known about potential mechanisms, which might  
Fig. 8. Expression of mexA in P. aeruginosa biofilms. Biofilms of P. aeruginosa PAO1 pmexA-gfp were grown for 4 days and then 
continuously exposed to 25 μg/ml colistin and propidium iodide. Confocal laser scanning micrographs were acquired at time point 
0 (prior to exposure) and after 4, 9, and 13 hours subsequent to treatment. The images represent vertical sections of biofilms, 
pectively. Live cells which express mexAB-oprM appear green due to expression of Gfp under control of the mexA-promotor and 
cells appear red, due to staining with the dead-cell indicator propidium iodide. 
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contribute to resistance or tolerance development in 
biofilms towards antimicrobial peptides.  
      Haagensen and colleagues recently reported that 
colistin kills preferably a distinct subpopulation of 
cells situated close to the substratum in P. 
aeruginosa PAO1 biofilms, whereas a distinct 
subpopulation situated on top, exhibits phenotypic 
tolerance to colistin (Haagensen et al., 2007). In 
addition, our results here suggest that this might be a 
general feature of P. aeruginosa flow-chamber-
grown biofilms, since in addition to the laboratory 
strain PAO1 also clinical isolates exhibited this 
phenotype under the same conditions.  
      Haagensen et al. (2007) previously presented 
results on 2-day-grown P. aeruginosa PAO1 
biofilms, which strongly suggested, that cellular 
migration is involved in tolerance development to 
colistin in P. aeruginosa PAO1 biofilms. Sur-
prisingly, we found in the present study that mature 
biofilms of various mutant strains, impaired in 
cellular migration, exhibited a similar tolerance 
phenotype as the wild type, independent of the 
actual three-dimensional structure of the biofilm: i.e. 
a colistin-sensitive subpopulation close to the 
substratum and a colistin-tolerant subpopulation on 
top. In addition, it should be noted, that also the 
clinical isolates used here are to different degrees 
impaired in cellular migration (data not shown). 
Altogether, this indicates, that cellular migration per 
se is not involved in tolerance development in 
mature P. aeruginosa biofilms. It might be 
speculated that cellular migration could be a major 
factor required for developmental processes during 
the first 2 days of biofilm formation of P. 
aeruginosa PAO1 and might be involved in colistin 
tolerance development (Haagensen et al., 2007; 
Klausen et al., 2003b). However, cellular migration 
might slow down during the following stages and 
structural maturing processes of the cap-forming 
subpopulation might then be mainly due to cell 
proliferation. Because of technical limitations of 
CLSM, it has not been possible to assess whether 
the cells of the cap-forming subpopulation in mature 
biofilms are still migrating (data not shown). More 
detailed investigations will be required to 
understand the impact of cellular migration on 
colistin tolerance development in young P. aeru-
ginosa PAO1 biofilms. 
Fig. 9. Targeting distinct subpopulations in P. aeruginosa 
biofilms by single and combined antimicrobial treatment and 
quantification of the surviving fraction. Biofilms of P. 
aeruginosa PAO1 Gfp were grown for 4 days and then 
continuously exposed to either 60 μg/ml ciprofloxacin and 
propidium iodide (A), 60 μg/ml ciprofloxacin, 25 μg/ml 
colistin and propidium iodide (B), 200 μg/ml tetracycline and 
propidium iodide (C), or to 200 μg/ml tetracycline, 25 μg/ml 
colistin and propidium iodide (D) for 24 hours. The confocal 
laser scanning micrographs show a horizontal section with two 
flanking images representing sections in the xz and yz planes, 
respectively. Live cells appear green due to expression of Gfp 
and dead cells appear red, due to staining with the dead-cell 
indicator propidium iodide. The number of cells (cfu), which 
survived the antimicrobial treatment, was determined by 
plating and counting of cells harvested from biofilms (E). The 
standard deviation for each point was calculated with n = 4. 
      Our results here provide evidence, that 
metabolic/physiological activity in the biofilm is 
highest in a distinct subpopulation of cells in the 
upper layer of the multicellular structures. This 
conclusion is based on experiments involving in situ 
gene expression studies using a fluorescent reporter 
fusion, expressing an unstable version of Gfp under 
the control of a ribosomal promotor. Moreover, this 
subpopulation exhibited increased sensitivity to 
antimicrobial agents interfering with bacterial 
replication processes (such as ciprofloxacin) and 
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translation processes (such as tetracycline). In 
addition, the antimicrobial agent tobramycin, which 
interferes with bacterial translation, was recently 
found to target specifically cells in the upper layer 
of a P. aeruginosa biofilm (Hentzer, et al., 2003). 
Altogether, these data provide evidence that 
metabolic activity is highest in the upper layer of P. 
aeruginosa flow-chamber-grown biofilms, whereas 
metabolic activity is low in the deeper layers. This 
seems plausible as cells in the upper layer of the 
multicellular structures can obtain oxygen and 
nutrients from the bulk liquid, in contrast to the 
cells in the deeper layers where concentrations of 
dissolved oxygen and nutrients are likely to be low. 
Because similar observations have been obtained 
for P. aeruginosa biofilms grown as colony or 
established in capillary glass tubes (Werner et al., 
2004), the observed spatial distribution of active 
and non-active cells might be a general charac-
teristic of P. aeruginosa biofilms. 
      We observed that the distinct subpopulation of 
cells, which exhibits high metabolic activity, is able 
to survive the colistin treatment, in contrast to the 
subpopulation exhibiting low metabolic activity. 
This suggested that an energy-driven adaptation 
response might be required which renders the cells 
in the upper part tolerant to colistin. Our hypothesis 
was supported by the finding that biofilm cells 
depleted of metabolic energy (using the 
protonophore CCCP), were unable to adapt to 
colistin exposure and therefore did not survive the 
treatment. Haagensen et al. (2007) recently reported 
that cells in the upper layer of P. aeruginosa 
biofilms exhibited an induced expression of the 
pmr-operon, after exposure to colistin for 24 hours. 
Here we found using in situ gene expression 
analysis that the metabolically active cells in the 
upper layer of the biofilm were able to induce 
expression of the pmr-operon, which allowed them 
to adapt to colistin and hence survive. In contrast, 
the subpopulation of cells situated closer to the 
substratum was not able to induce expression of the 
pmr-operon, and hence did not survive. In 
accordance, when biofilm cells were exposed to 
CCCP, induction of the pmr-operon did not occur in 
the presence of colistin, and therefore the cells in 
the confined upper part did not survive the 
treatment. However, disruption of the PMF by 
CCCP does not only inhibit metabolic/physiological 
processes within cells, it also inhibits H+- and ATP-
driven efflux-pumps. Although efflux-pumps have 
so far not been found to confer tolerance to colistin 
in P. aeruginosa, we investigated if our CCCP-
treatment might have interfered with the function of 
efflux pumps rendering cells sensitive to colistin. 
We found that two independently created mexAB-
oprM-mutants exhibited increased sensitivity to 
colistin compared to the wild type. Moreover, using 
a fluorescent reporter fusion we found that 
expression of mexAB-oprM in situ is induced upon 
colistin exposure. At present it is not clear whether 
the effect of CCCP on colistin treated biofilms is 
due to depletion of metabolic energy or inhibition of 
efflux pumps, or both.  
      Various compounds (such as chloramphenicol, 
β-lactams, macrolides, and SDS) have been 
identified as substrate for the MexAB-OprM efflux 
pump in P. aeruginosa, but to our knowledge no 
antimicrobial peptides so far (Schweizer, 2003; 
Poole, 2001). Until now, efflux-pumps have been 
found to be involved in natural resistance to 
antimicrobial peptides in the Gram-negative Neis-
seria gonorrhoeae and Neisseria meningitides 
(Schafer et al., 1998; Tzeng et al., 2005) and an 
efflux pump/potassium antiporter system has been 
found to be involved in resistance to polymyxin B in 
Yersinia enterocolitica (Bengoechea, et al., 2000). 
We found that mexAB-oprM is not involved in 
inherent resistance to colistin in P. aeruginosa, since 
the minimal inhibitory concentration (MIC) to 
colistin (as examined by macro-dilution method and 
E-test) does not significantly differ between the wild 
type and mexAB-oprM mutant under our ex-
perimental conditions (data not shown).  Instead, 
mexAB-oprM is involved in development of 
phenotypic tolerance to colistin in P. aeruginosa 
when grown as biofilm. The observation that an 
efflux pump might be involved in the development 
of colistin tolerance could indicate that colistin also 
has an intracellular target in addition to interfering 
with the membrane of P. aeruginosa. In agreement, 
results obtained from studying the interaction of 
polymyxins with membranes of P. aeruginosa have 
let to the conclusion that these compounds might 
also have cytoplasmatic targets (Zhang et al., 2000). 
      In some cases after prolonged colistin-exposure 
of biofilms formed by either the mexAB-oprM 
mutants or different pmr mutants we observed small 
randomly distributed aggregates of living cells in the 
biofilm (data not shown). This indicates, that a small 
fraction of single cells had survived the colistin 
treatment and were then able to initiate proliferation 
also in the presence of colistin. These cells did not 
exhibit any inherent resistance to colistin (data not 
shown). This might suggest that in a small fraction 
of pmr-mutant cells expression of mexAB-oprM 
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might be increased and that in a small fraction of 
mexAB-oprM-mutant cells expression of the pmr-
operon might be increased. Together, this might 
indicate that in the majority of the cells neither pmr 
nor mexAB-oprM alone is able to completely confer 
tolerance to colistin in biofilms, instead both 
systems seem to be required simultaneously under 
these conditions. The fact that mexAB-oprM is 
expressed to some degree also in unexposed 
biofilms, might indicate that the MexAB-OprM-
mediated efflux contributes to an intrinsic tolerance 
to colistin in biofilms. Increased expression of 
mexAB-oprM during prolonged exposure to colistin 
might indicate that MexAB-OprM in addition is 
involved in long-term survival during colistin 
exposure. In contrast, induction of LPS-modi-
fication, mediated by the pmr-operon, might be a 
specific adaptation response to colistin. However, 
more detailed investigations are required to 
understand the contribution of LPS-modification 
and efflux systems on colistin tolerance in P. 
aeruginosa biofilms. 
      Whereas conventional antimicrobial compounds 
(such as ciprofloxacin and tetracycline) specifically 
target metabolically active biofilm cells in the upper 
layer, our data indicated that colistin apparently 
specifically targeted the biofilm cells exhibiting low 
metabolic activity situated in the deeper areas. To 
investigate if cells, which have a low growth 
activity, exhibit increased sensitivity to colistin, we 
compared exponentially growing planktonic cells 
with stationary phase planktonic cells with respect 
to sensitivity to colistin. However, the survival rate 
upon colistin treatment was similar under both 
conditions (data not shown). In a number of other 
batch culture experiments we addressed the 
potential role of oxygen- or energy-depletion or pH 
on cellular sensitivity to colistin, however, also 
under these conditions no significant difference was 
observed (data not shown). We did not examine 
conditions under which the expression of the pmr-
operon is induced (e.g. Mg2+-limitation), since we 
did not observe any induction of pmr-genes in our 
biofilms in the absence of colistin. Moreover, we 
could not observe any significant differences in 
sensitivity to colistin in our batch culture 
experiments under non-inducing conditions, when 
we compared wild type and a pmrF-mutant (data 
not shown), which is in agreement with previous 
reports (McPhee et al., 2003). Altogether this 
supports the notion, that sensitivity to polymyxins is 
greatly dependent on the prevailing environmental 
conditions. With respect to our investigations on 
biofilms, this might indicate on the one hand, that a 
complex microenvironment of unknown compo-
sition in the deeper layers of the biofilm exist, which 
impacts on cellular metabolic activity and sensitivity 
to colistin, but might be difficult to simulate in batch 
cultures. On the other hand, the particular sub-
population of cells exhibiting low metabolic activity 
in the biofilms, might at the same time exhibit 
another specific characteristic, independent of 
metabolic activity, which renders it sensitive to 
colistin. Interestingly, the chelator EDTA targets the 
same subpopulation of cells in P. aeruginosa 
biofilms as colistin (Banin et al., 2006; data not 
shown), and investigations on batch culture grown 
cells have indicated, that EDTA preferably targets 
stationary phase cells compared to exponential 
phase cells (Imamura et al., 2005). Investigations 
are currently ongoing in our laboratory, to determine 
the factors, which render cells in the deeper layers 
of biofilms sensitive to colistin. 
      Our observation that conventional antimicrobial 
agents (e.g. ciprofloxacin and tetracycline) spe-
cifically target the distinct subpopulation of biofilm 
cells in the upper layer, whereas colistin preferably 
targets the distinct subpopulation of biofilm cells in 
the deeper layers, prompted us to study the killing-
effect of a combined treatment with these anti-
microbial compounds. The combined treatment with 
either colistin + ciprofloxacin or colistin + tetra-
cycline reduced the number of biofilm cells signi-
ficantly, compared to the single anti-microbial 
treatments. In particular the combined treatment 
with colistin + ciprofloxacin was very effective, 
eradicating nearly all cells of the biofilm. Intri-
guingly, the administration of aerosolized colistin in 
combination with oral ciprofloxacin has been found 
to significantly reduce the onset of chronic P. 
aeruginosa infection in cystic fibrosis patients 
(Valerius et al., 1991). Furthermore, this treatment 
strategy is part of a recommended early intervention 
and prevention therapy of lung disease in cystic 
fibrosis according to a European consensus report 
(Döring et al., 2004; Høiby et al., 2005). 
      Altogether, our data indicate that in general 
antimicrobial tolerant cells in biofilms are not 
randomly distributed. Instead, antimicrobial tole-
rance seems to be confined to physiologically 
distinct subpopulations of cells within the multi-
cellular structures, independent of the antimicrobial 
compound used. Tolerance development to colistin 
is confined to a distinct subpopulation of meta-
bolically active cells, which is able to adapt to 
colistin exposure by i) reducing interaction with the 
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antimicrobial compound (LPS-modification medi-
ated by the pmr-operon), and ii) export of the 
antimicrobial compound (efflux mediated by 
mexAB-oprM). Moreover, we found that a syste-
matic combined antimicrobial treatment, speci-
fically targeting distinct physiological subpopu-
lations, enables eradication of almost all cells in a 
biofilm. 
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Detailed knowledge of developmental processes that leads to the formation of complex multicellular structures in 
biofilms may be useful for creating strategies to control biofilm development. We previously presented evidence 
that formation of the cap-portion of mushroom-shaped structures in Pseudomonas aeruginosa biofilms occurs 
via type IV pili-driven bacterial motility (Mol. Microbiol. 50:61-68). In the present study we present evidence 
that, although type IV pili are required for the formation of mushroom caps in P. aeruginosa biofilms, flagellum-
driven motility is responsible for accumulation of the bacteria in the mushroom caps. In addition, we present 
evidence that extracellular DNA and quorum-sensing play a role in mushroom cap formation. The presented 
data are consistent with a model suggesting that formation of the mushroom shaped structures in P. aeruginosa 
biofilms occurs in a developmental process involving formation of initial microcolonies by a non-motile 
subpopulation that releases extracellular DNA, and subsequently become capped by a motile subpopulation that 
uses flagella for surface associated motility and type IV pili for binding to the extracellular DNA. 
 
Introduction 
 
During the last ten years there has been a rapidly 
increasing recognition of microbial biofilms as a 
highly significant topic in microbiology with 
relevance for a variety of areas in our society 
including the environment, industry, and human 
health. Growing appreciation of the importance of 
biofilms has led to the perception that these 
communities constitute the dominant mode of 
microbial life (Hall-Stoodley et al., 2004; Davey 
and O’Toole, 2000). Evidence is increasing that 
biofilms are complex and dynamic communities in 
which substantial phenotypic diversification allows 
microorganisms to adapt to different environments 
(Watnick and Kolter, 2000; Klausen et al., 2006). 
Understanding the pathways to biofilm development 
will eventually make it possible to manipulate the 
growth of biofilms in nature and disease.  
      The use of flow-chamber in vitro setups and 
confocal laser scanning microscopy (CLSM) has 
provided knowledge about mechanisms involved in 
biofilm formation. Pseudomonas aeruginosa, a 
model organism in biofilm research, can, dependent 
on the conditions, form biofilms with different 
spatial structures. For example, it has been reported 
that a flat biofilm was formed in flow-chambers 
irrigated with citrate minimal medium (Klausen et 
al., 2003b), while a heterogeneous biofilm with 
mushroom-shaped multicellular structures was 
formed in flow-chambers irrigated with glucose 
minimal medium (Klausen et al., 2003a). P. 
aeruginosa biofilm development in flow-chambers 
with citrate as carbon source was shown to occur via 
formation of initial microcolonies by clonal growth 
of sessile cells at the substratum, followed by 
expansive migration of the bacteria on the 
substratum, and the subsequent formation of a flat 
biofilm (Klausen et al., 2003b). Because biofilm 
formation by a P. aeruginosa pilA mutant (deficient 
in biogenesis of type IV pili) occurred without the 
expansive phase, and resulted in discrete protruding 
microcolonies, it was suggested that the expansive 
migration of the bacteria was type IV pili-driven. 
Moreover, it was shown that a P. aeruginosa fliM 
mutant (deficient in assembly of flagella) formed a 
hilly biofilm in flow-chambers with citrate as carbon 
source, indicating that flagella may play a role in 
surface-associated migration in P. aeruginosa 
biofilm in addition to type IV pili (Klausen et al., 
2003b). Evidence has been provided that the 
  1
formation of mushroom-shaped structures in 
glucose-grown P. aeruginosa biofilms occurs in a 
sequential process involving a non-motile bacterial 
subpopulation which forms the initial microcolonies 
by growth in certain foci of the biofilm, and a 
migrating bacterial subpopulation which initially 
forms a monolayer on the substratum, and 
subsequently forms the mushroom caps by aggre-
gating on top of the initial microcolonies (which 
then become mushroom stalks) via a type IV pili-
dependent process (Klausen et al., 2003a). In 
glucose-grown biofilms, that was initiated with a 
mixture of Cfp-tagged and Yfp-tagged P. aeru-
ginosa wild-type bacteria, mushroom-shaped 
structures were formed that had single-colour stalks 
indicating their formation via clonal growth, and 
two-colour caps indicating their formation via 
aggregation of bacteria. In pilA/wild-type mixed 
biofilms formation of mushroom-shaped structures 
occurred both with citrate and glucose as carbon 
source. In citrate-grown pilA/wild-type mixed 
biofilms the pilA bacteria formed stalks, and the 
wild-type bacteria accumulated on top of these 
stalks and formed caps. In glucose-grown pilA/wild-
type mixed biofilms either the pilA bacteria (most 
frequent) or the wild-type bacteria formed the 
stalks, and the wild-type bacteria accumulated on 
top of these stalks and formed the caps. 
Subsequently experiments involving microscopic 
tracking of fluorescent and non-fluorescent bacteria 
provided direct evidence that glucose-grown P. 
aeruginosa wild-type biofilms contain a non-motile 
stalk-forming subpopulation and a motile cap-
forming subpopulation (Haagensen et al., 2007). 
      The extracellular matrix that holds the cells 
together in P. aeruginosa biofilms mainly consists 
of polysaccharide, protein, and DNA (Pamp et al., 
2007). Evidence has been presented that a basal 
level of extracellular DNA in P. aeruginosa 
populations is generated via a pathway which is not 
linked to quorum-sensing, while a larger amount of 
extracellular DNA appears to be generated via a 
pathway that depends on quorum-sensing and 
results in lysis of a small subpopulation of the cells 
(Allesen-Holm et al., 2006). The P. aeruginosa 
quorum-sensing mutants lasIrhlI and pqsA formed 
biofilms with low extracellular DNA levels and 
increased susceptibility to treatment with SDS, 
indicating a stabilizing effect of the extracellular 
DNA in the biofilms (Allesen-Holm et al., 2006). In 
addition, mature wild-type biofilms that had been 
treated with DNase for a short time showed elevated 
susceptibility to the SDS treatment (Allesen-Holm 
et al., 2006). The extracellular DNA in P. 
aeruginosa biofilms appears to be organized in 
distinct patterns (Allesen-Holm et al., 2006). In 
young glucose-grown P. aeruginosa biofilms the 
extracellular DNA was shown to be present in high 
concentrations specifically in the outer layer of the 
microcolonies and upon the microcolonies (which 
subsequently become stalks). In mature glucose-
grown P. aeruginosa biofilms the extracellular DNA 
was shown to be present in high concentrations 
specifically in the outer layer of the stalks and 
between the stalk and cap portion of the mushroom-
shaped structures (Allesen-Holm et al., 2006). In 
agreement with the spatial distribution of the 
extracellular DNA and a role of quorum-sensing in 
DNA release, experiments involving a P. 
aeruginosa pqsA-gfp reporter strain suggested that 
the pqs genes were expressed specifically in the 
outer layer of the stalks that subsequently became 
capped by the migrating subpopulation (Yang et al., 
2007).  
      Based on agar plate assays two kinds of surface 
associated motility have been defined for P. 
aeruginosa. One kind of surface-associated motility 
which requires type IV pili has been termed 
twitching motility (Henrichsen, 1972; Semmler, et 
al., 1999; Mattick, 2002). Another kind of surface-
associated motility which requires functional 
flagella, biosurfactant production, and under some 
conditions type IV pili, has been termed swarming 
motility (Köhler et al., 2000; Rashid and Kornberg, 
2000; Déziel et al., 2003). Comparative sequence 
analysis has suggested that P. aeruginosa encodes 
four chemotaxis-like signal transduction systems 
(Stover et al., 2000). The Pil-Chp system (PA0408-
PA0417) is evidently involved in regulating 
twitching motility (Darzins, 1994; Whitchurch et al., 
2004). The Che (PA1464-PA1456 and PA3348-
PA3349) and Che2 (PA0173-PA0179) systems, 
both homologous to the E. coli Che chemotaxis 
system (Parales et al., 2004), have been implicated 
in flagella-mediated chemotaxis in P. aeruginosa 
(Kato et al., 1999; Ferrandez et al., 2002; Hong et 
al., 2004; 2005). The Wsp system (PA3702-3708) 
appears to control the expression of Cup fimbria 
(D’Argenio et al., 2002), and the PEL and PSL 
polysaccharides (Hickman et al., 2005), which are 
all compounds that have been implicated in P. 
aeruginosa biofilm formation (Vallet et al., 2001; 
Jackson et al., 2004; Matsukawa and Greenberg, 
2004; Friedman and Kolter, 2004). 
      The cap-forming and the stalk-forming sub-
population of the mushroom-shaped structures in P. 
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aeruginosa biofilms in many cases display 
differential tolerance to antimicrobial compounds. 
For example, the antibiotics tobramycin, cipro-
floxacin, and tetracycline were shown to kill 
preferentially bacteria located in the cap-portion of 
the mushroom-shaped structures, whereas the 
antibiotic colistin, the detergent SDS, and the 
chelator EDTA were shown to kill preferentially 
bacteria in the stalk-portion of the mushroom-
shaped structures (Bjarnsholt et al., 2005; Banin et 
al., 2006; Haagensen et al., 2007; Pamp et al., 
submitted). Evidence has been presented that P. 
aeruginosa biofilms that do not develop normally, 
either because the bacteria are mutated or because 
specific compounds are present, do not show the 
characteristic tolerance patterns after treatment with 
various antimicrobials including tobramycin, 
ciprofloxacin, colistin, and EDTA (Bjarnsholt et al., 
2005; Haagensen et al., 2007; Yang et al., 2007). 
Because the structure of a biofilm evidently can 
influence its antimicrobial tolerance properties, 
knowledge about structural biofilm development 
may be useful for creating strategies to control 
biofilm formation. The present study is focussed on 
elucidating factors which are involved in the 
formation of the mushroom-shaped structures in P. 
aeruginosa biofilms. 
 
Materials and Methods 
 
Bacterial strains and growth conditions 
P. aeruginosa PAO1 (Holloway and Morgan, 1986) 
from John Mattick’s laboratory was used as the wild 
type strain in the present study. The pilA, fliM and 
pilAfliM derivatives were constructed by allelic 
displacement as described by Klausen et al. 
(2003b). The pilAlasRrhlR triple mutant was 
derived from the pilA mutant via allelic exchange as 
described by Beatson et al. (2002). The chpA in 
frame deletion mutant was constructed by allelic 
displacement as described by Whitchurch et al. 
(2004). The chpB mutant was constructed as 
described below. The strains were fluorescently 
tagged at an intergenic neutral chromosomal locus 
with gfp, cfp or yfp in mini-Tn7 constructs as 
described by Klausen et al. (2003b). Modified FAB 
medium (Heydorn et al., 2000) was used 
supplemented with 30 mM glucose for batch 
overnight cultures, and with 0.3 mM glucose for 
biofilm cultivation. Biofilms and batch cultures 
were grown at 30oC.  
Construction of the P. aeruginosa chpB in frame 
deletion mutant 
 
The chpB mutant was constructed in two steps. 
First, the gene was replaced by a gentamycin 
resistance (GenR) cassette. Second, the cassette was 
crossed out using an untagged deletion construct to 
create the unmarked in frame deletion. This 
approach was taken to facilitate the identification of 
mutants, which do not have an obvious twitching 
motility defect on agar plates.  
The 5’ chpB deletion construct was amplified from 
PAO1 genomic DNA using the cbpB1/chpB2.1 PCR 
primer pair.  The 3’ chpB deletion construct was 
amplified from PAO1 genomic DNA using the 
chpB3/chpB4 PCR primer pair. PCR products were 
A-tailed and ligated into pGEM-T to form pJB51 (5’ 
deletion construct) and pJB52 (3’ deletion 
construct).  The 5’ deletion construct was excised 
from pJB51 as an EcoRI/HindIII fragment. The 3’ 
deletion construct was excised from pJB52 as a 
HindIII/PstI fragment (an overlapping Dam 
methylation site prevented us from using the XbaI 
site designed into the primer).  Excised 5’ and 3’ 
deletion construct fragments were concatamerized 
and cloned as an EcoRI/PstI fragment into pOK12 
to form pJB64. The unmarked deletion construct 
was excised from pJB64 as a SpeI fragment and 
ligated into the allelic exchange vector pJEN34 to 
form pJB91. A pJB95-derived GenR-cassette (GenR-
cassette from pX1918GT cloned as a HindIII 
fragment into pOK12) was ligated as a HindIII 
fragment into pJB64 to create pJB73. The GenR-
tagged deletion construct was excised from pJB73 
as a SpeI fragment and ligated into the allelic 
exchange vector pJEN34 to form pJB82. pJB82 was 
transformed into S17.1 and transformants were 
mated to PAO1 as previously described to create 
chpB-GenR intermediates. pJB91 was transformed 
into S17.1 and transformants were mated to PAO1 
chpB-GenR as previously described (Whitchurch et 
al., 2004) to create unmarked ∆chpB mutants. This 
procedure deleted amino acids 37-244 of ChpB. 
Sequences of the primers used will be supplied upon 
request. 
 
Cultivation of biofilms  
Biofilms were grown in flow chambers with 
individual channel dimensions of 1 × 4 × 40 mm. 
The flow system was assembled and prepared as 
described previously (Sternberg and Tolker-Nielsen, 
2005). The flow-chambers were inoculated by 
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injecting 350 µl of overnight culture diluted to an 
OD600 of 0.001 into each flow-channel with a small 
syringe. After inoculation flow-channels were left 
without flow for 1h, after which medium flow (0.2 
mm s-1) was started using a Watson Marlow 205S 
peristaltic pump. In one experiment the biofilm 
medium was supplemented with 100 μg/ml DNase I 
(Sigma) after 48 hours of biofilm cultivation. 
Microscopy and image acquisition 
 
All microscopic observations and image acqui-
sitions were done using a Zeiss LSM 510 Meta 
confocal laser scanning microscope (Carl Zeiss, 
Jena, Germany) equipped with detectors and filter 
sets for monitoring of Gfp, Cfp, and Yfp 
fluorescence. Images were obtained using a 63x/1.4 
oil objective or a 40x /1.3 oil objective. Simulated 
3-D images and sections were generated using the 
IMARIS software package (Bitplane AG, Zürich, 
Switzerland). 
 
Results 
 
Involvement of type IV pili and the Pil/Chp 
chemosensory system in structural development of 
P. aeruginosa biofilms 
 
Because local consumption may create nutrient 
gradients in biofilms (DeBeer et al .,  1994; 
Picioreanu et al., 1998), we speculated that the 
motile bacteria in glucose-grown P. aeruginosa 
biofilms might accumulate on top of the initial 
microcolonies through the use of the type IV pili-
coupled Pil/Chp chemosensory system. To test this 
hypothesis  we constructed an in frame  P. 
aeruginosa chpB deletion mutant. The chpB gene 
encodes a predicted MCP demethylase, and chpB 
mutants were previously shown to be able to move 
by the use of type IV pili in a Petri dish-based 
assay, but to be unable to display normal regulation 
of this motility, presumably due to a defect in 
relaxation of the chemosensory system (Whitchurch 
et al., 2004). We performed investigations of 
biofilm development of the P. aeruginosa chpB 
mutant in flow-chambers irrigated with glucose-
minimal medium. During biofilm development the 
chpB mutant was able to differentiate into a non-
motile subpopulation and a motile subpopulation. 
The non-motile subpopulation formed micro-
colonies, however the motile subpopulation did not 
form caps such as the wild-type but rather covered 
the microcolonies (Fig. 1A-D). Similarly, when the 
 
 
  
 
 
 
 
 
 
 
Fig. 1. Confocal laser scanning micrographs of 2-day-old (A, 
C, E, G) and 4-day-old (B, D, F, H) biofilms formed by P. 
aeruginosa chpB Gfp (A, B), P. aeruginosa wild type Gfp (C, 
D), a mixture of P. aeruginosa chpB Yfp and P. aeruginosa 
pilA Cfp (E, F), and a mixture of P. aeruginosa wild type Yfp 
and P. aeruginosa pilA Cfp (G, H). The central images show 
horizontal optical sections and the flanking images show 
vertical optical sections. The bars represent 40 μm.  
chpB mutant was cultivated in mixed biofilms 
together with a pilA mutant, the chpB mutant did not 
form caps on top of the pilA stalks such as the wild-
type, but rather covered the pilA microcolonies (Fig. 
1E-H). 
During the course of our investigations of the role of 
the Pil/Chp chemosensory system in P. aeruginosa 
biofilm development we also studied a P. aeru-
ginosa chpA in frame deletion mutant. The chpA 
gene encodes a composite response regulator, and 
evidence has been provided that chpA mutants are 
deficient in signal sensing through the Pil/Chp 
chemosensory system (Whitchurch et al., 2004).  
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The PAO1 chpA mutant used in the present study 
was previously shown to be deficient in twitching 
motility in a Petri dish-based assay (Whitchurch et 
al., 2004). It was therefore surprising to us that this 
mutant was able to form (irregular) mushrooms in 
mono-strain biofilms (Fig. 2A, B), and (irregular) 
caps in chpA/pilA mixed biofilms (Fig. 2C, D).  
From the experiments with the chpB mutant we 
conclude that the Chp chemosensory system plays a 
(minor) role in the formation of the mushroom-
shaped multicellular structures in P. aeruginosa 
biofilms. The experiments with the chpA mutant 
appears to disprove our previous suggestion that cap 
formation in P. aeruginosa biofilms occurs via type 
IV pili-driven motility (Klausen et al., 2003a). 
However, because the chpA mutant was shown to be 
sensitive to pili-specific phages it is evidently 
piliated (Whitchurch et al., 2004). Because the chpA 
and chpB mutants, unlike the pilA mutant, evidently 
are piliated, our new results lead to the suggestion 
that cap formation in P. aeruginosa biofilms 
depends on the presence of type IV pili on the cap-
forming bacteria. 
 
Involvement of flagella in structural development of 
P. aeruginosa biofilms 
 
Because our previous investigations clearly 
indicated a role of surface-associated motility in 
mushroom cap formation in P. aeruginosa biofilms 
(Klausen et al., 2003a; Haagensen et al., 2007), and 
the experiments described above indicated that a P. 
aeruginosa mutant deficient in type IV pili-driven 
motility can form (irregularly shaped) mushroom 
caps, we investigated a role of flagellum-driven 
surface-associated motility in structural develop-
ment of P. aeruginosa biofilms. We have previously 
presented evidence that in flow-chambers irrigated 
with citrate medium the P. aeruginosa wild-type 
displays extensive surface-associated motility and 
forms a flat biofilm, while the non-flagelated P. 
aeruginosa fliM mutant forms a hilly biofilm, and 
the non-piliated P. aeruginosa pilA mutant forms 
irregular protruding microcolonies, suggesting that 
surface-associated motility in citrate-grown P. 
aeruginosa PAO1 biofilms mainly depends on type 
IV pili, although flagella evidently also play a role 
(Klausen et al., 2003b). In order to investigate a role 
of flagella in the formation of the mushroom-shaped 
biofilm structures we studied biofilm formation of 
the P. aeruginosa fliM mutant in flow-chambers 
irrigated with glucose medium. As shown in Fig. 3A 
and 3B, the P. aeruginosa fliM mutant could not 
form mushroom-shaped structures in flow-chambers 
with glucose as carbon source. Furthermore, in 
mixed fliM/pilA biofilms the fliM  
 
 
Fig. 2. Confocal laser scanning micrographs of 2-day-old (A, C) 
and 4-day-old (B, D) biofilms formed by P. aeruginosa chpA Gfp 
(A, B), and a mixture of P. aeruginosa chpA Yfp and P. 
aeruginosa pilA Cfp (C, D). The central images show horizontal 
optical sections and the flanking images show vertical optical 
sections. The bars represent 40 μm. 
 
Fig. 3. Confocal laser scanning micrographs of 2-day-old (A, C) and 
4-day-old (B, D) biofilms formed by P. aeruginosa fliM Gfp (A, B), 
and a mixture of P. aeruginosa fliM Yfp and P. aeruginosa pilA Cfp 
(C, D). The central images show top-down views and the flanking 
images show vertical optical sections. The bars represent 20 μm. 
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mutant did not form caps on top of pilA 
microcolonies (Fig. 3C, D). The wild-type/pilA 
control biofilm (not shown) developed as shown in 
Fig 1G and 1H. These experiments with mono-
strain and mixed strain biofilms therefore suggest a 
role of flagellum driven motility in the formation of 
mushroom-shaped structures in P. aeruginosa 
biofilms. 
 
Involvement of extracellular DNA in structural 
development of P. aeruginosa biofilms 
 
The work described above indicated that formation 
of the cap of the mushroom-shaped structures in P. 
aeruginosa biofilms is dependent on flagellum 
driven motility. This finding, however, does not 
explain the requirement for type IV pili in cap-
formation, suggested by the fact that P. aeruginosa 
pilA mutants are deficient in the process. Because 
type IV pili have been shown to bind with high 
affinity to DNA (Aas et al., 2002; Van Schaik et al., 
2005), we found it of interest to investigate whether 
this component of the P. aeruginosa biofilm matrix 
might play a role in the formation of the mushroom-
shaped structures. We speculated that the large 
amounts of extracellular DNA present on the 
microcolonies (stalks) in young P. aeruginosa 
biofilms (Allesen-Holm et al., 2006) might cause 
accumulation of the migrating piliated bacteria, and 
thereby play a role in the formation of the 
mushroom caps.  
Although the extracellular DNA in P. aeruginosa 
PAO1 biofilms has a stabilizing function (Whitch-
urch et al., 2002; Allesen-Holm et al., 2006), we 
have found that under the conditions used in the 
present study DNase treatment of 2-day-old P. 
aeruginosa PAO1 biofilms does not result in 
dispersal of the biofilms. We hypothesized that, if 
the extracellular DNA present on the microcolonies 
in 2-day-old P. aeruginosa biofilms plays a role in 
accumulation of the cap-forming bacteria, then 
DNase treatment of the biofilms from day 2 might 
inhibit cap formation. Fig. 4A and 4C shows CLSM 
micrographs acquired in a 4-day-old P. aeruginosa 
wild-type/pilA mixed biofilm that had been treated 
with DNase from day 2. It is evident that the DNase 
treatment reduced cap formation compared to the P. 
aeruginosa wild-type/pilA mixed biofilm that was 
not subjected to DNase treatment (Fig. 4B and 4D). 
In addition the DNase treatment resulted in an 
unusual biofilm structure where the wild-type 
bacteria formed bridges between the pilA micro-
colonies (Fig. 4).  
 
 
 
 
Fig. 4. Confocal laser scanning micrographs of 4-day-old 
biofilms formed by mixtures of P. aeruginosa pilA Cfp and P. 
aeruginosa wild type Yfp with (A, C) or without (B, D) DNase 
treatment after two days of biofilm growth. The bars represent 
20 μm. 
We also studied the role of extracellular DNA in the 
development of the mushroom-shaped P. aeru-
ginosa biofilm structures via a genetic approach. We 
hypothesized that if a pilA mutant carried additional 
mutations so that it was unable to release extra-
cellular DNA it would form microcolonies that 
could not be capped by the wild-type in mixed 
biofilms. We have previously presented evidence 
that a P. aeruginosa lasIrhlI quorum sensing mutant 
releases considerably less DNA in biofilms than the 
wild-type (Allesen-Holm et al., 2006). It was 
therefore of interest to investigate whether a non-
piliated quorum-sensing mutant would be capped by 
the wild-type in mixed biofilms. We therefore 
constructed the non-piliated P. aeruginosa pilA-
lasRrhlR mutant, which is deficient both in 
production of and response to homoserine lactones, 
and investigated biofilm formation of this mutant in 
combination with the wild type. In wild 
type/pilAlasRrhlR mixed biofilms the wild-type was 
unable to form normal caps on top of the 
pilAlasRrhlR microcolonies (Fig. 5). The mush-
room-shaped structures that were observed con-
tained wild-type in both the stalk and the cap (Fig. 
5). The wild-type/pilA control biofilm (not shown) 
developed as shown in Fig. 1H and 4B. In order to 
obtain an objective measure of the role of quorum-
sensing and DNA release in the development of 
mushroom-shaped structures, we acquired a large 
number of CLSM images at random positions in 4-
day-old biofilms of wild-type/pilAlasRrhlR and 
wild-type/pilA, and assessed whether the pilA-
lasRrhlR and pilA microcolonies were colonized by 
the wild-type bacteria. In the wild-type/pilAlasRrhlR 
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biofilm 6 out of 200 pilAlasRrhlR microcolonies 
were colonized by the wild-type, whereas in the 
wild-type/pilA biofilm 198 out of 200 pilA 
microcolonies were capped by the wild-type.  
Together these experiments suggest that quorum-
sensing and DNA-release in the initial micro-
colonies in P. aeruginosa biofilms plays a role in 
the subsequent development of mushroom-shaped 
structures. 
 
Discussion 
 
We previously suggested that formation of the cap-
portion of the mushroom-shaped structures in P. 
aeruginosa biofilms occurs via type IV pili-driven 
motility (Klausen et al., 2003b). This suggestion 
was based on evidence that cap-formation occurs 
through aggregation of bacteria and requires type IV 
pili. The present study has shown that our previous 
model for the development of the mushroom-shaped 
structures in P. aeruginosa biofilms needs revision. 
The major findings that form the basis for a new 
model indicate that: i) non-motile bacteria form the 
stalks (initial microcolonies) and motile bacteria 
subsequently form the caps (Klausen et al., 2003b; 
Haagensen et al., 2007), ii) The bacteria in the outer 
layer of the stalks release extracellular DNA 
(Allesen-Holm et al., 2006; Yang et al., 2007). iii) 
cap formation depends on type IV pili (Klausen et 
al., 2003b), iv) piliated non-twitching bacteria can 
form caps (this study), v) cap formation depends on 
flagellum-driven motility (this study), and vi) cap 
formation depends on extracellular DNA released 
by the stalk-subpopulation (this study). In accord 
with this evidence we suggest the following model 
for the formation of the mushroom-shaped struc-
tures in P. aeruginosa biofilms: i) Non-motile 
bacteria form the mushroom stalks by growth in 
certain foci of the biofilm. ii) The bacteria in the 
outer layer of the stalks release extracellular DNA. 
iii)  Migrating bacteria climb the stalks in a process 
which is driven by flagella. iv) The migrating 
bacteria bind to the extracellular DNA on the stalks 
via type IV pili and form caps.  
      Stalk formation may initiate in certain foci of a 
P. aeruginosa biofilm as a consequence of down-
regulation of motility in a subpopulation of the cells. 
In agreement with a requirement of down-regulation 
of twitching motility for initial microcolony 
formation, it has been reported that lactoferrin 
inhibits the formation of microcolonies in P. 
aeruginosa biofilms by preventing down-regulation 
of twitching motility (Singh et al., 2002). In 
addition, evidence has been presented that 
microcolony formation in P. aeruginosa biofilms 
can be prevented by carbon-source dependent 
stimulation of type IV pili-driven motility (Klausen 
et al., 2003a) or flagella-driven motility (Shrout et 
al., 2006). However, it is also possible that 
microcolony formation initiates because the cells in 
certain foci of the biofilms produce matrix 
components and adhere strongly to each other so 
that motility becomes arrested.  
Fig. 5. Confocal laser scanning micrographs of a 2-day-old (A) and 
4-day-old (B) biofilm formed by a mixture of P. aeruginosa 
pilAlasRrhlR Cfp and P. aeruginosa wild type Yfp. The central 
images show top-down views and the flanking images show 
vertical optical sections. The bars represent 20 μm. 
      In agreement with our suggestion that type IV 
piliation of the cells is required for mushroom cap 
formation, whereas type IV pili-driven motility is 
not necessary, Chiang and Burrows (2003) reported 
that a P. aeruginosa pilT mutant, which is hyper-
piliated and twitching deficient, formed biofilms 
with large mushroom-shaped structures. 
      The finding that the P. aeruginosa chpB mutant 
did not form normal caps, but rather covered the 
stalks, and the finding that the P. aeruginosa chpA 
mutant formed caps of irregular shape, could 
suggest that type IV pili-driven motility plays a role 
in cap formation a long with flagella-driven 
motility. However, Caiazza et al. (2007) recently 
provided evidence that P. aeruginosa chpB mutants 
display reduced flagella-driven swarming motility, 
which may alternatively explain the finding that the 
chpB mutant was found to be affected in cap-
formation in the present study. In addition, evidence 
has been provided that the chpA mutant used in the 
present study display reduced surface piliation 
(Whitchurch et al., 2004), which might affect the 
suggested interaction with extracellular DNA and 
thereby cap formation.  
      The involvement of quorum sensing in P. 
aeruginosa biofilm development has been studied 
by crudely monitoring biofilm structures, and 
appears to play a role only under some conditions 
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(Davies et al., 1998; Stoodley et al., 1999; 
Purevdorj et al. 2002; Heydorn et al., 2002). 
Obviously the outcome of an analysis is restricted 
by its level of refinement, and quorum sensing 
could play roles in a biofilm that apparently does 
not affect its structure. In the present investigation 
the use of a model system consisting of Cfp-tagged 
stalk-formers and Yfp-tagged cap-formers provided 
evidence that quorum-sensing in the stalk-formers 
was necessary for the cap to be formed. The 
available evidence suggests that the observed lack 
of cap-formation is due to the stalk-formers de-
ficiency in DNA-release, but it can not be excluded 
that other quorum sensing controlled factors in the 
stalk subpopulation may affect cap-formation. 
Quorum sensing controls the production of bio-
surfactants in P. aeruginosa (Ochsner and Reiser, 
1995), and these amphipathic molecules appears to 
have multiple roles in P. aeruginosa biofilm 
development, one of which is to facilitate surface 
associated bacterial migration and thereby the 
formation of mushroom caps (Pamp and Tolker-
Nielsen, 2007). However, we find it unlikely that 
the P. aeruginosa pilAlasRrhlR mutants deficiency 
in biosurfactant production could be the cause of the 
observed phenotype in the wild type/pilAlasRrhlR 
mixed biofilm where the wild type, i.e. the potential 
cap-former, is able to produce biosurfactants.  
      The factors involved in coordinating the 
formation of the mushroom-shaped structures in P. 
aeruginosa biofilms has been investigated using 
computer based modelling (Picioreanu et al., 2007). 
In support of a coordinating role of matrix com-
ponents in the development of the mushroom caps, 
the computer simulations predicted that if motility 
and chemotaxis were the only factors in operation 
then vertical strings of cells would be formed in the 
biofilms (Picioreanu et al., 2007). 
      In summary the present work suggests that the 
formation of the mushroom-shaped structures in P. 
aeruginosa biofilms occurs in a developmental pro-
cess involving formation of initial microcolonies 
(stalks) by a non-motile subpopulation that releases 
extracellular DNA, and subsequently become 
capped by a motile subpopulation that uses flagella 
for surface associated motility and type IV pili for 
binding to the extracellular DNA. 
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Biofilms are reported to be inherently refractory towards antimicrobial attack and therefore might contribute to 
the persistence of infections. Pseudomonas aeruginosa biofilms with mushroom-like shaped multicellular 
structures consist of two phenotypic subpopulations, the cap-forming and the stalk-forming subpopulation. 
Recent data demonstrate that the cap-forming subpopulation is composed of cells exhibiting high metabolic 
activity, and that these cells specifically can be killed by antimicrobial agents that interfere with metabolic 
processes such as replication and translation. In contrast, the stalk-forming subpopulation is composed of cells 
exhibiting low metabolic activity and is refractory to the antimicrobial agents that are able to kill the cap-
forming subpopulation. Here we demonstrate that the stalk-forming subpopulation exhibits increased 
susceptibility towards membrane-targeting compounds. In most cases, concentrations equivalent to the minimal 
inhibitory concentration (MIC)-value of a particular membrane-targeting compound were sufficient to induce 
cell death in the stalk-forming subpopulation. In contrast to the stalk-forming subpopulation, the cap-forming 
subpopulation exhibited phenotypic tolerance to membrane-targeting compounds. Our data suggest that the 
cap-forming subpopulation is able to adapt to exposure with membrane-targeting agents involving different 
genetic determinants, dependent on the membrane-targeting compound used. 
 
 
Introduction 
 
      The majority of bacteria on Earth are assumed 
to live in multicellular communities, also referred to 
as biofilms. Occasionally, biofilms are harmful to 
humans as they can be the cause of persistent 
infections (Costerton et al., 1999; Høiby et al., 
2001; Hall-Stoodley, et al., 2004; Hall-Stoodley et 
al., 2006; Parsek and Singh, 2003). These biofilms 
do persist as they are difficult, and in some cases 
impossible, to eradicate by conventional anti-
microbial therapy (Costerton et al., 1999; Fux, et 
al., 2005; Stewart, 2002; Stewart and Costerton, 
2001; Donlan and Costerton, 2002). The reasons 
and mechanisms underlying this phenomenon are 
not completely understood and might vary, 
dependent on intrinsic features of the causative 
bacteria, prevailing environmental conditions and 
the antimicrobial compound used (Mah and 
O’Toole, 2001; Lewis, 2001; Stewart, 2002; 
Drenkard, 2003; Fux et al., 2005). However, 
evidence is increasing that bacteria living in 
biofilms are organized into distinct phenotypic 
subpopulations of cells, and that in fact only certain 
subpopulations are refractory to a particular 
antimicrobial compound, whereas the remaining 
cells exhibit sensitivity (Haagensen, et al., 2007; 
Pamp, et al., submitted; Walters, et al., 2003). 
Therefore, detailed knowledge about the nature and 
intrinsic characteristics of these distinct subpo-
pulations in biofilms might help to understand 
antimicrobial tolerance development in biofilms and 
to develop new treatment strategies to eradicate 
persistent infections. 
      Techniques and molecular tools, such as con-
focal laser scanning microscopy, flow-chamber 
technology, fluorescent ‘tags’ (such as Cfp, Gfp, 
and Yfp) and in situ gene expression greatly 
enhance the possibilities to study, under non-
destructive and hydrodynamic conditions, develop-
mental processes, dynamics and differentiations 
taking place in biofilms. Using combinations of 
these tools, recent studies discovered that clonal 
mature P. aeruginosa mushroom-like structured 
biofilms are composed of at least two confined 
subpopulations of cells, namely a stalk-forming and 
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a cap-forming subpopulation, each exhibiting a 
distinct phenotype, e.g. regarding metabolic/physio-
logical activity, gene expression, and production of 
matrix components (e.g. Allesen-Holm, et al., 2006; 
Klausen, et al., 2003b; Lequette and Greenberg, 
2005; Pamp, et al., submitted). The development of 
this mushroom-like structured biofilm appears to 
depend on a subpopulation of non-motile cells and a 
subpopulation of motile cells (Klausen, et al., 
2003b). In early stages of biofilm development the 
stalk-forming subpopulation is formed by clonal 
proliferation of non-motile cells. Subsequently the 
subpopulation of motile cells climbs up on the stalk-
forming subpopulation to establish as the cap-
forming subpopulation. Factors that facilitate 
cellular migration by the motile subpopulation of 
cells have been identified as flagella, biosurfactants, 
type IV pili and extracellular DNA (Allesen-Holm, 
et al., 2006; Barken, et al. in prep; Klausen, et al., 
2003b; Pamp and Tolker-Nielsen, 2007). Moreover, 
other factors such as quorum sensing, polysac-
charide synthesis, chemotaxis, and nutritional 
conditions, have been found to impact on the 
formation of these two subpopulations in P. aeru-
ginosa biofilms (e.g. Barken, et al., in prep.; 
Jackson, et al., 2004; Klausen, et al., 2003a; 
Matsukawa and Greenberg, 2004; Shrout, et al., 
2006).  
      Recent observations provide evidence, that the 
stalk-forming and cap-forming subpopulations 
exhibit differential susceptibility phenotypes 
towards various antimicrobial agents. Whereas the 
cap-forming subpopulation exhibits sensitivity to 
conventional antimicrobial compounds, such as 
ciprofloxacin, tetracycline, and tobramycin, the 
stalk-forming subpopulation survives these treat-
ments (Henzer et al., 2003; Pamp et al., submitted). 
Interestingly, the opposite is true when P. 
aeruginosa biofilms are exposed to either the 
antimicrobial peptide colistin, the chelator EDTA, 
or the detergent SDS. These three antimicrobial 
compounds kill preferentially the stalk-forming 
subpopulation, whereas the cap-forming subpopu-
lation survives these treatments (Banin, et al., 2006; 
Haagensen, et al., 2007; Pamp, et al., submitted). 
Consequently, combined antimicrobial treatments 
with either ciprofloxacin and colistin, or tetracycline 
and colistin are able to kill almost all cells in a 
mature P. aeruginosa flow-chamber-grown biofilm 
by targeting both subpopulations simultaneously 
(Pamp, et al., submitted).  
      The fact that conventional antimicrobial agents, 
which commonly interfere with general vital 
processes of a cell, such as replication, translation 
and transcription, preferentially kill the meta-
bolically active cells of the cap-forming sub-
population in a P. aeruginosa mature biofilms 
seems to be plausible. However, it is not entirely 
clear why compounds such as colistin, EDTA or 
SDS preferentially kill cells of the stalk-forming 
subpopulation, and why cells of the cap-forming 
subpopulation survive these treatments. Regarding 
colistin treatment recent data provide evidence that 
the metabolically active cells of the cap-forming 
subpopulation are able to develop tolerance to coli-
stin by mechanisms involving LPS-modification, 
mediated by pmrHFIJKLME, and antimicrobial 
efflux, mediated by mexAB-oprM (Haagensen, et 
al., 2007; Pamp, et al., submitted). In contrast, cells 
of the stalk-forming subpopulation are not able to 
develop tolerance to colistin, and are therefore 
killed. Mushroom-like structured biofilms formed 
by P. aeruginosa strains, which have either a defect 
in the pmr-operon or mexAB-oprM, are not able to 
develop a tolerant cap-forming subpopulation, and 
both, the pmr-operon and mexAB-oprM were 
induced in the cap-forming subpopulation upon 
colistin exposure (Haagensen, et al., 2007; Pamp, et 
al., submitted). However, it is unknown whether 
tolerance development to EDTA and SDS also 
require pmr-mediated LPS-modification and mexAB 
-oprM-mediated antimicrobial efflux. Moreover, 
also the factors, which render the cells of the stalk-
forming subpopulation sensitive to EDTA, and SDS 
are unknown by now and these issues will be 
addressed in this study. 
 
 
Materials and Methods 
 
Bacterial strains and growth conditions 
 
P. aeruginosa PAO1 wild type tagged with Gfp 
(Klausen et al., 2003a), P.aeruginosa PAO1 pmrF 
(mutant ID 35399) tagged with Gfp (Haagensen, et 
al., 2007), P. aeruginosa PAO1 ΔmexAB-
oprM::Gmr tagged with Gfp (Pamp, et al., 
submitted), P.aeruginosa PAO1 Δanr (Ye et al., 
1995), P.aeruginosa PAO1 dnr::tetr (Arai et al., 
1995), P.aeruginosa PAO1 narL::catr (Krieger et 
al., 2002), P.aeruginosa CHA ihfA::tetr (Delic-
Attree et al., 1996), P.aeruginosa PAO1 ΔptA:: 
aacC1-gfp (Eschbach et al., 2004), and P.aeru-
ginosa PAO1 ΔptA::aacC1-gfp (Eschbach et al., 
2004) were used in this study. To study the 
expression of the pmr-operon and mexAB-oprM, P. 
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aeruginosa PAO1 strains harbouring the fluorescent 
transcriptional reporter fusions PpmrH-gfp or 
pmexA-gfp were used (Pamp, et al., submitted). For 
batch cultures of P. aeruginosa AB minimal 
medium (Pamp and Tolker-Nielsen, 2007) sup-
plemented with 1 μM FeCl3 and 10 mM glucose 
was used. Where appropriate, antibiotics were used 
for bacterial growth cultures at the following 
concentrations: gentamycin (Biochrome AG, Ger-
many) at 30 μg/ml, streptomycin (Sigma) at 300 
μg/ml, and carbenicillin (Sigma) at 200 μg/ml. 
 
Determination of the Minimal inhibitory con-
centration (MIC) 
 
The Minimal inhibitory concentrations (MIC) for 
colistin (Colimycin, colistin methanesulfonate; 
Lundbeck A/S, Denmark), colistin sulfate (Sigma, 
Germany), EDTA (Ethylenediaminetetraacetic acid 
tetrasodium salt; VWR BDH Prolab, Germany), 
SDS (sodium dodecyl sulfate; Sigma, Germany), 
novispirin G10 (Novozymes A/S, Denmark), and 
chlorhexidine gluconate (Sigma, Germany) was 
determined by macrodilution method on aerobic 
planktonic cultures of P. aeruginosa grown in AB 
minimal medium (Pamp and Tolker-Nielsen, 2007) 
supplemented with 1 μM FeCl3 and 10 mM glucose.  
 
Cultivation of biofilms 
 
Biofilms were cultivated in flow-cells with 
individual channel dimensions of 1 x 4 x 40 mm, 
which were covered with a glass coverslip (Knittel 
Gläser, Germany). The biofilm flow-cell system 
was assembled and prepared as described elsewhere 
(Sternberg and Tolker-Nielsen, 2005). As culti-
vation medium, AB minimal medium sup-
plemented with 0.3 mM glucose as carbon source 
was used (Pamp and Tolker-Nielsen, 2007). 
Individual flow-cells were inoculated with 300 μl 
aliquots of overnight growth cultures of P. 
aeruginosa, adjusted to an optical density of 0.005 
at 500 nm, respectively. Overnight cultures of P. 
aeruginosa were grown in AB minimal medium 
supplemented with 30 mM glucose under vigorous 
shaking at 30ºC. To allow the bacterial cells to 
attach to the substratum, flow-cells were left 
without flow for 1 hour subsequent to inoculation. 
Then a laminar flow with a mean flow velocity of 
0.2 mm/s was achieved using a Watson Marlow 
205S peristaltic pump. The P. aeruginosa strain 
containing plasmid pmexA-gfp was cultivated as 
biofilm without supplementation of carbenicillin, as 
described previously (Pamp, et al., submitted). 
 
Exposure of biofilms to antimicrobial compounds 
 
Biofilms were exposed to the following anti-
microbial compounds where indicated: 25 μg/ml 
colistin, 17 μg/ml EDTA, 0.003% SDS, 20 μg/ml 
novispirin G10, and 0.002% chlorhexidine digluco-
nate. The colistin used here for biofilm treatment 
experiments is colistin methanesulfonate, which is a 
compound undergoing hydrolysis in aqueous solu-
tions to form the active compound colistin sulfate 
(CS) in a time-dependent manner (Bergen, et al., 
2006). On colistin (colistin methanesulfonate) is 
focused in this study, since this is the actual 
compound, which is mainly used in medical settings 
for treatment of infections, in particular for 
treatment of P. aeruginosa lung infections in cystic 
fibrosis patients (Høiby et al., 2005; Littlewood et 
al., 2000; Li et al., 2006). Treatment of biofilms 
with antimicrobial compounds was achieved by 
supplementing biofilm cultivation media with the 
required antimicrobial compounds at the appropriate 
final concentrations and addition of the fluorescent 
dead-cell indicator propidium idodide (Sigma, 
Germany) at a final concentration of 0.3 μM. In 
non-treated control experiments only 0.3 μM propi-
dium iodide was added to the biofilm cultivation 
media. Where indicated, 2.5 μM of the fluorescent 
indicator dye Syto 9 (Molecular Probes) was added 
15 minutes prior to image acquisition, to counter-
stain for live biofilm cells. 
 
Microscopy and image processing 
 
Image acquisition was performed with a Zeiss LSM 
510 confocal laser scanning microscope (Carl Zeiss, 
Germany) equipped with an argon and a NeHe laser 
and detectors and filter sets for simultaneous 
monitoring of Gfp and Syto 9 (excitation, 488 nm; 
emission, 517 nm) and propidium iodide (excitation, 
543 nm; emission, 565 nm). Images were obtained 
using a 40x/1.3 Plan-Neofluar oil objective. 
Simulated multichannel cross-sections were gene-
rated using Imaris software package (Bitplane AG, 
Switzerland). 
 
Results 
 
We recently observed that the stalk-forming 
subpopulation of mushroom-like structured biofilms 
of P. aeruginosa exhibits sensitivity to the 
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antimicrobial peptide colistin, whereas the cap-
forming subpopulation survives the treatment (Fig. 
1A) (Haagensen, et al., 2007; Pamp, et al., 
submitted). In addition it was reported that the 
chelator EDTA and the detergent SDS preferentially 
kill the stalk-forming subpopulation, whereas the 
cap-forming subpopulation survives the treatment 
(Banin, et al., 2006; Haagensen, et al., 2007). To 
verify the susceptibility/tolerance phenotype for 
EDTA and SDS using our experimental setup, we 
exposed 4-day-grown biofilms of P. aeruginosa 
(Gfp) either to 17 μg/ml EDTA or 0.003% SDS and 
followed the effect using confocal laser scanning 
microscopy (CLSM). Both antimicrobial agents 
killed nearly all cells of the stalk-forming 
subpopulation in a similar time-dependent manner 
as colistin (Fig. 1A-C). All cells of the stalk-for-
ming subpopulation were killed within 24 hours of 
exposure and the overall distribution of live and 
dead cells did not change during prolonged 
exposure (data not shown). 
 
The stalk-forming subpopulation of P. aeruginosa 
biofilms can be killed using membrane-targeting 
compounds  
 
The fact that colistin, EDTA, and SDS all 
preferentially kill the stalk-forming subpopulation is 
striking, and we speculated if the killing of this 
particular subpopulation by these, although 
structurally different, compounds might follow a 
common mechanism. We hypothesized that this 
phenoltype could be related to the general mecha-
nisms of action of colistin, EDTA, and SDS, since 
all three compounds are known to disturb the 
integrity of bacterial membranes (Hancock, 1984; 
Hancock and Chapple, 1999; Storm et al., 1977; 
Tamber and Hancock, 2004). To assess if the stalk-
forming subpopulation exhibits sensitivity to 
membrane-targeting compounds in general, or if the 
observed phenotype is specific for colistin, EDTA, 
and SDS, we decided to examine the killing effect 
of two additional compounds, which are known to 
exert their effects on bacterial membranes, namely 
the antimicrobial peptide novispirin G10 and the 
antiseptic chlorhexidine gluconate (Sawai et al., 
2000; Steinstraesser et al., 2002; Vitkov et al., 
2005). If these compounds also kill specifically the 
stalk-forming subpopulation, this would strongly 
support the notion that this cell subpopulation is 
particularly vulnerable to membrane-targeting 
compounds, in contrast to the cap-forming cell 
subpopulation. We exposed 4-day-grown biofilms 
of P. aeruginosa (Gfp) either to 20 μg/ml novispirin 
G10 or 0.002% chlorhexidine gluconate and 
followed the effect using CLSM. Indeed, also these 
two antimicrobial agents killed nearly all cells of the 
stalk-forming subpopulation in a similar time-
dependent manner as colistin, EDTA and SDS (Fig. 
1D and E). All cells of the stalk-forming sub-
population were killed within 24 hours of exposure 
and the overall distribution of live and dead cells did 
not change during prolonged exposure (data not 
shown). The cells of the cap-forming subpopulation, 
which survived the treatment, did not exhibit 
resistance to the antimicrobial agents used, as 
examined by plating of harvested biofilm cells on 
agar containing the particular antimicrobial agent. 
This suggests that the cells of the cap-forming 
subpopulation exhibited phenotypic tolerance to the 
antimicrobial compounds. Altogether, this indicates 
that the stalk-forming subpopulation of cells in P. 
aeruginosa biofilms exhibits sensitivity to 
membrane-targeting antimicrobial compounds, 
whereas the cap-forming subpopulation exhibits 
tolerance. 
 
The stalk-forming subpopulation exhibits sus-
ceptibility to concentrations of membrane-targeting 
compounds, which are equivalent to their respective 
MIC-value  
 
When we examined the effect of novispirin G10 and 
chlorhexidine gluconate on P. aeruginosa we 
recognized that concentrations nearly equivalent to 
the minimal inhibitory concentration (MIC) of the 
particular antimicrobial compound were sufficient to 
induce cell death in the stalk-forming cell sub-
population. The MIC for novispirin G10 was 
determined with 30 μg/ml, whereas only 20 μg/ml 
(0.67xMIC) novispirin G10 were sufficient to kill 
the cells of the stalk-part (Fig. 1D, and Table 1). 
This was surprising, as biofilms are often described 
to be relatively unaffected towards MIC-equivalent 
concentrations of conventional antimicrobial 
compounds. A similar effect was observed for 
chlorhexidine gluconate, as the MIC for this 
antimicrobial compound was 0.0008%, and the 
concentration sufficient to kill almost all cells of the 
biofilm cells in the stalk part was 0.001% (1.25x 
MIC) (Fig. 1E, and Table 1). With respect to SDS, 
accurate MIC-determinations were difficult, as P. 
aeruginosa was able to grow in the presence of 
relatively high concentrations of SDS, which is 
consistent with previous reports (Klebensberger et  
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al., 2006; Klebensberger et al., 2007). We found 
tha t  g rowth  in  the  p resence  o f  SDS was 
significantly inhibited at concentrations of 0.6%, 
whereas only 0.003% SDS (0.005xMIC) were 
required to kill the cells of the stalk-forming 
subpopulations in biofilms (Fig. 1C, and Table 1). A 
concentration of EDTA equivalent to the MIC-value 
for this compound (MICEDTA 0.1 μM) by contrast 
was not sufficient to kill the biofilm cells of the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. Spatio-temporal distribution of live and dead cells in P. aeruginosa biofilms treated with membrane-targeting antimicrobial 
agents. Biofilms of P. aeruginosa PAO1 (Gfp) were grown for 4 days and then continuously exposed to either 25 μg/ml colistin 
(A), 17 mg/ml EDTA (B), 0.003% SDS (C), 20 μg/ml novispirin G10 (D), or 0.001% chlorhexidine gluconate (E) in the presence of 
the dead cell indicator propidium iodide. Confocal laser scanning micrographs were acquired at time point t0 (prior to exposure) and 
4, 9, and 13 hours subsequent to the beginning of treatment. The images show a horizontal section with two flanking images 
representing sections in the xz and yz planes, respectively. Live cells appear green due to constitutive expression of Gfp and dead 
cells appear red, due to staining with the dead cell indicator propidium iodide. Scale bar 40 μm. 
 
 
stalk-part, as 17 mM were required to kill the stalk-
forming subpopulation within the timeframe of the 
experiment. To be able to determine the effect of 
MIC-equivalent concentrations of colistin in killing 
of the stalk-forming subpopulation of biofilm cells 
in a comparable manner, we examined the effect of 
colistin sulfate (CS), as this is the antimicrobial 
active form generated by hydrolysis of the prodrug 
colistin (Bergen, et al., 2006). The MIC for colistin  
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Table 1. Minimal inhibitory concentrations (MIC) and 
concentrations used to induce cell death in the stalk-
forming subpopulation of P. aeruginosa biofilm cells. 
Antimicrobial 
agent 
Minimal 
inhibitory 
concentration 
(MIC) 
Concentration used 
to kill the stalk-
forming biofilm 
cells 
colistin sulfatea 0.8 μg/ml 0.8 μg/ml 
EDTA 0.1 μM 17 mM 
SDS 0.6% 0.003% 
novispirin G10 30 μg/ml 20 μg/ml 
chlorhexidine 
gluconate 0.0008% 0.001% 
aColistin sulfate (also referred to as ‘colistin’ in other studies) 
exhibits antimicrobial activity, and is generated by hydrolysis 
of the prodrug colistin (colistin methanesulfonate) (Bergen et 
al., 2006). 
 
sulfate was 0.8 μg/ml (Table 1), and this 
concentration was also sufficient to kill all cells in 
the stalk within 24 hours of exposure (data not 
shown). If colistin (colistin methanesulfonate) was 
used for MIC determinations, instead of colistin 
sulfate, a slightly higher value (2.5 μg/ml) was 
achieved, most likely because colistin needs to 
undergo hydrolysis into colistin sulfate before 
exerting its antimicrobial activity. Exposure of P. 
aeruginosa biofilms to MIC-equivalent con-
centrations of conventional antimicrobial com-
pounds, such as ciprofloxacin or tetracycline, did 
not induce cell death in any of the biofilm cells 
(data not shown). Altogether the observations 
indicate that for most membrane-targeting com-
pounds used in this study, MIC-equivalent con-
centrations were sufficient to kill the stalk-forming 
biofilm cells of the P. aeruginosa biofilm. How-
ever, the cap-forming subpopulation survived the 
treatment by these compounds. 
 
The pmr-operon is not required for tolerance-
development of the cap-forming subpopulation to 
EDTA 
 
In contrast to the stalk-forming subpopulation, the 
cap-forming subpopulation survives treatment with 
EDTA. Development of tolerance of the cap-
forming cell subpopulation to colistin in P. 
aeruginosa biofilms was recently found to depend 
on the pmr-operon and a link between the pmr-
operon and resistance to the chelator EGTA was 
recently observed for Salmonella (Haagensen, et al., 
2007; Murray, et al., 2007; Pamp et al., submitted). 
EDTA is known to chelate divalent cations such as 
Mg2+, and Mg2+-limitation is known to induce 
expression of the pmr-operon in P. aeruginosa 
(McPhee, et al., 2003). To examine if the pmr-
operon is induced in P. aeruginosa biofilms upon 
EDTA exposure, which might indicate its possible 
involvement in tolerance development to EDTA, we 
exposed 4-day-grown biofilms of P. aeruginosa 
harbouring the fluorescent reporter fusion pmrH-gfp 
to 17 μg/ml EDTA in the presence of the dead cell 
indicator propidium iodide and followed the effect 
using CLSM. An induction of the pmr-operon in the 
cap-part of the biofilm was observed within 4 hours 
of exposure (Fig. 2A). The cells of the stalk-forming 
subpopulation, which did not exhibit an induction of 
the pmr-operon were killed by EDTA subsequently. 
The same phenotype was recently observed in 
biofilms of P. aeruginosa pmrH-gfp when exposed 
to colistin (Pamp et al., submitted). As biofilms 
formed by pmr-mutants of P. aeruginosa are not 
able to develop a colistin tolerant subpopulation 
(Haagensen, et al., 2007; Pamp, et al., submitted), 
we examined sensitivity of a pmrF-mutant to 
EDTA. Surprisingly, the pmrF-mutant did not 
exhibited increased sensitivity to EDTA, instead this 
strain exhibited wild type phenotype (Fig. 2B and 
Fig. 1B). Also a biofilm formed by a pmrB-mutant 
exhibited wild type phenotype when exposed to 
EDTA (data not shown). This indicates, that 
although EDTA can induce expression of the pmr-
operon in the cap-forming subpopulation, induction 
of this LPS-modification system does not confer 
tolerance of the cap-forming subpopulation to 
EDTA. 
 
The pmr-operon is not required for tolerance 
development of the cap-forming subpopulation to 
SDS 
 
To investigate if the pmr-operon is induced in the 
cap-forming subpopulation upon exposure to the 
detergent SDS, we exposed 4-day-grown biofilms of 
P. aeruginosa pmrH-gfp to 0.003% SDS in the 
presence of propidium iodide and followed the ef-
fect by CLSM. As can be seen in Fig. 3A, the pmr-
operon is not induced upon exposure of the biofilm 
to SDS. Cells of the stalk-forming subpopulation are 
killed by SDS-treatment, and the surviving cells of 
the cap-forming subpopulation can be visualized 
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with the fluorescent stain Syto 9. According to this, 
a pmr-mutant should not exhibit an increased 
sensitivity to SDS in biofilms compared to the wild 
type. Indeed, when we exposed a 4-day-grown 
biofilm formed by P. aeruginosa pmrF to 0.003% 
SDS the same phenotype was observed as for the 
wild type, namely sensitivity of the stalk-forming 
subpopulation to SDS and tolerance of the cap-
forming subpopulation (Fig. 3B and 1C). 
Furthermore, a biofilm formed by a pmrB-mutant 
did not exhibit increased sensitivity to SDS than the 
wild type (data not shown). This indicates that the 
pmr-operon is not involved in tolerance develop-
ment of the cap-forming subpopulation to SDS. 
 
Discussion 
 
Biofilms are said to be inherently refractory towards 
antimicrobial attack and therefore might contribute 
to the persistence of infections. Recent observations 
on P. aeruginosa biofilms indicate that these 
multicellular structures consist of two distinct 
phenotypic subpopulations and that in fact only one 
of these subpopulations is refractory towards a 
particular antimicrobial agent, whereas the other 
subpopulation exhibits susceptibility to the same 
agent (e.g. Haagensen et al., 2007; Pamp et al., 
submitted). Therefore detailed knowledge about the 
characteristic traits of these distinct subpopulations 
and the mechanisms involved in tolerance develop-
ment to antimicrobial agents in biofilms might help 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The pmr-operon is expressed upon EDTA exposure but not required for tolerance development to EDTA in P. aeruginosa 
biofilms. Biofilms of P. aeruginosa PAO1 Tn7-PpmrH-gfp (A) and P. aeruginosa PAO1 pmrF (Gfp) (B) were grown for 4 days and 
then continuously exposed to 17 μg/ml EDTA. Confocal laser scanning micrographs were acquired at time point t0 (prior to 
exposure) and 4, 9, and 13 hours subsequent to the beginning of treatment. The images represent vertical sections of biofilms, 
respectively. Live cells appear green due to inducing expression of the pmr-operon (A) or constitutively expression of Gfp (B) and 
dead cells appear red, due to staining with the dead cell indicator propidium iodide. Scale bar 40 μm. 
 
 to unravel the role of the bacterial biofilm mode of 
life in relation to the persistence of infectious 
diseases. 
     Recent studies observed that when P. aeruginosa 
mushroom-like structured biofilms are exposed 
either to colistin, EDTA, or SDS, the stalk-forming 
cell subpopulation is killed, whereas the cap-
forming cell subpopulation survives the treatment. 
Here we show that the same spatial distribution of 
live and dead cells can be observed when P. 
aeruginosa mushroom-like structured biofilms are 
exposed to the antimicrobial peptide novispirin G10 
or the antiseptic chlorhexidine gluconate. We 
conclude that the observed susceptibility/tolerance 
phenotype might be related to the mechanism of 
action of these antimicrobial compounds, as all 
compounds exert their effects on interference with 
the function of bacterial membranes. Interestingly, it 
appears as that relatively low concentrations of the 
respective antimicrobial agents, similar to their 
MIC-value, are sufficient to induce cell death in the 
stalk-forming subpopulation of biofilm cells. Only 
MIC-equivalent concentrations of EDTA are not 
able to induce cell death in the stalk-forming 
subpopulation. The reason might be in difficulties in 
determination of a precise MIC-value for EDTA, as 
EDTA is likely to chelate the iron ions in the growth 
medium, and as iron is essential for growth, P. 
aeruginosa might therefore not be able to grow in 
the presence of the amounts of EDTA used. 
Nevertheless, the fact that relatively low concentra- 
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tions of colistin sulfate, SDS, novispirin and 
chlorhexidine gluconate are able to kill the stalk-
forming subpopulation of cells suggests that these 
biofilm cells are particularly sensitive to membrane 
targeting antimicrobial agents. This is supported by 
the finding that in comparison to the stalk-forming 
biofilm cells, MIC-equivalent concentrations of e.g. 
colistin sulfate are not able to reduce the number of 
cells in exponential or stationary phase planktonic 
cell populations (data not shown).  
      Our recent study, aimed at understanding 
tolerance-development to colistin in P. aeruginosa 
biofilms, provides evidence that the prevailing 
metabolic/ physiological state of the two biofilm 
cell-subpopulations impact on the spatial dis-
tribution of live and dead cells upon exposure with 
various antimicrobial compounds (Pamp et al., 
submitted). The cells of the cap-forming sub-
population exhibited high metabolic activity and 
were able to develop tolerance to colistin, whereas 
the cells of the stalk-forming subpopulation 
exhibiting low metabolic activity were not able to 
develop tolerance, and hence were killed by colistin 
(Pamp et al., submitted). This could suggest that the 
growth state of P. aeruginosa cells per se might 
impact on antimicrobial susceptibility and ability to 
develop tolerance to colistin and other membrane-
targeting compounds. However, experiments aimed  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. The pmr-operon is not required for tolerance development to SDS in P. aeruginosa biofilms. Biofilms of P. aeruginosa 
PAO1 Tn7-PpmrH-gfp (A) and P. aeruginosa PAO1 pmrF (Gfp) (B) were grown for 4 days and then continuously exposed to 
0.0003% SDS. Confocal laser scanning micrographs were acquired at time point t0 (prior to exposure) and 4, 9, and 13 hours 
subsequent to the beginning of treatment. The images represent vertical sections of biofilms, respectively. Live cells appear green 
due to staining with the fuorescent dye Syto 9 (A) or constitutively expression of Gfp (B) and dead cells appear red, due to staining 
with the dead cell indicator propidium iodide. Scale bar 40 μm. 
 
 at examining the role of the bacterial growth activity 
on susceptibility to membrane targeting compounds, 
by involving exponential and stationary phase 
planktonic cell populations, could not support this 
hypothesis, as no difference in the killing-rate 
between the two planktonic cell populations was 
observed (data not shown). Alternatively, factors 
related to anaerobic conditions, but independent of 
the actual growth rate, might impact on the 
increased sensitivity of the stalk-forming sub-
population to the membrane-targeting com-pounds. 
Although so far, no direct measurements have been 
undertaken for the flow-chamber system used here, 
that demonstrate that anaerobic conditions are 
prevailing in the stalk of the mushroom-like struc-
ture, it is strongly assumed that the concentration of 
dissolved oxygen is low in these areas of the 
biofilm. Oxygen profiles have been measured in a 
similar flow-chamber system and provided evidence 
that oxygen is limited in the deeper areas of the 
multicellular structures (DeBeer et al., 1994). 
Moreover, induction of nirS gene expression 
(required for anaerobic respiratory metabolism) in 
the cells situated in the deeper layers of the 
multicellular structures, and the presence of reactive 
nitrogen intermediates (resulting as by-products of 
anaerobic respiratory metabolism) indicate that low 
oxygen conditions are prevailing in the deeper areas 
of P. aeruginosa flow-chamber-grown biofilms 
  8
(Barraud et al., 2006). To investigate the possible 
role of anaerobic meta-bolism in susceptibility of 
the stalk-forming subpopulation towards mem-
brane-targeting com-pounds, we tested various P. 
aeruginosa mutant-strains, affected to different 
degrees in anaerobic metabolism, in their sensitivity 
to colistin when grown as biofilms. However, all 
tested mutants (anr-, dnr-, narL-, pta-, ldh-, and 
ihfA-mutant) exhibited wild type phenotype with 
respect to susceptibility to colistin in biofilms, 
namely a colistin-sensitive subpopulation close to 
the sub-stratum, and a colistin tolerant sub-
population on top (data not shown). Another 
possibility, that could explain the sensitivity of the 
stalk-forming cell subpopulation to membrane-
targeting compounds, might be that the target of 
stalk-forming biofilm cells differs from the target of 
cap-forming biofilm cells. One hypothesis might be 
that the composition of the membrane of biofilm 
cells, which are localized in the deeper layers of the 
biofilm, differs from the composition of the 
membrane of biofilm cells situated in the upper 
layers of the biofilm. Although so far no distinct 
cell subpopulation in biofilms has been assigned to 
exhibit compositional changes in lipopolysaccharide 
(LPS), evidence has been provided that the 
composition of LPS of biofilm-grown cells differs 
from the LPS composition of planktonic-grown 
cells (Beveridge et al., 1997; Hunter and Beveridge, 
2005). It appears that the relative abundance of A-
band and B-band O-antigen varies between these 
two cell populations, as most notably the amount of 
B-band LPS is reduced in biofilm-grown cells 
compared to planktonic-grown cells, resulting in 
changes of the overall cell surface hydrophobicity 
(Beveridge et al., 1997; Hunter and Beveridge, 
2005). Alternatively, also the relative abundance or 
com-position of the membrane protein fraction (e.g. 
efflux pumps, porins) in cells of the stalk-forming 
subpopulation might differ from cells of the cap-
forming subpopulation, and impact on differential 
uptake or efflux rates of antimicrobial compounds. 
Investigations are currently ongoing in our 
laboratory to investigate these issues in relation to 
the susceptibility phenotype of the stalk-forming 
cell subpopulation to membrane-targeting com-
pounds. 
      In contrast to the stalk-forming cell sub-
population, the cap-forming cell subpopulation, 
exhibits tolerance to the membrane targeting 
compounds colistin, EDTA, SDS, novispirin G10, 
and chlorhexidine gluconate. In a recent report we 
provide evidence that the metabolic active cells of 
the cap-forming subpopulation are able to develop 
tolerance to colistin via pmr-mediated LPS-
modification and mexAB-oprM-mediated antimicro-
bial efflux. It is obvious to assume that pmr-
mediated LPS modification and/or antimicrobial 
efflux mediated by the mexAB-oprM-genes are 
likely candidates that might also be involved in 
adaptation to other membrane targeting compounds. 
However, our initial experiments aimed at exa-
mining the role of the pmr-operon and mexAB-oprM 
in tolerance development to these compounds 
indicated that differential adaptation mechanisms to 
the single membrane targeting compounds exist. 
Although the pmr-opron is induced in the cap-
forming subpopulation of cells upon EDTA-expo-
sure, it is not involved in tolerance development to 
this compound, as pmr-mutants do not exhibit 
increased sensitivity to EDTA. Also mexAB-oprM-
mediated antimicrobial efflux is not involved in 
tolerance development to EDTA, as a mexAB-oprM-
mutant does not exhibit increased sensitivity to 
EDTA, and mexA-expression is also not induced 
upon EDTA exposure (data not shown). This 
suggests, that other determinants must be involved 
in tolerance development to EDTA. The fact that 
induction of cell death in the stalk-forming 
subpopulation by EDTA could be inhibited by the 
addition of Mg2+, Ca2+, or Fe3+ ions (Banin et al., 
2006), could suggest that possible prevailing 
amounts of ions in the cap-part might facilitate some 
protection of the cap-forming cell subpopulation 
against EDTA-treatment. However, other deter-
minants are likely to play role as well. Our data 
concerning the role of the pmr-operon in tolerance 
development of the cap-forming subpopulation to 
SDS exposure indicate that this LPS-modification 
system is not involved in tolerance development. A 
recent study demonstrates that expression of the 
mexAB-oprM-genes from P. aeruginosa in a hetero-
logous system confers resistance to a variety of 
antimicrobial compounds to that strain, among those 
also SDS (Srikumar et al., 1998). This suggest that 
tolerance development to SDS might be facilitated 
by mexAB-oprM-mediated antimicrobial efflux. An 
initial experiment, involving the mexAB-oprM-
mutant strain P. aeruginosa PAO200, showed that a 
biofilm formed by this strain exhibited an increased 
sensitivity to SDS during long-term exposure (~30 
hours), suggesting that mexAB-oprM-mediated 
efflux might confer some protection towards SDS 
(data not shown). A recent study aimed at 
investigating growth of P. aeruginosa in the 
presence of SDS in liquid culture provides data that 
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suggest that SDS-induced cell-aggregation, faci-
litated by c-di-GMP-signaling and production of the 
polysaccharide PSL, confers a survival advantage 
towards this detergent (Klebensberger et al., 2007). 
Therefore PSL might also be able to confer 
protection to SDS in P. aeruginosa flow-chamber-
grown biofilms. However, to address this issue, a 
more sophisticated experimental setup is required, 
as psl-mutants are defective in biofilm formation 
(Jackson et al., 2004; Ma et al., 2006; Matsukawa 
and Greenberg, 2004), and therefore a proper 
comparison directly between wild type and psl-
mutant SDS-treated biofilms is not possible. So far, 
nothing is known about possible genetic 
determinants and mechanisms that are involved in 
tolerance development of the cap-forming cell 
subpopulation towards the antimicrobial peptide 
novispirin G10 or the antiseptic chlorhexidine 
gluconate. Preliminary observations indicate that 
the pmr-LPS-modification system might be 
involved in tolerance development to novispirin 
G10, as pmr-expression was induced in the cap-
forming subpopulation of cells upon novispirin G10 
exposure, and a biofilm formed by a pmr-mutant 
exhibited increased sensitivity to this compound. 
However, this observation needs to be verified. 
With respect to tolerance development towards 
chlorhexidine gluconate, a recent study demon-
strates that expression of mexCD-oprJ is induced 
upon exposure to chlorhexidine gluconate (Morita 
et al., 2003). Therefore antimicrobial efflux of 
chlorhexidine gluconate might be an adaptation 
strategy that could apply under conditions when P. 
aeruginosa biofilms are exposed to this anti-
microbial agent. 
      Together the results and preliminary obser-
vations described here suggest that the confined 
stalk-forming subpopulation exhibits increased 
sensitivity towards the membrane-targeting com-
pounds colistin, EDTA, SDS, novispirin G10, and 
chlorhexidine gluconate. We hypothesize that also 
other membrane-targeting compounds might speci-
fically kill cells in this area of the biofilm. The 
mechanism(s) underlying the increased suscepti- 
bility of this cell-subpopulation is unclear at present 
and will be addressed as part of our ongoing 
investigations. In contrast to the stalk-forming 
subpopulation the cap-forming subpopulation exhi-
bits tolerance to the membrane-targeting com-
pounds used here. Our data indicate, that pmr-
mediated LPS-modification and mexAB-oprM-
mediated anti-microbial efflux might confer 
tolerance to some, but not all, membrane targeting 
compounds in P. aeruginosa biofilms. Other 
determinants are obviously involved and the 
identification of these determinants is part of our 
present research. 
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